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1.1. Cyclophanes and Shape-Persistent Macrocycles 
The term cyclophane is a restrained form obtained from “cyclophenylene alkane” and was 
used initially for compounds with two para-phenylene units disposed in a face to face 
orientation and connected by aliphatic chains. Vögtle and Neumann developed this concept 
and introduced the name phane, which describes compounds with at least one aromatic 
ring bridged by at least one aliphatic n-membered bridge (n  1).1 Recently, more complex 
rules were introduced by IUPAC:2 cyclophanes are considered cyclic compounds, bearing 
the highest possible number of non-cumulative double bonds (mancude-ring systems, such 
as benzene, indene, indole) and saturated or non-saturated chains, with or without 
heteroatoms, forming with the aromatic component(s), a macrocyclic system. 
Cyclophanes are attractive synthetic targets due to their interesting chemical, 
physicochemical and biological properties.3 The origin of cyclophane chemistry can be 
related to the synthesis of [2,2]metacyclophane 1.1 by Pellegrin in 1899 (Figure 1.1),4 but 
the real development of cyclophane chemistry began half a century later, with the synthesis 
of [2,2]paracyclophane 1.2 reported independently by Cram and Steinberg5 and by Brown 
and Farthing.6 
 
Figure 1.1. Structure of [2,2]metacyclophane 1.14 and [2,2]paracyclophane 1.2.5,6 
                                                 
1 Vögtle, F.; Neumann, P. Tetrahedron Lett. 1970, 11, 115. 
2 IUPAC. Compendium of Chemical Terminology, 2nd ed. (the "Gold Book"). Compiled by A. D. McNaught 
and A. Wilkinson. Blackwell Scientific Publications, Oxford (1997). XML online corrected version: 
http://goldbook.iupac.org (2006-) created by M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. 
3 a) Diederich, F. Cyclophanes; Royal Society of Chemistry: Cambridge, UK, 1991. b) Vögtle F. Cyclophane 
Chemistry, Wiley, New York, 1993. c) Bodwell, G. J.; Satou, T. Angew. Chem. Int. Ed. 2002, 41, 4003. d) 
Gleiter, R.; Henning, H. Modern Cyclophane Chemistry, Wiley-VCH; Weinheim, 2006. e) Ramaiah, D.; 
Neelakandan, P. P.; Nair, A. K.; Avirah, R. R. Chem. Soc. Rev. 2010, 39, 4158. f) Cragg, P. J.; Sharma, K. 
Chem. Soc. Rev. 2012, 41, 597. 
4 Pellegrin, M. M. Rec. Tray. Chim. 1899, 18, 457. 
5 Cram, D. J.; Steinberg, H. J. Am. Chem. Soc. 1951, 73, 5691. 
6 Brown, C. J.; Farthing, A. C. Nature (London), 1949, 164, 915. 
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When considering compounds composed of aromatic units linked by unsaturated bridges, 
the distinction between a cyclophane and a dehydrobenzannulene (DBA) can become 
unclear, or even disappear entirely. A basic criterion for distinguishing these two classes of 
compounds is that DBA has only 1,2-disubstituted aromatic units, such as bisDBA 1.3, 
(Figure 1.2a),7 whereas cyclophane has at least one non-1,2-disubstituted aromatic unit, 
like as seen for cyclophane 1.4 (Figure 1.2b).8 
Figure 1.2. a) Dehydrobenzaannulene, bisDBA 1.3.7 b) Cyclophane 1.4.8 
In contrast to their open-chain analogues and conformationally flexible macrocycles, 
shape-persistent macrocycles (SPMs) have often a regular repeating unit with few degrees 
of conformational freedom creating a defined interior well separated from the exterior.9 
SPMs allow the incorporation of functional side groups at defined positions which strongly 
influence the properties and applications of these compounds. 
The design, synthesis, and study of the properties of SPMs structures with novel and 
interesting shapes remains a challenge despite the efforts made during the last two decades. 
In this sense, acetylenic building blocks have played a crucial role in the construction of 
SPMs, and, more recently, the development of modern metal-catalyzed coupling reactions 
to form sp–sp2 and sp–sp carbon–carbon bond has significantly advanced this field.  
                                                 
7 Kehoe, J. M.; Kiley, J. H.; English, J. J.; Jonhson, C. A.; Petersen, R. C.; Haley, M. M. Org. Lett. 2000, 2, 
969. 
8 Odashima, K.; Itai, A.; Itaka, Y.; Koga, K. J. Am. Chem. Soc. 1980, 102, 2504. 
9 Höger, S. Chem. Eur. J. 2004, 10, 1230. 
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1.2. Acetylenic Coupling 
In 1869, Carl Glaser reported the formation of 1,3-butadiyne from the oxidative 
homocoupling reaction of phenylacetylene in the presence of a solution of ammonia and 
copper(I) chloride in ethanol (Scheme 1.1).10 
 
Scheme 1.1. The first acetylenic coupling described by Glaser.10 
The method became widely applied due to the finding that the copper(I) derivative, often 
characterized by poor crystallizability and a tendency to explode in the dry state, could be 
obtained in situ. 
A step forward in the development of the oxidative acetylenic coupling was the copper(II) 
salt oxidation in methanolic pyridine introduced by Eglinton and Galbraith in 1956 
(Scheme 1.2).11 
 
Scheme 1.2. Acetylenic coupling describe by Eglinton and Galbraith.11 
Another important modification was reported in 1960 by Hay, who performed oxidative 
acetylenic couplings with oxygen in the presence of copper(I) chloride and catalytic 
amounts of the bidentate ligand N,N,N',N'-tetramethylethylenediamine (TMEDA) (Scheme 
1.3).12 
 
Scheme 1.3. Hay coupling method.12 
The Glaser reaction and related methods normally give unsatisfactory results for 
unsymmetrical couplings because of the simultaneous and rather predominant formation of 
symmetrical products. A solution to this problem was reported by Chodkiewicz and Cadiot 
                                                 
10 a) Glaser, C. Ber. Dtsch. Chem. Ges. 1869, 2, 422. b) Glaser, C. Ann. Chem. Pharm. 1870, 154, 137. 
11 Eglinton, G.; Galbraith, A. R. Chem. Ind. (London) 1956, 737. 
12 a) Hay, A. S. J. Org. Chem. 1960, 25, 1275; b) Hay, A. S. J. Org. Chem. 1962, 27, 3320. 
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in 1955, involving a terminal alkyne and 1-bromoacetylene in the presence of an amine 
and catalytic amounts of copper(I) salt (Scheme 1.4).13  
 
Scheme 1.4. Cadiot-Chodkiewicz heterocoupling conditions.13 
This method has been extensively used to synthesize a wide range of diacetylenic 
compounds and the influence of base and the reagent, as well as solvent, time and 
temperature on the reaction has been investigated in great detail.14 
The mechanism of the Glaser coupling and related methods is rather complex and is not 
fully understood. Studies revealed that the mechanism is highly dependent on the 
experimental conditions. The first proposed mechanism suggested radical intermediates 
that have now been rejected. Since then, one widely accepted mechanism involves the 
formation of a dimeric copper(II)acetylide complex that undergoes coupling of the alkynyl 
fragments to afford the diyne product (Scheme 1.5).15 
 
Scheme 1.5. The proposed mechanism for Glaser homocoupling and related method.15 
Oxidative coupling reactions are usually the method of choice for the construction of 
macrocyclic oligoacetylenes containing buta-1,3-diynyl fragments, 16  all based on 
                                                 
13 a) Chodkiewicz, W.; Cadiot, P. C. R. Hebd. Seances Acad. Sci. 1955, 241, 1055. b) Chodkiewicz, W. Ann. 
Chim. (Paris) 1957, 2, 819. 
14 a) Eglinton, G.; McCrae, W. Adv. Org. Chem. 1963, 4, 225. b) Rutledge, T. F. Acetylenic Compounds, 
Reinhold, New York, 1968, chap. 6, pp. 245. c) Cadiot, P.; Chodkiewicz, W. in Chemistry of Acetylenes 
Viehe, H. G, Eds.; Dekker, New York, 1969, chap. 9, pp. 597. 
15 a) Fomina, L.; Vazquez, B.; Tkatchouk, E.; Fomine, S. Tetrahedron 2002, 58, 6741. b) Kürti. L.; CzaKó, 
B. Strategic Application of Named Reaction in Organic Synthesis, Elsevier Academic Press: Burlington, 
M.A. 2005. c) Wendlant, A. E.; Suess, A. M.; Stahl, S. S. Angew. Chem. Int. Ed. 2011, 50, 11062. 
16 a) Höger, S. J. Polym. Sci. Part A: Polym. Chem. 1999, 37, 2685. b) Siemsen, P.; Livingston, R. C; 
Diederich, F. Angew. Chem. Int. Ed. 2000, 39, 2632. c) Stefani, H. A.; Guarezemini, A. S.; Cella, R. 
Tetrahedron 2010, 66, 7871. 
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adaptations of the Glaser original report. Conditions by Hay (CuCl, TMEDA, O2, 
CH2Cl2),
12 Eglinton (CuSO4, or Cu(OAc)2, pyridine)
11 and Breslow (CuCl, CuCl2, oxygen-
free pyridine)17 are the most commonly employed. More recently, the use of Pd(II) as 
cocatalyst in the presence of Cu(I) and O2 (or an external oxidant such as chloroacetone or 
I2) has emerged as an alternative for the traditional Cu(I)/Cu(II) homocoupling-based 
methods.18 
There are no real agreements as how to predict which homocoupling protocol may be the 
most suitable for a particular target, although reagent solubility, for example, has been 
shown to dictate the success of one method over another.19 
1.3. Strategies for Macrocyclic Synthesis 
Shape-persistent macrocycles can be synthesized by two different approaches, kinetic or 
thermodynamic. Reactions that are kinetically controlled are irreversible reactions and 
therefore, undesired bond formations cannot be corrected. On the other hand, 
thermodynamically controlled reactions are reversible reactions and show self-healing 
behavior and, moreover, can give high yields of specific structures under specific 
conditions.20 
1.3.1 Kinetic Approach 
Strategies employed in macrocycle synthesis can be classified into four major types: a) 
one-step cyclooligomerization, b) intramolecular ring closure of bisfunctionalized 
oligomers, c) intermolecular coupling between two or more ring fragments followed by 
unimolecular cyclization, d) template cyclization of two or more fragments (Figure 1.3). 
                                                 
17 O’Krongly, D.; Denmeade, S. R.; Chiang, M. Y.; Breslow, R. J. Am. Chem. Soc. 1985, 107, 5544. 
18 Rossi, R.; Carpita, A.; Bigelli, C. Tetrahedron Lett. 1985, 26, 523. 
19 Diederich, F.; Stang, P. J.; Tykwinski, R. R. Modern Supramolecular Chemistry, Wiley-VCH, Weinheim, 
2008. 
20 a) Zhao, D.; Moore, J. S. Chem. Commun. 2003, 807. b) Zhang, W.; Moore, J. S. Angew. Chem. Int. Ed. 
2006, 45, 4416. 
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Figure 1.3. Different strategies in macrocycle synthesis: a) One-step cyclooligomerization, b) intramolecular 
ring closure of bisfunctionalized oligomers, c) intermolecular coupling between two or more ring fragments 
followed by unimolecular cyclization, d) template cyclization of two or more fragments.20 
All these strategies are kinetically controlled reactions and, as mentioned above, undesired 
bond formations cannot be corrected due to the irreversible nature of the reaction. One 
solution to this problem is employing high-dilution conditions to increase the yield of 
cyclic products over linear oligomers. This method was first formulated and applied by 
Ruggli21 in 1912, and it is based on the following factors: cyclization is an intramolecular 
reaction occurring between the two ends of a precursor and depends on the probability of 
them finding each other and, is in competition with an intermolecular reaction which gives 
linear oligomers. The intramolecular ring closure is a first order reaction; its rate is 
proportional to the concentration of the precursor. The intermolecular process is a second 
order reaction, and its rate is, therefore, proportional to the square of the concentration. 
Consequently, high dilution should favor the intramolecular ring closure reaction. 
Nevertheless, there is no case known in which linear growth was completely suppressed. 
High-dilution conditions require a large amount of solvent (high dilution generally means a 
reactant concentration of about 1 mM). Therefore, it is common to use pseudohigh-dilution 
conditions (the term influxion procedure is also used), in which the reactants are added 
slowly, over a period of hours or days, to the reaction. 
a) Cyclooligomerization 
One of the simplest routes to the synthesis of acetylenic SPMs is the one-step approach, in 
which a suitable precursor is subjected to conditions causing cyclooligomerization. For 
example, Pan and coworkers synthesized trimeric macrocycle 1.5 in one step in the ionic 
liquid 1-butyl-3-methylimidazolium tetrafluoroborate (BMIMF4) through a Sonogashira 
cross-coupling reaction (Scheme 1.6).22 
                                                 
21 Ruggli, P. Liebigs Ann. Chem. 1912, 392, 92. 
22 Li, Y.; Zhang, J.; Wang, W.; Miao, Q.; She, X.; Pan, X. J. Org. Chem. 2005, 70, 3285. 
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Scheme 1.6. Synthesis in one step of the trimeric macrocycle 1.5.22 
Another example of cyclooligomerization is the reported by Iyoda and coworkers to form 
selectively the cyclic trimer 1.6 based on the combination of a linear acetylene linker and a 
diiodobenzene corner building block (Scheme 1.7).23 
Scheme 1.7. Synthesis of macrocycle 1.6 by ciclooligomerization.23 
The great advantage of this one-step procedure is obvious: the starting materials are easy to 
obtain and the target molecule is generated in a single step. However, the yield of this kind 
of reactions is inevitably low due to the competition of the desired cyclic structure with the 
broad, statistical distribution of products, including a large collection of linear/cyclic 
oligomers and polymers of different chain lengths. Moreover, the separation and 
purification of the target macrocycle is difficult in the presence of large quantities of 
byproducts with similar structures.  
Alternative synthetic approaches, such as intramolecular ring closure of difunctionalized 
oligomers, were developed to improve the yield of the synthesis, to simplify purification 
process, and to produce site-specifically functionalized structures. 
b) Intramolecular Ring Closure of Bisfunctionalized Oligomers 
To achieve more precise control over a cyclization process, it is often desirable to reduce 
the cyclization to a single, intramolecular bond-forming reaction. This approach requires 
                                                 
23 Iyoda, M.; Vorasingha, A.; Kuwatani, Y.; Yoshida, M. Tetrahedron Lett. 1998, 39, 4701. 
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the stepwise assembly of an acyclic oligomer, the synthesis of which can be tedious and 
time-consuming relative to a one-pot cyclooligomerization. However, the intramolecular 
nature of the cyclization guarantees high selectivity towards the formation of a single 
cyclic product, so that purification is greatly simplified and the yield of the final product is 
significantly improved. Moreover, this stepwise synthesis allows the introduction of 
functional groups at defined positions of the oligomeric sequence. Thus, the position of 
various side-chain functionalities can be precisely controlled according to the design 
requirements. Another advantage of this kind of reaction is the adaptability to a wide 
variety of coupling procedures, and thus to macrocycles with diverse backbone structures. 
For instance, Moore and coworkers performed the synthesis of the macrocycle 1.7 by an 
intramolecular ring closure of α-iodo--ethynylfunctionalized m-phenyleneethynylene 
oligomer 1.8 (Scheme 1.8).24  
Scheme 1.8. Synthesis of macrocycle 1.7 by an intramolecular ring closure.24 
A series of Sonogashira cross-couplings reactions alternating with selective deprotection 
steps were first used to prepare the oligomer 1.8. Cyclization was then accomplished by 
using Sonogashira coupling under pseudohigh-dilution conditions and macrocycle 1.7 was 
obtained in high yield. 
 
 
                                                 
24 Zhang, J.; Pesak, D. J.; Ludwick, J. L.; Moore, J. S. J. Am. Chem. Soc. 1994, 116, 4227. 
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c) Intermolecular Coupling between Two or More Ring Fragments Followed 
by Unimolecular Cyclization 
Although the intramolecular ring-closure strategy provides the greatest versatility for 
structural control along with good cyclization yields, the labor-intensive and time-
consuming synthesis and purification of the precursors impede the efficient, large-scale 
preparation of macrocycles by these routes. An alternative strategy is the intermolecular 
coupling between two or more ring fragments with appropriate chain length and suitable 
terminal functionalities, followed by unimolecular cyclization.  
One example of this kind of reaction was carried out by Baxter, where a Sonogashira 
reaction between 1.9 and 2 equivalents of 1.10 followed by desilylation of 1.11 provided 
the oligomer 1.12. Eglinton–Galbraith ethyne-coupling of this oligomer under moderate 
dilution conditions with an excess of Cu2(OAc)4 gave macrocycle 1.13 in 46% yield 
(Scheme 1.9).25 
 
Scheme 1.9. Synthesis of macrocycle 1.13 by an intermolecular coupling.25 
In the intermolecular approach, the starting materials can typically be prepared in relatively 
few steps, but the probability of forming numerous cyclooligomeric macrocycles is high. 
Unfortunately, this fact reduces the yield of the desired product and can make purification 
of the target molecule very difficult. However, the overall yield is often higher because 
fewer synthetic steps are used to synthesize the precursors, thus making this procedure 
more time efficient. 
                                                 
25 Baxter, P. N. W. J. Org. Chem. 2004, 69, 1813. 
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d) Templated cyclization of two or more fragments. 
An attractive way to overcome the problem described above is the use of templates. 
Anderson and Sanders were the first to use the template methodology26  to synthesize 
shape-persistent macrocycles following the pioneering work of Busch and coworkers about 
the study of different modes of templating.27 As a first attempt bisacetylene 1.14 was 
cycled under oxidative conditions and a mixture of macrocycles of different size was 
obtained. However, when cyclization was performed in the presence of an appropriate 
template, such as 4,4’-bipyridyl or terpyridyl, the cyclic dimer 1.15 or cyclic trimer 1.16 
were selectively obtained in 70% and 50% yields respectively (Scheme 1.10).26a 
Scheme 1.10. Selective synthesis of macrocycles 1.15 and 1.16 using different templates.26a 
                                                 
26 a) Anderson, H. L.; Sanders, J. K. M. Angew. Chem. Int. Ed. 1990, 29, 1400. b) McCallien, D. W. J.; 
Sanders, J. K. M. J. Am. Chem. Soc. 1995, 117, 6611. 
27 Thompson, M. C.; Busch, D. H. J. Am. Chem. Soc. 1964, 86, 213. 
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An arrangement of 1.14 around the template is suggested to be the reason for the kinetic 
selectivity in these reactions.28 
A distinction between a template and a reagent is that a template participates in the 
macroscopic geometry of the reaction rather than in the intrinsic chemistry. Template 
provides instructions for the formation of a single product from a substrate or substrates 
which otherwise have the potential to assemble and react in several different ways. 
Changing the template should result in a different substrate assembly and, consequently, a 
different product.29 
1.3.2 Thermodynamic Approach 
The synthesis of cyclic structures under kinetic control has the great disadvantage, as 
mentioned before, of the formation of higher oligomers (overshooting) that lowers the 
yield of the desired product. A solution to this problem can be the thermodynamic 
approach, where, if the desired structure is the most stable under the given conditions and 
the cyclization reaction is reversible, one might be able to obtain a single macrocyclic 
product in quantitative yield. 
Examples of reactions under thermodynamic control are the non-covalent metal 
coordination interactions to prepare shape-persistent metal-linked macrocycles,30 as well as 
the use of dynamic covalent chemistry (DCC)31 (imine metathesis,32 alkyne metathesis33) 
to provide SPMs in high yield. 
Zhang and Moore described the synthesis of arylene-ethylene macrocycles taking 
advantage of the reversibility of alkyne metathesis (Scheme 1.11). 34  Reaction in the 
multigram scale of bisacetylene 1.17 with the highly active Mo(VI) alkylidyne catalyst 
employing the precipitation–driven strategy, i.e., precipitation of the insoluble byproduct 
that serves as the driving force to shift the metathesis equilibrium, afforded the macrocycle 
1.18 in 84% yield.  
                                                 
28 Anderson, S.; Anderson, H. L.; Sanders, J. K. M. J. Chem. Soc. Perkin Trans 1 1995, 2255. 
29 Gunter, M. J.; Johnston, M. R. J. Chem. Soc. Chem. Commun. 1992, 1163. 
30 a) Seidel, S. R.; Stang, P. J. Acc. Chem. Res. 2002, 35, 972. b) Fujita, M.; Tominaga, M.; Hori, A.; 
Therrien, B. Acc. Chem. Res. 2005, 38, 369.  
31 Rowan, S. J.; Cantrill, S. J.; Cousins, G. R. L.; Sanders, J. K. M.; Stoddart, J. F. Angew. Chem. Int. Ed. 
2002, 41, 898. 
32 Zhao, D.; Moore, J. S. Macromolecules 2003, 36, 2712. 
33 Fürstner, A. Handbook of Metathesis, Vol. 2, Grubbs, R. H., Eds.; Wiley-VCH, Weinheim, 2003, chap. 
2.12; pp. 432. 
34 Zhang, W.; Moore, J. S. J. Am. Chem. Soc. 2004, 126, 12796. 
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Scheme 1.11. Synthesis of squared-shaped macrocycle 1.18 by an alkyne metathesis.34 
The choice of the appropriate method for the synthesis of macrocycles is a complex task, 
especially if the precursors are not easy to obtain as in the case of chiral building blocks. 
1.4. Chiral Macrocycles 
Chiral shape-persistent macrocycles are of great interest, because their unique structures 
provide potential utilities for chirality sensing, chiral guest recognition, chiral separation, 
as well as ligands for asymmetric catalysis.35 
One method to prepare chiral macrocycles or cyclophanes involves the use of achiral 
building blocks to construct helically chiral species. This approach takes advantage of 
geometrical constraints and/or steric interactions between the building blocks to provide a 
conformational twist, and, therefore helical chirality. Although this strategy is one of the 
simplest and most economical methods for introducing chirality, it provides mainly 
racemic products. For example, Vollhardt and coworkers employed the rigid geometry of 
the aryl-acetylene moiety to obtain helical dehydroannulene 1.19, which structure was 
confirmed by X-ray crystal structure analysis (Figure 1.4).36  
                                                 
35 a) Schafer, L. L.; Tilley, T. D. J. Am. Chem. Soc. 2001, 123, 2683. b) Kawase, T. Angew. Chem. Int. Ed. 
2005, 44, 7334. c) Campbell, K.; Tykwinski, R. R. Carbon-Rich Compounds, Haley, M. M.; Tykwinski R. R. 
Eds.; Wiley-VCH, Weiheim, 2006; pp. 229. d) Jiang, H.; Lin, W. J. Am. Chem. Soc. 2006, 128, 11286. 
36 Boese, R.; Matzger, A. J.; Vollhardt, K. P. C. J. Am. Chem. Soc. 1997, 119, 2052. 
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Figure 1.4. Molecular structure of helical annulene 1.19.36 
Another synthetic approach to obtain macrocycles in an enantio- or diastereoselective 
manner is the use of chiral and, in many cases, enantiopure building blocks. For example, 
Yamaguchi and coworkers reported the synthesis of chiral (M,M,M)-helicene-containing 
macrocycle (M,M,M)-1.20 (Figure 1.5).37 Helicenes are polycyclic aromatic compounds 
possessing non-planar helical structures, and therefore, they are chiral. Conversion of 
achiral compounds into chiral ones by incorporation of these helicene moieties is an 
attractive method to obtain new chiral compounds. 
 
Figure 1.5. Chiral (M,M,M)-1.20 helicene-containing macrocycle.37 
Metal–ligand interactions can be utilized to form chiral, metal-containing macrocycles 
through the application of self-assembly process or through the formation of covalent 
metalligand bonds. Tykwinski and coworkers have reported a method for the introduction 
of chirality into metal–acetylide based macrocycles.38 Treatment of the achiral pyridine 
                                                 
37 Nakamura, K.; Okubo, H.; Yamaguchi, M. Org. Lett. 2001, 3, 1097. 
38 Campbell, K.; McDonald, R.; Ferguson, M. J.; Tykwinski, R. R. J. Organomet. Chem. 2003, 683, 379. 
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containing oligomer 1.21 with [PtCl2(PPh)3] under high dilution in the presence of a 
catalytic amount of CuI afforded trans-platanacycle 1.22a, which was converted into cis-
derivative 1.22b via ligand exchange with cis-1,2-bis(diphenylphosphino)ethylene 
(Scheme 1.12). 
 
Scheme 1.12. Synthesis of chiral metalacetylide based macrocycles 1.22a and 1.22b.38 
 
The incorporation of an allene skeleton into a compound leads to a three-dimensional 
structure and imparts chirality to the molecule. Allenophanes (allenic macrocycles 
incorporating aromatic rings in the backbone) and alleno-acetylenic macrocycles (without 
any aromatic rings in the backbone) are fascinating and attractive compounds for creating 
new nonplanar, chiral topologies and for developing new functional materials. 
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1.5. Allenophanes and Alleno-Acetylenic Macrocycles 
Cyclophane chemistry has continuously advanced and expanded over the years and 
researchers in this field have designed and created new cyclophanes with a variety of 
structures. However, cyclophanes bearing allene (1,2-propadiene) bridges, termed 
allenophanes, have received little attention probably due to the difficulties associated with 
their synthesis and the high reactivity of allene moieties. 
In 1875, Van´t Hoff predicted that the four substituents in an allene must be arranged in 
two perpendicular planes.39 This proposal implied that suitably substituted allenes can be 
axially chiral. The prediction was confirmed 60 years later.40 Thus, the incorporation of an 
allene skeleton in a compound leads to a three-dimensional structure and imparts chirality 
to the molecule. 
The first synthesis of a “true” allenophane 1.23, was presented by Thorand, Vögtle, and 
Krause in 1999 (Scheme 1.13).41 The cyclophane consists of four 1,4-phenylene and four 
1,3-dimethylallene moieties and was obtained as a mixture of four diastereomers with 
different topologies. These isomers could not be separated, and therefore the physical and 
chiroptical properties were not discussed. 
 
Scheme 1.13. Synthesis of the [34]allenophane 1.23.41 
In 2005, Clay and Fallis reported the first synthesis of enantiomerically pure acetylenic 
allenophane (P,P)-1.24 via an Eglinton-Galbraith intermolecular coupling between two 
                                                 
39  a) Van´t Hoff, J .H. La Chimie dans L´Espace, Bazendijk, Rotterdam, 1875; Van´t Hoff, J. H. Die 
Lagerung der Atome im Raume, Vieweg, Braunschweig, 1877. b) Ogasawara, M. Tetrahedron: Asymmetry, 
2009, 20, 259. 
40 Maitland, P.; Mills, W. H. Nature 1935, 135, 994. 
41 Thorand, S.; Vögtle, F.; Krause, N. Angew. Chem. Int. Ed. 1999, 38, 3721. 
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units of oligomer (P)-1.25 (Scheme 1.14).42 Circular dichroism (CD) spectroscopy and 
molecular modeling were used to probe its chiral nature.  
 
Scheme 1.14. Synthesis of enantiopure allenophane (P,P)-1.24.42 
In the same year, Diederich and coworkers in collaboration with Cid´s group published the 
synthesis of chiral alleno-acetylenic macrocycle 1.26 that do not bear aromatic rings 
(Scheme 1.15).43  
Scheme 1.15. Synthesis of the cyclic tetraallene 1.26 as a mixture of seven stereoisomers.43 
                                                 
42 Clay, M. D.; Fallis, A. G. Angew. Chem. Int. Ed. 2005, 44, 4039. 
43 Odermatt, S.; Alonso-Gómez, J. L.; Seiler, P.; Cid, M. M.; Diederich, F. Angew. Chem. Int. Ed. 2005, 44, 
5074. 
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The synthesis starts with oligomerization of (±)-1,3-diethinylallene44 (±)-1.27 followed by 
intramolecular ring closure reaction under Breslow conditions to give the cyclic tetraallene 
1.26 as a mixture of seven stereoisomers (two pairs of enantiomers and three achiral 
diasteroisomers), which were separated by HPLC. 
In the same publication the synthesis of the allenophane 1.28 bearing anthracene units was 
also presented (Scheme 1.16). A series of Sonogashira cross-coupling reactions alternating 
with deprotection steps afforded linear tetraallene 1.29 as a mixture of stereoisomers. 
Intramolecular ring closure of this compound via a Sonogashira cross-coupling provided 
anthracene-allenophane 1.28 as a mixture of four diastereoisomers that were resolved by 
HPLC. The four diastereoisomers presented different symmetries and therefore, their 
relative configuration could be assigned taking into consideration the number of non 
equivalent groups in the NMR spectra. Moreover, the structure of one of these isomers was 
confirmed by X-ray crystal-structure analysis. 
 
Scheme 1.16. Synthesis of anthracene-allenophane 1.28 as a mixture of four diasteroisomers.43 
In 2008, Leclére and Fallis reported the synthesis of two meta-allenophanes, the tris-meta-
allenophane (P,P,P)-1.30a, and the higher homologue, tetrakis-meta-allenophane 
(P,P,P,P)-1.30b from asymmetric tertiary propargyl alcohol (R)-1.31 (Scheme 1.17).45 
Despite the fact that the compounds were only stable when handled in hydrocarbons or 
                                                 
44 a) Livingston, R. C.; Cox, L. R.; Gramlich, V.; Diederich, F.; Angew. Chem. Int. Ed. 2001, 40, 2334; b) 
Livingston, R. C.; Cox, L. R.; Odermatt, S.; Diederich, F. Helv. Chim. Acta 2002, 85, 3052. 
45 Leclére, M.; Fallis, A. G. Angew. Chem. Int. Ed. 2008, 47, 578. 
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ether solvent and stored in the freezer at –20 ºC, the CD spectra of these two allenophanes 
in hexane could be measured.  
 
Scheme 1.17. Synthesis of the tris-meta-allenophane (P,P,P)-1.30a and tetrakis-meta-allenophane (P,P,P,P)-
1.30b.45 
In 2009, Diederich and coworkers synthesized the first enantiomerically pure alleno-
acetylenic macrocycle (Scheme 1.18).46 The enantiopure macrocycle (P,P,P,P)-1.32 and 
its enantiomer (M,M,M,M)-1.32 were obtained from enantiomerically pure diethynylallene 
(P)-1.27 and (M)-1.27, 47  respectively, through dimerization by palladium-catalyzed 
oxidative coupling followed by deprotection and intermolecular ring closure under 
Breslow conditions. The structural, chiroptical, and electronic properties of these chiral 
allenic macrocycles were studied experimentally and by quantum mechanical calculations. 
This chiral alleno-acetylenic macrocycle presents exceptional CD intensities, the  value 
of the CD band at 252 nm is one of the largest ever reported for organic molecules.  
                                                 
46 a) Alonso-Gómez, J. L.; Rivera-Fuentes, P.; Harada, N.; Berova, N.; Diederich, F. Angew. Chem. Int. Ed. 
2009, 48, 5545. b) Rivera-Fuentes, P.; Alonso-Gómez, J. L.; Petrovic, A. G.; Seiler, P.; Santoro, F.; Harada, 
N.; Berova, N.; Rzepa, H. S.; Diederich, F. Chem. Eur. J. 2010, 16, 9796. 
47 Alonso-Gómez, J. L.; Schanen, P.; Rivera-Fuentes, P.; Seiler, P.; Diederich, F. Chem. Eur. J. 2008, 14, 
10564. 
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Scheme 1.18. Enantioselective synthesis and experimental CD measured in n-hexane of the macrocycle 
(P,P,P,P)-1.32.46 
In the same year, in line with the synthesis of anthracene-allenophane 1.28, Cid´s group 
synthesized the chiral macrocycle 1.33, bearing four 2,5-substituted pyridine moieties, as a 
mixture of four diastereoisomers (twist, chair, crown and boat), which were separated by 
preparative HPLC (Scheme 1.19).48 
 
Scheme 1.19. Synthesis of (2,5)pyrido[74]allenoacetylenic cyclophane 1.33.48 
 
                                                 
48 Alonso-Gómez, J. L.; Navarro-Vázquez, A.; Cid, M. M. Chem. Eur. J. 2009, 15, 6495. 
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As in the case of 1.28, the relative configuration of these four diastereoisomers was 
assigned due to their different symmetry by taking into consideration the number of non-
equivalent groups in the NMR spectra. Moreover, chiral crown isomer (P,P,P,P)-1.33 and 
its enantiomer were resolved by HPLC on a chiral stationary phase (CSP) (Figure 1.6). 
 
Figure 1.6. a) Tube model (MMFF optimized geometry) of (P,P,P,P)-1.33. b) CD spectrum measured in 
CH2Cl2 of the two enantiomers of crown isomer 1.33.48 
More recently, the synthesis of a series of enantiopure, monodisperse alleno-acetylenic 
cyclooligomers and the theoretical study of their chiroptical properties was presented: 
electronic circular dichroism (ECD), optical rotatory dispersion (ORD), Raman 
spectroscopy and vibrational circular dichroism (VCD).49 The X-ray crystal structures of 
the cyclic trimer (P,P,P)-1.34a and hexamer (P,P,P,P,P,P)-1.34c were also resolved 
(Figure 1.7). 
                                                 
49 Rivera-Fuentes, P.; Nieto-Ortega, B.; Schweizer, W. B.; López Navarrete, J. T.; Casado, J.; Diederich, F. 
Chem. Eur. J. 2011, 17, 3876. 
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Figure 1.7. Chiral cyclooligomers (P,P,P)-1.34a, (P,P,P,P,P)-1.34b and (P,P,P,P,P,P)-1.34c.49 
 
Chiral macrocycles, and particularly allenophanes and allene-acetylenic macrocycles with 
helical chirality, present a unique combination of electronic and geometric properties 
which give rise to outstanding chiroptical responses. 
1.6. Chiroptical Spectroscopy 
In recent years, there has been an increase in the usage of chiroptical spectroscopic 
methods for determining the absolute configuration and to study the conformation of chiral 
molecules. One of the reasons for this fact is the recent progress in ab initio methods and in 
computer hardware, which make computations in medium size molecules (ca. 102 non-
hydrogen nuclei) feasible. The most frequently used chiroptical spectroscopic methods 
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include electronic circular dichroism (ECD), vibrational circular dichroism (VCD), 
vibrational Raman optical activity (VROA) and optical rotatory dispersion (ORD). 
In order to assign the absolute configuration or conformation of new compounds, it is 
necessary to use more than one of these methods, because an independent verification of 
the structural conclusions obtained with a given method can be obtained when the same 
conclusions are obtained with different methods. Moreover, changing the method can 
resolve the ambiguity when the analysis with a particular method is uncertain or additional 
evidence is needed to reach the conclusions.50 
 
Chiroptical spectroscopy is based on how chiral medium interacts with anisotropic 
radiation (polarized light). Light is an electromagnetic radiation, which can be considered 
to behave as two wave motions: electric and magnetic. Electric and magnetic waves (or 
fields), propagated in time, are generated by oscillating electric and magnetic dipoles that 
lie perpendicular to one another (Figure 1.8).51 
 
Figure 1.8. Electromagnetic radiation is made up of two wave motions perpendicular to each other. For 
electromagnetic fields propagated along the z-axis, the electric wave oscillates in the xz-plane and the 
magnetic wave in the yz-plane.51 
In ordinary radiation, the electric field (vectors) associated with the light oscillates in all 
directions perpendicular to the direction of propagation. Such radiation is called isotropic 
(or unpolarized). In contrast, if the radiation is filtered so as to remove all oscillations but 
those in a single direction, then the light is anisotropic and said to be linearly polarized, or 
less rigorously, plane polarized (Figure 1.9).52 
                                                 
50 Polavarapu, P. L. Chirality, 2008, 20, 664. 
51  Lightner, D. A.; Gurst, J. E. Organic Conformational Analysis and Stereochemistry from Circular 
Dichroism Spectroscopy, Wiley, New York, 2000. 
52 Eliel, E. L.; Wilen, S. H.; Doyle, M. P. Basic Organic Stereochemistry, Wiley, New York, 2001. 
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Figure 1.9. Light is linearly and vertically polarized (in the xz plane) when the isotropic light is passed 
through a polarizing filter.52 
Linearly polarized light can be represented mathematically and graphically as a 
combination of left and right circularly polarized light (cpl) which have the same 
amplitude and phase (Figure 1.10).53  
 
Figure 1.10. Linearly polarized light can be viewed as a superposition of opposite circularly polarized light 
of equal amplitude and phase. ER and EL are electric field vectors of right and left circularly polarized light.53 
When linearly polarized light is passed through a sample of chiral compound containing 
unequal amounts of the two enantiomers, one of these enantiomers interacts, for instance, 
different with left than with right circularly polarized light beams, and therefore, the 
refractive indices for left (nL) and right (nR) circularly polarized light become unequal (n 
= nL - nR  0) leading to a phase difference that causes a rotation of the plane of 
polarization of linearly polarized light. Then, the medium is said to be birefringent (Figure 
1.11). 
                                                 
53 Allenmark, S.; Gawronski, J. Chirality, 2008, 20, 606. 
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Figure 1.11. The electric vector for left circularly polarized light (EL), moves slower than electric vector for 
right circularly polarized light (ER), therefore nL > nR and the resultant plane of linearly polarized light (Pr) is 
rotated by +º from the original plane of polarization (P0). [ (degrees) = 1800(nL - nR)/λ] 
The measurement of optical rotation as a function of wavelength is called optical rotatory 
dispersion (ORD).54 ORD makes an S-shaped curve in the region of light absorption; that 
means that the curve ascends or descends rapidly and then turns over, becoming 
anomalous. This anomalous dispersion effect is called the Cotton effect, on account of the 
discoverer of the phenomenon. At wavelengths far from the region of absorption of light, 
one observes a smooth plain dispersion curve (Figure 1.12). 
 
Figure 1.12. ORD curve. An anomalous dispersion or Cotton effect occurs in the region of an electronic 
transition. The crossover point λ0, correspond to the absorption maximun of the compound. At wavelenghts 
far from the region of electronic transitions, the ORD tail are said to be plain dispersion curves. 
When right- and left-circularly polarized light are absorbed to different extents (AL  AR) 
in the region of an absorption band of an optically active sample, a second chiroptical 
phenomenon is observed, namely circular dichroism.55 Accordingly, the circular dichroism 
is defined as: 
                                                 
54 a) Giorgio, E.; Viglione, R. G.; Zanasi, R.; Rosini, C. J. Am. Chem. Soc. 2004, 126, 12968. b) Castiglioni, 
E.; Abbate, S.; Longhi, G. Chirality, 2011, 23, 711. 
55 a) Nordén, B.; Rodger, A. Circular Dichroism and Linear Dichroism, Oxford University, Press, Oxford, 
1997 b) Pescitelli, G.; Di Bari, L.; Berova, N. Chem. Soc. Rev. 2011, 40, 4603. c) Berova, N.; Di Bari, L.; 
Pescitelli, G. Chem. Soc. Rev. 2007, 36, 914. d) Furche, F.; Warnke, I. WIREs Comput. Mol. Sci. 2012, 2, 
150. 
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CD = AL – AR = A      [1.1] 
where AR and AL are the absorptions of right and left circularly polarized light, 
respectively.  
In analogy to the Lambert and Beer law, one can define a molar quantity, 
 (Lmol–1cm–1) = L  R     [1.2] 
where, L and R are the molar absorption coefficients at the absorption wavelength for left 
and right cpl, respectively.  
An electronic transition associated with a chiral chromophore causes a different absorption 
of right and left cpl. Provided that the chiral sample contains an excess of one enantiomer, 
the intensities of the two cpl beams are not longer equal when leaving the sample, and thus, 
the absorbances are different (AL  AR). This difference in the absorbances of both cpl (A 
= AL – AR ) constitutes the measure of the CD (Figure 1.13). 
 
Figure 1.13. Differential absorption of right- and left-circularly polarized light of (R)-2-(4-
isobutylphenyl)propanoic acid results the CD spectrum of this enantiomer.  
For historical reasons, the output of CD instruments is usually measured as ellipticity () 
[mdeg], related to CD through 
 (mdeg)= 33000·CD     [1.3] 
which is independent of the concentration c [molL–1], and of the pathlength b [cm].  
 
When the differential absorption of left versus right circularly polarized light is due to the 
interaction of polarized IR radiation with chiral substances, the phenomenon is called 
vibrational circular dichroism (VCD).56  
                                                 
56 Stephens, P. J.; Devlin, F. J.; Pan, J-J. Chirality, 2008, 20, 643. 
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The chiral efficiency of a system can be measured by the anisotropy or dissymmetry factor, 
also called g factor at different regions of the spectra.  
The g factor is the ratio of circular dichroism to conventional absorption for an individual 
wavelength, 
𝑔 =
∆𝜀
𝜀
=
AL−AR
A
      [1.4] 
where A represents the conventional absorbance of non polarized light.  
1.6.1 Theoretical Bases for ECD Calculations 
Electronic circular dichroism (ECD) arises from electronic transitions, that is, the 
promotion of an electron from an occupied orbital i to an unoccupied orbital j by 
interaction with an electromagnetic wave. For each electronic transition, an electric and 
magnetic transition dipole moment (ETDM and MTDM) can be defined. They arise from 
the redistribution of the electron density taking place during the transition. A linear charge 
displacement brings about a non-vanishing electric transition dipole moment  𝑖𝑗⃗⃗ ⃗⃗ ⃗⃗  0 
whereas a non linear displacement of electrons leads to a magnetic transition dipole 
moment 𝑚𝑖𝑗⃗⃗ ⃗⃗ ⃗⃗  0. 
Both situations can lead to absorption of radiation. The intensity of this absorption band is 
directly related to the oscillator strength (ij). 
∫ 𝜀 𝑑𝜈 ∝ ij  ≈  |𝑢𝑖𝑗⃗⃗⃗⃗  ⃗|
2
+ |𝑚𝑖𝑗⃗⃗ ⃗⃗ ⃗⃗ |
2
    [1.5] 
By analogy with this equation, the integral of a CD band is obtained from the scalar 
product of ETDM and MTDM and is directly related to the rotational strength (Rij). 
∫∆𝜀 𝑑𝜈 ∝ 𝑅𝑖𝑗  ≈  𝑢𝑖𝑗⃗⃗⃗⃗  ⃗  ∙ 𝑚𝑖𝑗⃗⃗ ⃗⃗ ⃗⃗ = |𝑢𝑖𝑗⃗⃗⃗⃗  ⃗||𝑚𝑖𝑗⃗⃗ ⃗⃗ ⃗⃗ |𝑐𝑜𝑠𝜃    [1.6] 
The rotational strength is related to the intensity of a dichroic peak. Since the orientation of 
ETDM and MTDM is not defined, only their modules and the angle between them are 
relevant. The Rij value will be positive if the angle is smaller than 90º, negative if the angle 
is larger than 90º, and 0 if the angle is equal to 90º.  
1.6.2 Full CD Calculations 
Many rules, derived from empirical knowledge and theoretical analysis, have been 
proposed for the interpretation of CD spectra. One of the most successful approaches is the 
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exciton chirality method. 57  Whatever approach is used, a basic understanding of 
chromophore transitions is needed and some hypotheses about the way in which interact 
with each other and/or with the skeleton of the molecule.  
Absorption and CD spectra can be predicted if ETDM and MTDM can be calculated. The 
quantities related to absorption and dichroic peaks are the oscillator strength ij and the 
rotational strength Rij, respectively. In principle, these two quantities can be obtained 
directly from quantum mechanics. In recent years, technological progress has made 
quantum mechanical calculations feasible with a sufficient consistency, and they can be 
used for moderately complex compounds. 
The most popular methods for calculating electronic CD are the semi-empirical method 
ZINDO-S/CI (Zerner’s intermediate neglect of differential overlap/spectroscopic-
configuration interaction), and the ab initio method TDDFT (time dependent density 
functional theory). 
ZINDO-S/CI is a version of the semi-empirical method ZINDO, modified by Zerner for 
spectroscopic purposes, and includes configuration interaction (CI) correction of single 
excited states.58  The main advantage of this method is that it reproduces qualitatively 
electronic spectra with low computational cost. However, as is the case for the rest of 
semi-empirical methods, it depends on the robustness and quality of parameters, and may 
not be universally applicable. 
TDDFT is an ab initio method. Ab initio methods are, in principle, applicable to any 
molecule, but tend to be computationally demanding, limiting their application to small 
and medium-sized systems. However, DFT approaches can lead to predictions of high 
accuracy at a reasonable cost. For such calculations, a functional and a basis set have to be 
choosen. The best performing functionals are the so-called hybrid ones, such as B3LYP 
and CAM-B3LYP, and the basis sets commonly employed are of the split-valence type and 
include polarization and possibly diffuse functions, for example, 6-31G+(d,p).  
The use of TDDFT has grown exponentially in the last years. A whole volume of the series 
Lecture Notes in Physics59 is dedicated to the formulation and applications of TDDFT. 
                                                 
57  Harada, N.; Nakanishi, K. Circular Dichroic Spectroscopy Exciton Coupling in Organic Chemistry, 
University Science Books, Mill Valley, California and Oxford University Press, Oxford, 1983. 
58 a) Ridley, J.; Zerner, M. Theor. Chim. Acta 1973, 32, 111. b) Zerner, M. Reviews in Computational 
Chemistry, Vol 2 Lipkowitz, K.; Boyd, D. Eds.; VCH Publishers, New York, 1991, 313. 
59 Time Dependent Density Functional Theory, Lecture Notes in Physics, Vol 706 Marques, M. A. L.; Ullrich, 
C. A.; Nogueira, F.; Rubio, A.; Burke, K.; Gross, E. K. U. Eds.; Springer-Verlag, Berlin, 2006. 
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1.6.3 Simulation of Spectra 
Quantum-mechanical calculation of chiroptical properties (ORD, ECD, VCD) can allow the 
determination of the relative and absolute configuration.60  
It is necessary to follow several steps in order to compute a chiroptical property for a 
molecule. In molecules with conformational flexibility, the observed properties are an 
average over all the conformers present in solution. Thus, first, a conformational search is 
essential. Additional geometry optimization of the selected pool of conformations is 
performed. Various levels of theory are available, from molecular mechanics to DFT, 
depending on the nature of the system. Then, harmonic frequencies are computed for the 
selected pool of conformers. The Gibbs free energies of the conformers are also obtained 
directly from the frequency calculation and the nature of the stationary points as true 
minima is verified by the absence of imaginary frequencies. Once the potential energy 
surface (PES) is characterized, that is, when all local minima and their relative energies 
have been identified, it is necessary to evaluate the conformer populations with Boltzmann 
relation according to their relative Gibbs free energies. For each stable conformer present 
in the PES, chiroptical observables are then computed. These theoretical values may be 
obtained as weighted averages on the Boltzmann populations in order to compare them 
with the experimental ones. 
It is noteworthy, that the comparison between the entire computed and experimental 
spectra need to be careful and critical, because theoretical spectrum does not always 
reproduce the experimental one due to inadequately estimated intensities and transition 
energies  
As an example, Diederich and coworkers reported the conformational assignment of 
1,1,4,4-tetracyanobuta-1,3-dienes (TCBDs) by circular dichroism.61 In the case of TCBD 
(M)-1.35, an exhaustive conformational search gave 18 initial structures, which converged 
into 15 structures after geometry optimization at the B3LYP/6-31G(d) level of theory. All 
minima were characterized by the absence of imaginary frequencies from the IR DFT 
calculation that reconfirms their identity as true minima. The PES showed that the global 
minimum (M)-1.35b is 3.9 kcalmol–1 more stable than the next more energetic conformer 
                                                 
60 Petrovic, A. G.; Navarro-Vázquez, A.; Alonso-Gómez, J. L. Current Organic Chemistry 2010, 14, 1612. 
61 Alonso-Gómez, J. L.; Petrovic, A. G.; Harada, N.; Rivera-Fuentes, P.; Berova, N.; Diederich, F. Chem. 
Eur. J. 2009, 15, 8396. 
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(M)-1.35i, therefore being the most populated conformer expected in solution (Figure 
1.13).  
 
Figure 1.14. Relative energy for the conformers (M)-1.35a to (M)-1.35o after optimization on the B3LYP/6-
31G(d) level of theory.61 
The ECD (Figure 1.15) and UV/Vis (Figure 1.16) spectra of (M)-1.35b were calculated 
considering the first 50 transitions at the TDDFT B3LYP/6-31G(d) level of theory. 
 
Figure 1.15. Experimental CD spectra of (M)-1.35 (black line) recorded in CH2Cl2, calculated CD spectra for 
(M)-1.35b (grey line) at the TDDFT B3LYP/6-31G(d) level of theory, and rotational strenghts for the 
different transitions (grey bars).61 
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Figure 1.16. Experimental UV/Vis spectra of (M)-1.35 (black line) recorded in CH2Cl2, calculated UV/Vis 
spectra for (M)-1.35b (grey line) at the TDDFT B3LYP/6-31G(d) level of theory, and oscillator strenghts for 
the different transitions (grey bars).61 
The calculated ECD and UV/Vis spectra for (M)-1.35b agrees in terms of position and 
sign, for all Cotton effects when compared to the experimental one. The only apparent 
variation is the underestimated intensity between λ=400–600 nm and could be due to 
solvent effects, vibronic coupling and inaccuracies of TDDFT. Therefore, the comparison 
of the calculated and experimental ECD and UV/Vis spectra confirms the geometry of the 
minima and, moreover, this theoretical geometry is in good agreement with the geometry 
obtained from the X-ray diffraction. 
1.7. Outline 
Shape-persistent macrocycles based on acetylene moiety present important applications in 
supramolecular chemistry, materials science, and theoretical chemistry. They have been 
used in a very broad range of applications, including the formation of liquid crystals, 
extended tubular channels, porous organic solids, aggregates on surfaces, and host–guest 
complexes. Also their linear and non-linear optical behavior, fluorescence, as well as their 
electrochemistry have been the subject of many studies.  
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Particularly, chiral alleno-acetylenic macrocycles present a unique combination of 
electronic and geometric properties which give rise to outstanding chiroptical responses. 
These chiral properties can be further combined with other properties to furnish new 
functional materials, such as chiral molecular switches, chiral magnets, chiral 
semiconductors or fluorophores exhibiting circularly polarized luminescence.  
Moreover, macrocycles of different structures which contain pyridine fragments, have 
attracted the interest of researchers during the last decade because the incorporation of a 
pyridine moiety strongly influences the properties of the macrocycles and gives the 
opportunity to explore chiral host–guest complexes of these systems with metals and small 
organic molecules. 
Our group has previously reported the synthesis of (2,5)pyrido-[74]allenoacetylenic 
cyclophane as a mixture of four diastereoisomers, which were separated by preparative 
HPLC and their structures were assigned through their symmetry by using 13C NMR 
spectroscopy. para-Substituted pyridine rings allow direct communication between 
diethynylallenes attached to the aromatic spacer that can rotate freely around the axis 
connecting them. This is an important issue because conformationally stable compounds 
are desirable in order to relate the chiroptical properties to structural and electronic 
features. Therefore, herein, we present the design, synthesis, and characterization of 
(2,6)pyrido[142]allenoacetylenic cyclophane in order to obtain an allenophane 
conformationally stable, where the rotation of the pyridine ring is now blocked. 
The first synthetic efforts will be devoted towards the preparation of (2,6)pyrido-
allenophanes by two different strategies. For both approaches, the synthesis of these 
pyrido-allenophanes will begin by a Pd-catalyzed C(sp2)–C(sp) Sonogashira cross-
coupling between 1,3-diethynylallenes (DEAs) and commercially available 2,6-
dibromopyridine. Alkyne deprotections, followed by intermolecular ring closure will 
afford the desire allenophanes (Scheme 1.20). 
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Scheme 1.20. General retrosynthetic scheme of allenophanes. 
 
In the first approach (Chapter 2), DEAs will be used as a racemic mixture and, therefore, 
the (2,6)pyrido-allenophane would be obtained as a mixture of two chiral enantiomers and 
three achiral isomers, which could be resolved by preparative HPLC. The isomers will be 
characterized through their chirality and also by their symmetry properties taking into 
account the number of non-equivalent cumelinc carbon atoms in the 13C NMR spectra and 
non-equivalent tert-butyl protons in the 1H NMR spectra. Moreover, X-ray diffraction will 
be used to assign and to corroborate the configuration of the diastereoisomers. 
In the second approach (Chapter 3), DEAs will be resolved by HPLC or prepared 
enantioselectively. With enantiomerically pure DEA building blocks at hand, the proposed 
synthesis allows the specific preparation of enantiomerically pure homochiral 
allenophanes. Several diastereoisomers could be prepared by controlling the relative 
configuration of the four DEAs present in the macrocycle. However, we have chosen the 
homochiral isomer, incorporating all allenes with the same absolute configuration, since it 
presents the highest symmetry. This homochiral isomer can be more easily synthesized due 
to its high symmetry, which also will facilitate the analysis of the chiroptical properties. 
Characterization of the conformational distribution of these cyclophanes will be addressed 
by the interplay between ORD, ECD, VCD, and NMR, assisted by ab initio calculations. 
In addition, solvent effects and protonation studies will be also discused. 
In order to extend the variety of these systems, the synthesis of indolizines from 2-
enynylpyridines will be described (Chapter 4), as these hetero-aromatic spacers could be 
incorporated into novel allenophanes. 
Finally, general conclusions will be drawn in Chapter 5. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Synthesis and Characterization of 
Pyrido-Allenophanes from (±)-1,3-
Diethynylallenes 
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Insertion of aromatic chromophores, spacers, between two 1,3-diethynylallene (DEA) 
moieties leads to hybrid oligomers that may present interesting electronic and photonic 
properties.  
Previously, in the Cid´s group, different hybrid oligomers were prepared to study their 
electrochemical and photophysical properties in comparison with the corresponding DEA 
dimer (Figure 2.1). 62  Sonogashira reaction of 1,3-diethynylallenes with appropriately 
dihalogenated spacers provided the different heterotrimers. 
 
Figure 2.1. Hybrid oligomers prepared by incorporation of different spacers between two DEA moieties.62 
In the electronic absorption spectra, 1,3-diethynylallene oligomers showed a bathochromic 
shift, longer wavelength, of λmax as compared to DEA or the pure aromatic spacers, which 
is indicative of a more efficient -electron delocalization along the oligomeric backbone 
when the spacers are introduced. A bathochromic shift is also observed with the insertion 
of a pyridyl moiety as compared to the hybrid incorporating a phenyl unit due to the 
reduced benzenoid aromaticity of pyridine compared to benzene.  
para-Substituted six membered rings allow direct communication between both arms 
attached to the spacer that can rotate freely about the axis connecting them (Figure 2.2).  
                                                 
62 Alonso-Gómez, J. L. Doctoral Thesis: Síntese de hetero-oligómeros cíclicos e non cíclicos de cromóforos 
aromáticos e 1,3-dietinilaleno. Estudo das súas propiedades electroquímicas, fotoquímicas e fotofísicas, 
2006. 
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Figure 2.2. Example of the free rotation of a para-substituted six membered ring. 
Nevertheless, meta-substituted spacers will confer rigidity to the macrocycles and 
therefore, the molecules display less conformational variability. This is an important issue 
because conformationally stable compounds are desirable to relate the chiroptical 
properties to structural and electronic features. Chiroptical properties accompanied with 
theoretical calculations can provide information about the assignment of Cotton effects to 
specific transitions, determination of absolute configuration and conformational 
preferences. 
The incorporation of functionality into the spacer such as nitrogen in pyridine, sulfur in 
thiophene or oxygen in furan, gives the opportunity to explore chiral hostguest complexes 
of these systems with metals and small organic molecules. 
Thus, (2,6)pyrido[142]allenoacetyleneciclophane MC[142] was designed and its synthesis 
planned by an intermolecular homocoupling of the heterotrimer with a pyridine meta-
substituted spacer (HT-H) (Scheme 2.1) in order to obtain an allenophane 
conformationally stable. Moreover, the introduction of a pyridine moiety should affect the 
properties of the macrocycle due to the basicity and complexating ability of the nitrogen 
atom. 
 
Scheme 2.1. Retrosynthetic scheme of (2,6)pyrido[142]allenophane MC[142]. 
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2.1. 1,3-Diethynylallenes as Building Blocks 
The simplest cumulated diene is 1,2-propadiene, H2C=C=CH2, also known as allene. 
Indeed, cumulated dienes are often called allenes. The central carbon of an allene, the 
cumulenic carbon, is sp-hybridized, and as a result, the double bond array is linear. Since 
the π-bonds of allenes are orthogonal, the planes defined by the end carbon substituents are 
also orthogonal. An interesting consequence of this configuration is that allenes having two 
different substituents on each terminal carbon are chiral 
Since the first correct illustration of their structure by Van´t Hoff in 187539 and the first 
synthesis described by Burton and Pechmann in 1887, 63  allenes have largely been 
considered highly unstable and thus, poorly suited for synthesis. Only during the last 
decade, the use of allenes in organic synthesis has undergone rapid development due to 
their synthetic potencial in regio- and stereoselective C–C and C–X bond forming 
transformations, unique axis-to center chirality transfer, occurrence in a variety of natural 
products and presence in pharmacologically active compounds.64,65 
Nowadays, a variety of useful methodologies to access substituted allenes are available.66 
The most popular methods to prepare substituted allenes, including axially chiral ones, are 
metal–catalyzed synthesis, and comprise SN2' nucleophilic substitution reactions of 
propargylic electrophiles, 1,4-additions to enynes and 1,6-addition reactions to acceptor-
substituted enynes (Scheme 2.2).  
Palladium-catalyzed cross-coupling reactions have proven valuable in the preparation of 
allenes from bearing propargylic leaving groups, such as halides, epoxides, acetates or 
carbonates by SN2'-type substitution of the propargylic compounds.
67 
                                                 
63 Burton, B. S.; Pechmann, H. V. Ber. Dtsch. Chem. Ges. 1887, 20, 145. 
64 Yu, S.; Ma, S. Chem. Commun. 2011, 47, 5384. 
65 Hoffmann-Roder, A.; Krause, N. Angew. Chem. Int. Ed. 2004, 43, 1196.  
66 a) Schuster, H. F.; Coppola, G. M. Allenes in Organic Synthesis, Wiley, New York, 1984. b) Krause, N.; 
Hoffmann-Röder, A. Tetrahedron 2004, 60, 11671; c) Modern Allene Chemistry; Krause, N.; Hashmi, A. S. 
K., Eds.; Wiley-VCH: Weinheim, Germany, 2004, Vols. 1 and 2. d) Deutsch, C.;Lipshutz, B. H.; Krause, N. 
Angew. Chem. Int. Ed. 2007, 46, 1650. e) Xiao, Q.; Xia, Y.; Li, H.; Zhang, Y.; Wang, J. Angew. Chem., Int. 
Ed. 2011, 50, 1114. 
67 a) Ogasawara, M.; Ikeda, H.; Hayashi, T. Angew. Chem. Int. Ed. 2000, 39, 1042. b) Lee, K.; Seomoon, D.; 
Lee, P. H. Angew. Chem. Int. Ed. 2002, 41, 3901. 
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Scheme 2.2. Metal-mediated synthesis of allenes.66b 
The inherent 90º twist in allenes makes them interesting for three-dimensional acetylenic 
scaffolding. It has been observed that the more hindered the cumulenic unit, the less 
promptly it participates in reactions. In this regard, tert-butyl-substituted DEAs are ideal 
for the construction of novel topologies because deleterious reactions on the cumulenic 
moiety are suppressed.44b 
The synthesis of 1,3-diethynylallenes has already been reported by the Diederich research 
group.43,44 Pd-catalyzed SN2' reaction of pentafluorobenzoate (±)-2.3 with trimethylsilyl 
(TMS) acetylene followed by deprotection of the TMS group with potassium carbonate 
afforded the allene (±)-DEA-TIPS in 76% yield over two steps (Scheme 2.3). 
 
Scheme 2.3. Synthesis of allene (±)-DEA-TIPS. 
This well-established methodology for the synthesis of stable DEAs provides access to 
higher-order structures, such as alleno-acetylenic cyclophanes. 
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2.2 Synthesis of (2,6)Pyrido[142]allenophane 
The Sonogashira cross-coupling reaction is the most straightforward and powerful method 
for the construction of C(sp)–C(sp2) bonds due to the ability to tolerate a large variety of 
functional groups.68 Moreover, a tremendous number of modifications have been reported 
to improve the yield, to create even milder reaction conditions for inactivated organic 
electrophiles, and to overcome some of the limitations of the reaction, such as the 
formation of homocoupled byproducts and difficulties with the cross-coupling of alkynes 
bearing electron withdrawing groups.69  
In the first step of the synthesis toward (2,6)pyrido[142]allenophane, Sonoghasira cross-
coupling reaction of commercially avalaible 2,6-dibromopyridine with 2.2 equiv. of 
diethinylallene (±)-DEA-TIPS, 2 mol% of [PdCl2(PPh3)2], and 5 mol% of CuI in toluene 
with TMEDA as base at 110 ºC afforded bis(1,3-diethynylallene)pyridine HT-TIPS as a 
mixture of stereoisomers in 83% yield. Deprotection of the two triisopropylsilyl-protected 
acetylenes by treatment with nBu4NF (TBAF) in THF at 25 ºC gave HT-H in 89% yield. 
Then, intermolecular acetylenic homocoupling between two units of this compound, 
provided the desired pyrido-allenophane MC[142], as a mixture of five diastereoisomers 
(Scheme 2.4). This macrocyclization was carried out using three different conditions: 
Breslow, modification of the standard Hay method, and a Pd/Cu-catalyzed reaction. Hay 
and Pd method were employed as an alternative to the Breslow method, in order to avoid 
the use of pyridine as solvent due to its higher toxicity. 
 
                                                 
68 Sonogashira, K. J. Organomet. Chem. 2002, 653, 46. 
69 a) Chinchilla, R.; Nájera, C. Chem. Rev. 2007, 107, 874. b) Chinchilla, R.; Nájera, C. Chem. Soc. Rev. 
2011, 40, 5084. 
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Scheme 2.4. Synthesis of pyrido-allenophane MC[142] as a mixture of five diastereoisomers. 
Under Breslow conditions, compound HT-H was treated with a large excess of CuCl and 
CuCl2 in oxygen-free pyridine at 25 ºC under pseudo-high dilution conditions for 92 h. 
This was performed in such a way that a solution of the bisacetylene HT-H in pyridine was 
slowly added (20 h, flow rate: 0.5 mLh–1) to a suspension of the copper catalyst in the 
same solvent. After purification on silica gel, macrocycle MC[142] was obtained in 63% 
yield. 
 
When standard Hay methodology was employed, slow addition of deprotected acetylene 
HT-H to a solution of CuCl and catalytic amounts of the bidentate ligand TMEDA in 
acetone under O2 atmosphere, only starting material was recovered after 48 h. This was 
attributed to the low solubility of compound HT-H in acetone. 
The oxidative coupling of terminal acetylenes is quite dependent on the proportion of 
copper salt, oxidizing agent, pH, time, temperature, solvent, base and the character of the 
alkyne. 70  Taking these into account, compound HT-H was added under pseudo-high 
dilution (6 h, flow rate: 1mLh–1) over a solution of CuI and TMEDA in dichloroethane 
under air atmosphere at room temperature. After 11 days, the desired macrocycle MC[142] 
                                                 
70 a) Eglinton, G.; McCrae, W. Adv. Org. Chem. 1963, 4, 225. b) Cadiot, P.; Chodkiewicz, W. in Chemistry 
of Acetylenes Ed. H.G. Viehe, Dekker, New York, 1969, chap. 9, pp. 597. c) Brandsma, L. Preparative 
Acetylenic Chemistry, Elsevier, Amsterdam, 1988, chap. 10, pp. 219. d) Siemsen, P.; Livingston, R. C.; 
Diederich, F. Angew. Chem. Int. Ed. 2000, 39, 2632. 
Synthesis of (2,6)pyrido[142]allenophane 
 
45 
 
was obtained in 68% yield along with other compounds that were identified by mass 
spectroscopy analysis as the diiodinated heterotrimer HT-I and the diiodinated dimer D-I . 
 
Figure 2.3. Diiodinated derivatives, HT-I and D-I. 
In fact, when Tykwinski and coworkers attempted the synthesis of pyridine macrocycle 2.4 
based on isopropylidene subunits, the only isolated product was the corresponding diiodo 
oligomers 2.5 (Scheme 2.5).71 The reason for that could be a reductive elimination across 
Cu(II) species to yield the alkynyl iodide.  
 
Scheme 2.5. Intermolecular coupling under Hay conditions carried by Tykwinski and coworkers.71 
                                                 
71 Campbell, K.; McDonald, R., Tykwinski, R. R. J. Org. Chem. 2002, 67, 1133. 
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Inspired by the results obtained by Tykwinski, we exchanged CuI for CuCl, and after 5 
days no remaining starting material was observed. However, instead of the formation of 
the desire macrocyclic product, another unidentified product was formed.  
 
The third method employed for the macrocyclization of HT-H into MC[142] was the 
Pd/Cu-catalyzed homocoupling reaction in which a solution of compound HT-H in toluene 
was added under pseudo-high dilution (26 h, 1.5 mLh–1) to a solution of 10 mol% 
[PdCl2(PPh3)2], 20 mol% CuI, and 20 equivalents of TMEDA in toluene under air 
atmosphere at 60 ºC. After 50 h, the pyrido-allenophane was obtained in 56% of yield 
along with the diiodinated compounds HT-I and D-I. 
The use of iodine as oxidant72 did not improve the outcome of the reaction and after 2 days 
only starting material was recovered.  
 
Hay and Pd method do not follow an established pattern, for instance, the compound 
(2,6)pyrido[143]allenophane MC[143] (Figure 2.4) was obtained from Pd method 
employing different conditions such as, time, number of equivalents of TMEDA and 
concentration. 
 
Figure 2.4. (2,6)pyrido[143]allenophane MC[143]. 
All these results are summarized in Table 2.1 
 
 
  
                                                 
72 Liu, Q.; Burton, D. J. Tetrahedron Lett. 1997, 38, 4371. 
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Table 2.1. [a]: Solution A ([A] = 2,75 x 10-03 M) HT-H + solvent, was slowly added over solution B ([B]= 
0,15 M) [a*]: [A] = 7 x 10-03 M and [B] = 0,05 M. [b] General Breslow conditions: the reaction was run at 25 
ºC under Ar atmosphere. [c] General Hay conditions: the reaction was run at 25 ºC under Air atmosphere. [d] 
General Pd conditions: the reaction was carried out in toluene under air atmosphere at 60 ºC. [e] T = 50 ºC.   
[f] Under Argon atmosphere. ‡ = Compound identified by mass spectroscopy. ? = Unidentified compound. 
  
 Conditions Yield (%) 
 Catalyst (equiv) Base (equiv)/solvent[a]/Other t (h) 
F.R 
mLh1 
M
C
[1
4
2
] 
M
C
[1
4
3
] 
H
T
-I
 
D
-I
 
O
th
er
s 
B
re
sl
o
w
[b
] 
CuCl (75) CuCl2 (11) py 92 0.5 63 — — — — 
H
a
y
[c
]  
CuCl (1) TMEDA (0.3)/Acetone 48 0.5 — — — — HT-H 
CuCl (8) TMEDA (20)/CH4Cl2 129 0.5 — — — — ? 
CuI (8) TMEDA (20)/CH4Cl2 66 0.5 — — 92  ‡ — 
 
 288 0.5 ‡ — 36  ‡ — 
 
 270 1 68          — ‡ ‡ — 
P
d
[d
] 
CuI (0.3)/Pd (0.1) TMEDA (2,5)[e] 39 0.3 26  — ‡ ‡ — 
 
 41 1 26 24 — — HT-H‡ 
CuI (0.3)/Pd (0.1) TMEDA (20) 52 1 — — ‡ ‡ — 
CuI (0.2)/Pd (0.1) TMEDA (20) 76 1.5 56  — 14  ‡ — 
 
 216 0.5 23 — ‡ ‡ — 
CuI (0.2)/Pd (0.1) TMEDA (20)[a*] 132 0.5 51 30 — — — 
CuI (0.06)/Pd (0.04) TMEDA (5)[f]/ I2 45 0.5 — — — — HT-H 
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Presumably, the diiodo compound HT-I was formed due to a trasmetalation of copper to 
iodine of the copper-acetylide intermediate, as proposed by Zhang and coworkers.73 Once 
the halo-alkyne intermediate is formed, it could react with copper-acetylide to give 1,3-
dyines (Scheme 2.6).  
 
Scheme 2.6. Possible explanation for the formation of the diiodo compounds.73 
From these results describe above, the method of choice for the synthesis of pyrido-
allenophane MC[142] employs Breslow conditions (CuCl, CuCl2, oxygen-free pyridine, 
argon, 25 ºC). When Pd/Cu-catalyzed homocoupling reaction conditions were employed 
[Pd[Cl(PPh3)2], CuI, TMEDA, toluene, air, 60 ºC), MC[142] was also obtained in a good 
yield (56%). However, this methodology has the handicap of the formation of diiodinated 
oligomers and higher macrocycles. The worst result was achieved with Hay conditions 
(CuI, TMEDA, dichloroethane, air, 25 ºC). In this case, in almost all attempts, only 
diiodinated oligomers were obtained. 
2.3 Separation and Assignment of the Different Diastereoisomers of Pyrido-
allenophane MC[142] 
The use of racemic allene (±)-DEA-TIPS led to shape-persistent chiral (2,6)-
pyrido[142]allenoacetylenecyclophane MC[142] as a mixture of two pairs of enantiomers 
(P,P,P,P)/(M,M,M,M)-MC[142] and (P,P,M,P)/(M,M,P,M)-MC[142], and three achiral 
isomers (P,M,M,P)-MC[142], (P,M,P,M)-MC[142] and (P,P,M,M)-MC[142] in a 1:4:1:1:1 
predicted statistical distribution showed in Table 2.2.  
                                                 
73 Li, L.; Wang, J.; Zhang, G.; Liu, Q. Tetrahedron Lett. 2009, 50, 4033. 
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Table 2.2. Statistical distributions of the stereoisomers of MC[142]. 
The diastereoisomers were separated by preparative HPLC on a ‘Buckyclutcher 1’ column 
by using CH2Cl2/hexane (80:20) as eluent and a flow rate of 5 mLmin
–1. Figure 2.5 shows 
the chromatogram of the diastereoisomeric mixture of allenophane MC[142].  
 
Figure 2.5. Chromatogram of the diasteroisomeric mixture of allenophane MC[142] (Buckyclutcher 1, 
eluent: CH2Cl2/hexane (80:20); flow rate: 5 mLmin–1; 5 mg of MC[142] dissolved in 500 µL of 
CH2Cl2/hexane (80:20); injection 100 µL; λ = 320 nm).The unlabeled peaks are the diiodo oligomers. 
(P,P,P,P)/(M,M,M,M) (P,P,M,P)/(M,M,P,M) (P,P,M,M) (P,M,P,M) (P,M,M,P)
12.5 % 50 % 12.5 % 12.5 % 12.5 %
MC[142]
(P) (M)
50 % 50 %
( )-DEA-TIPS
(P,P) (M,M) (P,M)
25 % 25 % 50 %
HT-H
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As we can observe in the chromatogram, there are four visible peaks, whereas theoretically 
five diastereoisomers are expected. 
Comparing the area under the peaks of the chromatogram, that is proportional to the 
amount of sample, with the statistical distribution of the different isomers of MC[142], 
peak C can be presumed to correspond to the isomer (P,P,M,P)-MC[142] and its 
enantiomer (M,M,P,M)-MC[142].  
NMR study of every peak is shown in Figure 2.6:  
 
Figure 2.6. Chromatogram of the mixture of isomers of allenophane MC[142] (Buckyclutcher 1, eluent: 
CH2Cl2/hexane (80:20); flow rate: 5 mLmin–1; 5 mg of MC[142] dissolved in 500 µL of n-hexane; injection 
100 µL; λ = 320 nm). 1H and 13C NMR for each of the stereoisomers resolved by HPLC. 
 
13C and 1H NMR spectra of all compounds present only one cumulenic carbon, and two 
signals for tert-butyl protons, except peak C, showing four signals for cumulenic carbons, 
and eight signals for tert-butyl protons. However, the NMR spectra of compound C, 
suggests the presence of more than one isomer. For this reason it was injected into a HPLC 
system with a chiral stationary phase (ChiralPack IA) and eluted with hexane/methyl tert-
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butylether (MTBE) (83:17) and as expected, the fraction was resolved into three peaks 
(Figure 2.7). 
 
Figure 2.7. Chromatogram of fraction C resolved by HPLC on chiral stationary phase ChiralPack IA (eluent: 
hexane/MTBE (83:17); flow rate: 4 mLmin–1; λ = 320 nm). 
 
For a deeper understanding of this system and, moreover, in order to verify if peak C1 and 
C2 of the chromatogram correspond to chiral isomer (P,P,M,P)-MC[142] and its 
enantiomer (M,M,P,M)-MC[142], the chirality and the symmetry properties of the different 
isomers were studied to assign the relative configuration, taking into account the number of 
non-equivalent cumulenic carbon atoms in the 13C NMR spectra and the non-equivalent 
tert-butyls in the 1H NMR spectra. 
First of all, a conformational search was performed for every diastereoisomer of MC[142]. 
The starting geometries were then optimized at Austin Model 1 (AM1) level of theory. For 
all achiral isomers, only two conformers were found, which were denoted cis and trans 
(this terms are used to refer to the position of the pyridine rings in respect to each other). 
However, for the chiral isomer (P,P,P,P)-MC[142], three conformations, cis, trans, and 
twist (this term is used due to their geometry) were found. The other chiral isomer, 
(P,P,M,P)-MC[142], presents four conformations, two cis and two trans geometries.  
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Next, optimization and harmonic frequencies were calculated at the CAM-B3LYP/6-
31G(d) level of theory for all conformers of each diastereoisomer. The absence of 
imaginary frequencies confirmed the identity of all the conformers as true minima. The 
Gibbs free energies of the conformers were also obtained directly from this calculation. 
The difference of the thermal energy between the conformers is less than 1 kcalmol–1, 
hence all the conformers of each diastereoisomer are, in principle, equally populated. 
The optimized geometry and the symmetry of the possible conformers of each 
diasteroisomer of MC[142] are shown below. 
 
Chiral (P,P,P,P)-MC[142] and its enantiomer (M,M,M,M)-MC[142] have three possible 
conformations: cis and trans with C2 symmetry and twist with D2 symmetry (Figure 2.8). 
 
Figure 2.8. Conformers of (P,P,P,P)-MC[142], top: trans, bottom-left: twist, bottom-right: cis. The non-
equivalent cumulenic carbons are depicted in red and the non-equivalent tert-butyl groups in orange. 
 
The other pair of enantiomers (P,P,M,P)-MC[142] and (M,M,P,M)-MC[142], has four 
conformers, cis-(P,P,M,P)-MC[142] (cis1), cis-(P,M,P,P)-MC[142] (cis2), trans-
(P,P,M,P)-MC[142] (trans1) and trans-(P,M,P,P)-MC[142] (trans2) with C1 symmetry 
(Figure 2.9). 
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Figure 2.9. Conformers of (P,P,M,P)-MC[142], top-left: cis1, top-right: cis2, bottom-left: trans1, bottom-
right: trans2. The non-equivalent cumulenic carbons are depicted in red and the non-equivalent tert-butyl 
groups in orange. 
The achiral isomer (P,M,P,M)-MC[142] has two conformations: cis with C2v symmetry and 
trans with Cs symmetry (Figure 2.10). 
 
Figure 2.10. Conformers of (P,M,P,M)-MC[142], left: cis, right: trans. The non-equivalent cumulenic 
carbons are depicted in red and the non-equivalent tert-butyl groups in orange. 
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The achiral isomer, (P,M,M,P)-MC[142], has two conformations: cis with Cs symmetry 
and trans with Ci symmetry (Figure 2.11). 
 
Figure 2.11. Conformers of (P,M,M,P)-MC[142], left: cis, right: trans. The non-equivalent cumulenic 
carbons are depicted in red and the non-equivalent tert-butyl groups in orange. 
 
The achiral isomer, (P,P,M,M)-MC[142] has two possible conformations as seen for the 
other two achiral isomers, cis with Cs symmetry and trans with C2h (Figure 2.12).  
 
Figure 2.12. Conformers of (P,P,M,M)-MC[142], left: cis, right: trans. The non-equivalent cumulenic 
carbons are depicted in red and the non-equivalent tert-butyl groups in orange. 
 
Table 2.3 summarizes these results along with the torsion angles between the pyridine ring 
and the tert-butyl groups (). 
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Table 2.3. The torsion angles 1, 2, 3, 4 correspond as indicated in the figure. 
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P
P
P
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cis -140.3 8.1 -140.3 8.1 C2 2 4 
 
1 
 
2 
trans 8.4 8.4 -140.4 -140.4 C2 2 4 
twist -21.8 -21.8 -21.8 -21.8 D2 1 2 
 
P
P
M
P
 cis1 -113.6 23.01 -15.7 -0.3 C1 4 8 
 
3 
 
6 
trans1 -4.5 20.5 -19.5 -115.4 C1 4 8 
P
M
P
P
 cis2 -144.7 131.2 -130.5 15.1 C1 4 8 
trans2 14.1 130.6 -131.5 -145.4 C1 4 8 
 
P
M
P
M
 cis -139.9 139.9 -139.9 139.9 C2v 1 2 
1 2 
trans 26.0 111.7 -111.7 -26.1 Cs 2 4 
 
P
M
M
P
 cis -135.7 135.7 -8.4 8.4 Cs 2 4 
1 2 
trans 8.2 135.6 -8.2 -135.6 Ci 2 4 
 
P
P
M
M
 cis -110.7 25.9 -25.9 -110.7 Cs 2 4 
1 2 
trans 4.3 4.3 -4.3 -4.3 C2h 1 2 
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Based on the number of non-equivalent cumulenic carbon atoms and tert-butyl groups, and 
moreover, since compounds C1 and C2, present mirror image circular dichroism spectra 
(Figure 2.13), we can assign them to the chiral isomer (P,P,M,P)-MC[142] and its 
enantiomer (M,M,P,M)-MC[142].  
 
 
Figure 2.13. CD and UV/Vis spectra recorded in CHCl3 of C1 (black solid line) and C2 (black dashed line). 
On the other hand, fraction B was injected into a recycling HPLC system with a chiral 
stationary phase (ChiralPack IA) and eluted by using hexane/MTBE (83:17). After 5 
cycles fraction B was resolved into two peaks, B1 and B2 (Figure 2.14).  
 
Figure 2.14. Chromatogram of compound B resolved by recycling HPLC on the CSP ChiralPack IA (eluent: 
hexane/MTBE (83:17); flow rate: 2.5 mLmin–1; λ = 320 nm). 
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The CD spectra of compounds B1 and B2 were mirror images, allowing the assignment 
these compounds to the other chiral isomer (P,P,P,P)-MC[142] and its enantiomer 
(M,M,M,M)-MC[142] (Figure 2.15).  
 
Figure 2.15. CD and UV/Vis spectra recorded in CHCl3of B1 (black solid line) and sB2 (black dotted line). 
 
X-ray diffraction is a powerful technique for characterizing crystalline material. Knowing 
the structure of a crystal means determining the relative position of all atoms of a 
compound in the crystalline/solid state with accuracy. This allows accessing a high degree 
of information, for example, connectivity, bond order, conformation, symmetry, and 
additionally, absolute configurations can be obtained. It also gives inter and intra molecular 
interactions which may provide insight into the properties of the compound. 
 
Suitable single crystals were obtained by slow evaporation of a CHCl3/C6H6 solution of 
compound A of the chromatogram at 4 ºC. The X-ray crystal structure analysis revealed 
that peak A corresponds to the achiral isomer (P,M,M,P)-MC[142]. This achiral isomer 
crystallized with two CHCl3 molecules per macrocycle in the monoclinic space group 
P21/c. 
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Figure 2.16. ORTEP plot of (P,M,M,P)-MC[142]. Displacement ellipsoids are drawn at 30% probability. For 
clarity, H atoms and solvent molecules have been omitted.  
 
The CHCl3 molecules and macrocycle (P,M,M,P)-MC[142] are involved in H-bonding 
interactions. The interaction distance between nitrogen atoms of the macrocycle as the 
acceptor and chloroform as the donor is 3.254 (5) Å, which indicates the presence of a 
weak N…H–CCl3 hydrogen bond (Figure 2.17).74  
 
Figure 2.17. ORTEP plot of C–H…N hydrogen bond between solvent CHCl3 molecules and macrocycle 
(P,M,M,P)-MC[142]. Displacement ellipsoids are drawn at 30% probability. 
                                                 
74 Giacovazzo, C.; Monaco, H. L.; Artioli, G.; Viterbo, D.; Ferraris, G.; Gilli, G.; Zanotti, G.; Catti, M. 
'Fundamentals of Crystallography' 2nd Edition, Oxford University Press, Oxford, 2002. 
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Moreover, the CHCl3 molecules connect two macrocycle moieties acting as acceptor in 
weak C–H...Cl hydrogen bonds (Table 2.4). tert-Butyl groups are H-donors in these 
interactions as it is shown in Figure 2.18. 
D–H...A d(D–H) Å d(H...A) Å d(D...A) Å < (DHA) º 
C1–H...N1 1.00 2.48 3.254(5) 134.0 
C43–H...Cl3 0.98 2.90 3.522(6) 122.5 
C44–H...Cl2 0.98 2.90 3.625(5) 128.8 
Table 2.4. Hydrogen bond distances (Å) and angles (º). D: donor; A: acceptor. 
 
Figure 2.18. Crystal structure of macrocycle (P,M,M,P)-MC[142] and CHCl3 solvent molecules, showing 
details of C–H…N and C–H…Cl interactions. 
Due to these interactions, the macrocycle (P,M,M,P)-MC[142] adopts a zig-zag 
arrangement in the cb plane (Figure 2.19). 
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Figure 2.19. Crystal packing of complex (P,M,M,P)-MC[142] and CHCl3.  
The geometry observed by X-ray diffraction is close to the theoretically predicted trans 
conformer (Figure 2.20). 
 
Figure 2.20. Overlay of X-ray structure of (P,M,M,P)-MC[142] (grey) and calculated minimum at the AM1 
level of theory (trans conformer, blue). 
On the other hand, slow evaporation of a CHCl3/hexane solution at 4 ºC of compound C3 
rendered suitable single crystals for X-ray crystal structure analysis. The isomer 
crystallized in the monoclinic space group P21/c. Based on this result, compound C3 to was 
assigned to the achiral isomer (P,P,M,M)-MC[142] (Figure 2.21). 
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Figure 2.21. ORTEP plot of (P,P,M,M)-MC[142] (30% probability thermal ellipsoids). H atoms are omitted 
for clarity. 
As for (P,M,M,P)-MC[142], the geometry observed by X-ray diffraction for (P,P,M,M)-
MC[142] is very similar to the calculated trans conformer (Figure 2.22). 
 
Figure 2.22. Overlay of X-ray structure of (P,P,M,M)-MC[142] (grey) and calculated minimum at the AM1 
level of theory (trans conformer, blue) 
With four of the five diastereoisomers identified, compound D can be assigned to achiral 
isomer (P,M,P,M)-MC[142]. Thus, all the diastereoisomers of pyrido-allenophane 
MC[142] were assigned. The HPLC chromatograms with the assignment of the different 
stereoisomers are shown in Figure 2.23. 
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Figure 2.23. Assignment of the different stereoisomers of MC[142]. 
In conclusion, novel (2,6)pyrido[142]allenoacetylenecyclophane MC[142] was synthesize 
as a mixture of two pairs of enantiomers (P,P,P,P)-/(M,M,M,M)-MC[142], and (P,P,M,P)-
/(M,M,P,M)-MC[142] and three achiral isomers (P,M,M,P)-MC[142], (P,M,P,M)-MC[142] 
and (P,P,M,M)-MC[142]. Interplay between NMR spectroscopy, HPLC on chiral 
stationary phase, circular dichroism spectroscopy, X-ray crystallography and theoretical 
calculations allowed the assignment of all different diastereoisomers.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Synthesis of Enantiopure 
(2,6)Pyrido[142]allenophane
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The synthesis of pyrido-allenophane MC[142] from the diethynylallene (±)-DEA-TIPS, 
gave a mixture of two pairs of enantiomers and three achiral isomers, which were resolved 
by HPLC. However, the methodology is limited by the amount of product obtained of each 
stereoisomer. On the other hand, the synthesis of (P,P,P,P)-MC[142] from enantiopure 
DEA (P)-DEA-OH (Scheme 3.1) could provide the final product with total enantiomeric 
purity.  
 
Scheme 3.1. Retrosynthesis of (P,P,P,P)-MC[142] from enantiopure DEA (P)-DEA-OH. 
3.1 Enantiopure DEAs 
As discussed previously, allenes are characterized by two cumulated carbon–carbon double 
bonds, which are perpendicular to each other. The substituents in an allenic framework are 
arranged in an elongated tetrahedral fashion. When these substituents are different from 
each other (R1 ≠ R2 and R3 ≠ R4), the substituted allene is axially chiral (Figure 3.1). 
 
Figure 3.1. Enantiomeric pair of axially chiral allenes. 
The potential of using axially chiral allenes as chiral synthons has been hindered by limited 
access to enantiomerically enriched compounds.  
One method commonly employed in the resolution of racemates is kinetic resolution.75 The 
success of kinetic resolution depends on the fact that the two enantiomers react at different 
                                                 
75 Ghanem, A.; Aboul-Enein, H. Y. Chirality 2005, 17, 1. 
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rates with a chiral entity. This chiral entity should be present in catalytic amounts; it may 
be a biocatalyst (enzyme or a microorganism) or a chemocatalyst (chiral acid or base or 
even a chiral metal complex). 
Enzymes are the most common catalyzers in the kinetic resolution of racemic mixtures, in 
which the enzyme discriminates between the two enantiomers of a racemic mixture, so that 
one enantiomer is more readily transformed to the product than the other.76 If the kinetic 
resolution is efficient, one enantiomer of the racemic mixture is transformed to the desired 
product while the other is recovered unchanged (Scheme 3.2). 
 
Scheme 3.2. Catalytic kinetic resolution.76 
Kinetic resolution occurs when kR≠kS and the reaction is stopped somewhere between 0 
and 100% conversion.  
This procedure has the limitation of a maximum theoretical yield of 50%. To achieve 
higher yields, the unwanted enantiomer can be separated and re-racemized in a further 
step. Alternatively, dynamic kinetic resolution (DKR) combines the resolution step of 
kinetic resolution with an in situ racemization of the chirally label substrate (Scheme 
3.3).77 
 
Scheme 3.3. DKR with a theoretical 100% yield.77 
3.1.1 Kinetic Resolution of Tertiary Alcohols 
Tertiary alcohols and their esters are an important class of compounds, which are found in 
numerous natural products. They also represent a useful group of building blocks. In 
                                                 
76 a) Drauz, K.; Waldmann, H. Enzyme Catalysis in Organic Synthesis: A Compresive Handbook;. Willey-
VCH: Weinheim, 2002. b) Bommorius, A. S.; Riebel, B. R. Biocatalysis Willey-VCH: Weinheim, 2004. c) 
Ghanem, A.; Aboul-Einen, H. Y. Tetrahedron: Asymmetry 2004, 15, 3331. 
77 Pellissier, H. Tetrahedron 2003, 59, 8291. 
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addition to numerous methods for the synthesis of enantiopure tertiary alcohols,78 enzyme-
catalyzed approaches have also been established, and especially, hydrolases, i.e. lipases 
and esterases, are employed for kinetic resolution of tertiary alcohols.79 
The ability of lipases and esterases to accept and to enantiomerically resolve tertiary 
alcohols has successfully been associated with structural properties of their binding sites. 
The majority of these hydrolases have a wider active site with a highly conserved 
GGG(A)X amino acid motif (where G denotes glycine, A denotes alanine and X denotes a 
bulky residue).79d,80 The discovery of this motif has facilitated the identification of new 
hydrolases capable of resolving tertiary alcohol acetates. Some examples of these 
hydrolases are lipase from Candida rugosa (Candida cylindracea), 81 lipase from porcine 
pancreas, 82 lipase A from Candida antarctica, 83 esterase from Bacilus subtilis BS2.81a 
 
In order to obtain enantiomerically pure diethynylallenes, a lipase-catalyzed kinetic 
resolution of the precursor of allene was pursued in the lab of Professor Krause (Dortmund 
University, Germany) (Scheme 3.4). 
 
Scheme 3.4. Lipase catalyzed reactions of the precursors of DEA. 
                                                 
78 a) Noyori, R. Asymmetric Catalysis in Organic Synthesis; Wiley: New York, 1994; 255. b) García, C.; 
Martín, V. S. Curr. Org. Chem. 2006, 10, 1849. c) Cozzi, P. G.; Hilgraf, R.; Zimmermann, N. 
Eur. J. Org. Chem. 2007, 5969. d) Hatano, M.; Ishihara, K. Synthesis 2008, 11, 1647. e) Hasegawa, Y.; 
Gridnev, I. D.; Ikariya, T. Angew. Chem. Int. Ed. 2010, 49, 8157. d) Sonawane, R. P.; Jheengut, V.; 
Rabalakos, C.; Larouche-Gauthier, R.; Scott, H. K.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2011 50, 3760. 
79 a) Bornscheuer, U. T.; Kazlauskas, R. J. Hydrolases in Organic Synthesis Regio- and Stereoselective 
Biotransformations, Wiley-VCH: Weinheim, 1999. b) Henke, E.; Pleiss, J.; Bornscheuer, U. T. Angew. 
Chem. Int. Ed. 2002, 47, 3211. c) Robert, K.; Dominguez de Maria, P.; Bornscheuer, U. T. ChemBioChem. 
2008, 9, 491. d) Kourist, R.; Bornscheuer, U. T. Appl. Microbiol. Biotechnol. 2011, 91, 505. 
80 Pleiss, J.; Fischer, M.; Peiker, M.; Thiele, C.; Schmid, R.-D. J. Mol. Catal. B: Enzym. 2000, 10, 491. 
81 a) Henke, E.; Bornscheuer, U.T.; Schmid, R. D.; Pleiss, J. ChemBioChem. 2003, 4, 485. b) Holt, J., 
Arends, I. W. C. E.; Minnaard, A. J.; Hanefeld, U. Adv. Synth. Catal. 2007, 349, 1341. 
82 Gosseline, F.; Britton, R. A., Mowat, J.; O`Shea, P. D.; Davies, I. W. Synlett 2007, 2193. 
83 Baba, A.; Yoshioka, T. Org. Biomol. Chem. 2006, 4, 485. 
Synthesis of Enantiopure (2,6)Pyrido[142]allenophane 
68 
 
The enantioselectivity of enzyme-catalyzed esterification of alcohol (±)-3.1 was evaluated 
in organic media with vinyl acetate as the acetate donor. Two lipases, Candida cylindracea 
and Candida antarctica immobilized in Sol-Gel-AK, were employed in the assays. In a 
typical experiment, lipase was added to a solution of racemic mixture of alcohol (±)-3.1 
and vinyl acetate in dry n-hexane with 4 Å molecular sieves. The mixture was stirred at 
room temperature under argon atmosphere and the course of conversion was followed by 
TLC and gas chromatography (GC). After 3 days, no conversion of (±)-3.1 to acetylated 
compound 3.2 was observed (Scheme 3.5). 
 
Scheme 3.5. Lipase catalyzed reaction of alcohol (±)-3.1. 
For this reason, the synthesis of acetate (±)-3.2 was carried out by the acetylation of 
alcohol (±)-3.1 with acetic anhydride catalyzed by DMAP (Scheme 3.6). This basic 
catalyst is typically regenerate in situ through addition of a cheap auxiliary base such as 
triethylamine.84 
 
Scheme 3.6. Synthesis of acetate (±)-3.2. 
Several conditions, shown in Table 3.1, were employed to carry out the formation of 
acetate (±)-3.2. 
Entry Equiv. Ac2O [(±)-3.2] molL–1 Time (h) T ( ºC) Yield (%) 
1 3.0 1.3 24 25 33  
2 3.0 0.4 24 25 46  
3 2.0 0.4 96 25 54  
4 2.0 0.4 24 40 58  
Table 3.1. Formation of the acetate (±)-3.2 under various conditions in CH2Cl2. 
                                                 
84 Xu, S.; Held, I.; Kempf, B.; Mayr, H.; Steglich, W.; Zipse, H. Chem. Eur. J. 2005, 11, 4751. 
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Despite varying the reaction conditions, compound (±)-3.2 was obtained in moderate yield 
and, starting material was always recovered. The highest yield 58%, was obtained when 
the reaction was heated at 40 °C for 24 hours. 
With acetyl compound (±)-3.2 in hand, a general screening of lipases was performed: with 
Candida antarctica (immobilized in Sol-Gel-AK), Candida cilindracea, also known as 
Candida rugosa, hog pancreas, Rhizopus niveus, Rhizopus arrhizus, Mucor miehei and 
Aspergilius niger. The kinetic resolution was carried out by adding the lipase to a solution 
of acetate (±)-3.2 in THF and phosphate buffer (pH = 7) at 25 °C. The reaction was 
followed by TLC and GC. Unfortunately, no conversion was observed with any lipase 
under different conditions (time of reaction, amounts of enzyme, volume of THF) (Table 
3.2). 
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Candida antarctica inmobilized in Sol-Gel-AK 0.003 38 24 — — 
Candida antarctica inmobilized in Sol-Gel-AK 0.003 158 24 — — 
Candida cylindracea 2.4 40 24 — — 
Candida cylindracea 2.4 151 24 — — 
Hog pancreas 21 50 24 — — 
Rhizopus niveus 0.0026 125 96 — — 
Rhizopus niveus 0.0026 168 24 — — 
Mucor miehei 1.6 74 96 — — 
Aspergilus niger 1.4 62 96 — — 
Rhizopus arrhizus 0.002 163 24 — — 
Table 3.2. Reaction conditions tested for the kinetic resolution of acetate (±)-3.2. 
These results can be explained by the steric hindrance present in tertiary acetylalcohol (±)-
3.2. To reduce the steric bulk, the TIPS protecting group was removed with n-Bu4NF 
(TBAF) to give free acetylene (±)-3.3 (Scheme 3.7). 
 
Scheme 3.7. Synthesis of (±)-3.3. 
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The kinetic resolution failed also using the deprotected acetylated compound (±)-3.3 
following the same procedure described for the resolution of compound (±)-3.2 (Table 
3.3). 
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Candida antarctica inmobilized in Sol-Gel-AK 0.003 50 6 — — 
Candida antarctica inmobilized in Sol-Gel-AK 0.003 55 26 — — 
Candida cylindracea 2.4 50 6 — — 
Candida cylindracea 2.4 48 26 — — 
Candida cylindracea 2.4 150 48 — — 
Rhizopus niveus 0.0026 150 48 — — 
Rhizopus arrhizus 0.002 60 48 — — 
Table 3.3. Reaction conditions tested for the kinetic resolution of acetate (±)-3.3. 
Due to the failure to obtain enantiomerically pure the precursor of the allene by kinetic 
resolution catalyzed by lipases, the resolution of the allene was carried out by HPLC. 
3.1.2 HPLC Resolution of Racemic Mixture (±)-DEA-OH 
Allene (±)-DEA-OH was synthesized following the procedure previously described for the 
synthesis of (±)-DEA-TIPS (Chapter 2.1). The allene was then resolved with an 
enantiomeric excess up to 99% by HPLC using a semipreparative chiral stationary phase 
Chiralpack IA column (Figure 3.2). 
 
Figure 3.2. HPLC chromatogram of (±)-DEA-OH (Chiralpack IA; eluent: hexane/isopropanol 99.2:0.8; flow 
rate: 2.5 mLmin–1; 5 mg of (±)-DEA-OH dissolved in 100 µL of n-hexane; injection 100 µL; λ = 260 nm) 
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With the enantiomerically pure DEAs in hand, the synthesis of the enantiopure pyrido-
allenophane MC[142] was carried out. 
3.2 Synthesis of Enantiopure MC[142] 
Sonogashira cross-coupling reaction between enantiopure allene (P)-DEA-OH and 2,6-
dibromopyridine, following the same conditions as those for the racemic mixture, afforded 
the enantiopure heterotrimer (P,P)-HT-OH in 79% yield. Removal of the acetonide 
protecting group employing NaOH in toluene at 110 ºC for 2 h gave (P,P)-HT-H in 80% 
yield. Similarly, its enantiomer, (M,M)-HT-H was obtained starting from enantiopure 
allene (M)-DEA-OH (Scheme 3.8). 
 
Scheme 3.8. Synthesis of enantiopure heterotrimer (P,P)-HT-H. 
The removal of the two acetonide protecting groups proceeds in a stepwise fashion, and 
therefore, allowed the isolation of the monoprotected heterotrimer (P,P)-HT-MP in 
addition to the completely deprotected hetero-oligomer (P,P)-HT-H, which are easily 
separated by flash column chromatography. Therefore, open-chain oligomers can be 
constructed in a controlled manner.  
The heterorimer (P,P)-HT-MP was dimerized under Sonogashira type conditions 
affording dimer (P,P,P,P)-D-OH in 62% yield (Scheme 3.9). 
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Scheme 3.9. Synthesis of dimer (P,P,P,P)-D-OH. 
Intermolecular ring closing of (P,P)-HT-H under Breslow conditions gave enantiopure 
(P,P,P,P)-MC[142] in 57% yield (Scheme 3.10). A similar result was obtained with 
enantiomer (M,M)-HT-H. The stability of MC[142] and its enantiomer is extraordinary. 
These pyrido-allenophanes are stable under air atmosphere and in the presence of moisture 
for weeks.  
Scheme 3.10. Synthesis of (P,P,P,P)-MC[142]. 
Macrocycle (P,P,P,P)-MC[142] was subjected to recycling HPLC on CSP to confirm the 
absence of other enantiomer. The chromatogram reveals no presence of the enantiomer 
(M,M,M,M)-MC[142], thus confirming that chiral allenophane was obtained 
enantioselectively. 
The CD spectra of both enantiomers are shown in Figure 3.3. The CD curves are mirror 
images along the abscissa and their enantiomeric purity can be compared by the intensity 
of their Cotton effects. 
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Figure 3.3. UV/Vis and CD spectra of (P,P,P,P)-MC[142] (black solid line) and (M,M,M,M)-MC[142] 
(black dashed line) measured in CHCl3. 
The structure of (P,P,P,P)-MC[142] was further confirmed by X-ray diffraction analysis. 
Suitable single crystals of (P,P,P,P)-MC[142] were obtained by slow evaporation of 
CHCl3/hexane solution at 4 ºC. The macrocycle crystallized in the monoclinic space group 
C2 (Figure 3.4).
85 
 
Figure 3.4. ORTEP plot of (P,P,P,P)-MC[142]. Displacement ellipsoids are drawn at 30% probability and H 
atoms are omitted for clarity.  
                                                 
85 It seems that the cavity of the macrocycle is filled with halogenated and linear hydrocarbon solvent 
molecules, but the solvent structure could not be accurately solved from the X-ray data. 
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A systematic potential energy surface (PES) scan of allenophane (P,P,P,P)-MC[142] at the 
CAM-B3LYP/6-31G(d) level of theory showed that this allenophane have three possible 
conformers: cis, trans and twist as was already discussed in Chapter 2 (Figure 3.5). 
 
Figure 3.5. Theoretical (CAM-B3LYP/6-31G(d) level of theory) conformers of (P,P,P,P)-MC[142]: a) cis; 
b) trans; c) twist. 
The three conformers are very close in energy, with relative energies within around 0.5 
kcalmol–1. Further analysis was performed at MO6 level of theory, and a similar result was 
obtained. 
The conformation observed by X-ray diffraction is similar to the calculated twist 
conformer (Figure 3.6). 
 
Figure 3.6. Overlay of X-ray structure of (P,P,P,P)-MC[142] (grey) and calculated minimum (twist 
conformer, blue) at CAM-B3LYP 6-31G(d) level of theory. 
In order to study the conformational distribution in solution, chiroptical properties of 
(P,P,P,P)-MC[142] were studied. 
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3.3 Chiroptical Properties 
The chiroptical properties of (P,P,P,P)-MC[142] were investigated by electronic circular 
dichroism (ECD), vibrational circular dichroism (VCD) and optical rotatory dispersion 
(ORD). A combination of these experimental measurements and theoretical calculations 
was expected to aid in deducing the preferred conformation of (P,P,P,P)-MC[142] in 
solution.  
3.3.1 UV/Visible and Electronic Circular Dichroism Measurements 
The ECD spectra enclose information not only on the absolute configuration of optically 
active molecules but also on their conformation. In order to extract structural information 
from the experimental ECD spectra, theoretical ab initio calculations are necessary since 
simple empirical correlations are in many cases insufficient for rationalizing the 
experimental observations. The comparison of theoretical and experimental ECD spectra 
is, however, hampered by many issues, such as solvent and temperature effects. Moreover, 
ECD spectra depend on the electronic and geometric molecular structure.  
First of all, the ECD and UV/Vis spectra of the different pyridine-DEA-hybrids were 
measured in CHCl3 at 25 ºC and are shown in Figure 3.7. The results show that there are 
no significant shifts in the absorption maximum. The main difference lies in the absorption 
intensity: the bigger the molecule the higher the absorbance. Likewise, the ECD intensities 
(in Lmol–1cm–1) increase remarkably from the monomer (P,P)-HT-OH (+ 12 
Lmol–1cm–1 at λ = 317 nm) to the dimer (P,P,P,P)-D-OH (+ 120 Lmol–1cm–1 at λ = 
325 nm). Moreover, the macrocycle (P,P,P,P)-MC[142] (125 Lmol–1cm–1 at λ = 336 
nm) present a very different shape of ECD spectra with respect to the monomer and the 
dimer. 
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Figure 3.7. A comparison of UV/Vis and CD spectra of (P,P,P,P)-MC[142] (black line), (P,P,P,P)-D-OH 
(red line) and (P,P)-HT-OH (blue line). 
To find out which conformation of (P,P,P,P)-MC[142] among the possible three is present 
in solution or if the allenophane is better described as an average of them, the CD spectrum 
was calculated employing density functional theory (DFT) using the CAM-B3LYP 
functional in combination with the 6-31G(d) basis set in terms of the best compromise 
between accuracy and computational cost, as demonstrated in previous works where the 
chiroptical properties of alleno-acetylenic macrocycles were calculated.46 
This Coulomb-attenuated hybrid exchange-correlation functional (CAM-B3LYP) was 
introduced by Yanai and coworkers86 in 2004, and it has the same correlation functional as 
the traditional B3LYP functional, but combines the exact Hartree-Fock and DFT exchange 
in a ratio depending on the interelectronic distance. 
However, as we can observe in Figure 3.8, the experimental CD is not in good agreement 
with any of the three conformations predicted at the CAM-B3LYP level of theory, nor the 
theoretical average of the three possible conformers. 
                                                 
86 Yanai, T.; Tew, D. P.; Nicholas, N. C. Chem. Phys. Lett. 2004, 393, 51. 
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Figure 3.8. CD and UV/Vis spectra of (P,P,P,P)-MC[142]: solid black line: experimental spectra measured 
in hexane; solid red line: theoretical spectra of cis conformer; solid blue line: theoretical spectra of trans 
conformer; solid green line: theoretical spectra of twist conformer; black dashed line: theoretical average 
spectra of the three possible conformers. 
This could be due to the vibronic coupling,87 because the UV/Vis spectra shows the typical 
pattern of peaks with a regular spacing of about 2200 cm–1 corresponding to the –CC– 
stretch frequency (Figure 3.9). 
 
Figure 3.9. UV/Vis spectrum of (P,P,P,P)-MC[142] measured in hexane showing the typical pattern of a 
vibronic coupling. 
                                                 
87 Fischer, G. Vibronic coupling. The interaction between the Electronic and Nuclear motions, Academic 
Press, 1984. 
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The word vibronic originates from the union of the terms vibrational and electronic. In 
basic terms, vibronic coupling is due to transitions from ground to excited electronic state 
coupled with transitions to the various vibrational levels of the excited state. Vibronic 
coupling is capable of influencing optical, magnetic and electronic properties of a 
molecule. 
For this reason, further theoretical analysis was performed in the group of Fabrizio Santoro 
(CNR-Istituto di Chimica dei Composti Organo Metallici, Pisa; Italy). In this new 
theoretical analysis, vibronic coupling was simulated, i.e., the UV/Vis and ECD spectra 
were computed through the Frank Condon transitions between the vibrational states of the 
initial and final electronic state taking into account the transitions with the most intense 
oscillator/rotator strength for each conformer. 
These electronic calculations were performed at DFT and TDDFT level of theory in gas 
phase by employing the 6-31G(d) basis set. Bulk solvent effects were also investigated by 
polarizable continuum model (PCM),88 while the effect of the functional and the basis sets 
were evaluated by single point calculations adopting either the B3LYP functional or the 
larger 6-311G(d,p) and 6-311+G(d,p) basis sets. The results obtained in these calculations 
are summarized in the following. 
1. It appears that extension of the basis set toward a triple-zeta split-valence basis set, 
and even the inclusion of diffuse functions, have negligible effects on the ECD 
spectrum, so further analysis will be performed adopting the 6-31G(d) basis set. 
2. Introduction of bulk solvent effects in chloroform does not appear to change 
drastically the spectra. This was expected due to the low polarity of the solvent. 
3. Analysis of the computed Gibbs free energy shows that at any level of computation, 
cis conformer is the less populated specie while the relative population of twist and 
trans depends on the level of theory and cannot be considered assessed. Interestingly 
bulk solvent effects in chloroform seem to stabilize the twist conformer. 
4. The Vibronic Spectra computed at the CAM-B3LYP/6-31G(d) level of theory in 
gas phase cannot provide a clear assignment of the spectra to one conformer or a 
mixture of them (Figure 3.10). Nevertheless it looks like: 
                                                 
88 a) Miertus, S.; Scrocco, E.; Tomasi, J. Chem. Phys. 1981, 55, 117. b) Cammi, R.; Tomasi, J. J. Comput. 
Chem. 1995, 16, 1449. c) Tomasi, J.; Mennucci, B.; Camm, R. Chem. Rev. 2005, 105, 2999. 
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 Conformer cis does not seem compatible with the experimental spectra because the 
strong UV/Vis band at 285 nm and the strong negative ECD band at 305 nm do not 
appear in the experimental spectra. 
 Strong UV band at 285 nm predicted for the trans conformer does not well-match 
with UV experimental spectrum. 
 The twist isomer is the one that fit best with the experimental spectra because the 
2200 cm–1 progression in the UV/Vis spectrum is correctly predicted even if the 
relative intensities are underestimated. An increased broadening of the ECD 
spectrum would cause the disappearance of second negative peak at 305 nm, not 
observed in experiment, and also decrease the intensity of the positive peak at 290 
nm. The peculiar “ladder-like” shape between 310 and 285 nm observed in the 
experimental spectra seems out of reach for the theoretical simulations but at least 
it is not in clear contradiction with them. However, there is not a strong reason to 
exclude a mixture of trans and twist conformers. 
 
Figure 3.10. CD and UV/Vis spectra of (P,P,P,P)-MC[142]: solid black line: experimental spectra measure 
in hexane (CD spectra scaled by 50 and UV/Vis spectra scaled by 300000); solid blue line: theoretical spectra 
of trans conformer; solid green line: theoretical spectra of twist conformer; solid redline: theoretical spectra 
of cis conformer, black dashed line: theoretical average spectra of the three possible conformers. 
5. Finally, vibronic calculations at TDDFT/B3LYP/6-31G(d) level of theory in gas 
phase provide a worse agreement with the experimental data than CAM-B3LYP. 
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3.3.2 Vibrational Circular Dichroism Measurements 
The combination of IR and VCD measurement and theoretical calculations enable the 
determination of the absolute configuration and the conformation assignment of large and 
small molecules that in some cases are unavailable from any other method.  
VCD provides rich spectral information manifested through many, well resolved peaks in 
the mid-IR region (900-2000 cm1). Moreover, VCD is a ground state chiroptical 
spectroscopy and, therefore, it is potentially easier to model in DFT computations. 
However, a disadvantage of VCD, due to its low sensitivity, is the requirement of a big 
amount of sample (~10 mg) or longer signal-collections times (1 hour or even days) in 
comparison with ECD that only needs µg amounts of sample. 
VCD measurements were carried out by Dr. Ana G. Petrovic (Columbia University, 
U.S.A.). 
Solutions of (P,P,P,P)-MC[142] (0.19 M) and (M,M,M,M)- MC[142] (0,084 M) have been 
prepared in CDCl3 in order to provide VCD spectra with a sufficient signal-to noise ratio. 
The use of CDCl3 serves to avoid the shift solvent interference band because its C–D 
bending mode is at ~912 cm1, instead of ~1220 cm1 when CHCl3 is used. 
The measured of enantiomer (M,M,M,M)-MC[142] was unfruitful due to the low amount 
of sample and only noise was observed. The other enantiomer, (P,P,P,P)-MC[142] are 
reported in Figure 3.11 (IR spectra) and 3.12 (VCD spectra).  
In the calculated spectra (CAM-B3LYP/ 6-31G(d)) we are able to identified the stretching 
mode of –CC– in the region of ~2180 cm1 and the stretching mode of the allene moiety 
at ~1959 cm1.  
It is worth mentioning that calculated wavenumbers are typically scaled by a so-called 
frequency scaling factor,89 which originates from the fact that calculated normal modes 
have systematic deviations from reality. The reasons for this are the approximate treatment 
of electron correlation and the harmonic approximation, which is assumed for the atomic 
bond. Therefore, the harmonic frequencies obtained with the CAM-B3LYP force fields 6-
31G(d) level of theory were scaled by a factor of 0,9485.90 
The effect of solvent environment on the conformations of the chiral isomer (P,P,P,P)-
MC[142] through the calculation of their IR and VCD spectra was taking into account 
employing PCM with chloroform as solvent.  
                                                 
89 Merrick, J. P., Moran, D.; Radom, L. J. Phys. Chem. A 2007, 111, 11683. 
90 Jiménez-Hoyos, C. A.; Janesko, B. G.; Sauseria, G. E. Phys. Chem. Chem. Phys. 2008, 10, 6621. 
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Figure 3.11. IR spectra of (P,P,P,P)-MC[142] (measurements in the upper region 2000-4000 cm1 were not 
possible due to glitch with the detector specialize for that region); A: calculated spectra for the cis conformer 
at the CAM-B3LYP/ 6-31G(d) level of theory in gas phase. B: calculated spectra at the CAM-B3LYP/ 6-
31G(d) level of theory simulated with PCM (solvent: CHCl3); C: experimental spectra measured in CHCl3. 
The gas phase IR and the spectra simulated with PCM looks similar, except that the 
intensity of the PCM IR spectrum is higher.  
Unfortunately, theoretical IR absorptions cannot correlate peak to peak with the 
experimental one, and therefore they cannot be use to assign the VCD correspondence.  
Theoretical VCD spectra along with the experimental VCD of the three possible 
conformers of (P,P,P,P)-MC[142] (cis, trans and twist) are reported in Figure 3.12. 
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Figure 3.12. VCD spectra of (P,P,P,P)-MC[142]; black solid line: experimental VCD spectra measured in 
CHCl3. Red solid line: calculated cis spectra; blue solid line: calculated trans spectra; green solid line: 
calculated twist spectra at the CAM-B3LYP 6-31G(d) level of theory. Top: PCM solution phase (CHCl3). 
Botton: in gas phase. 
As we can observe, the VCD spectra simulated with PCM show small changes in some 
peak intensities when we compared to the corresponding gas phase spectra. Moreover, 
peak to peak correlation between observed and calculated spectra might not be possible; 
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therefore, by VCD spectroscopy we cannot predict which conformer is present in 
(P,P,P,P)-MC[142] or if there is a mixture of them. 
3.3.3 Optical Rotatory Dispersion Measurements 
Optical Rotation (OR) or birefringence results from different indices of refraction for left 
and right circularly polarized light. The magnitude of OR is characteristic of each chiral 
compound and varies with the wavelength of the incident light (ORD) and environment 
(temperature, solvent, pH…). 
ORD spectra of (P,P,P,P)-MC[142] and (M,M,M,M)-MC[142] were measured in 
chloroform by Dr. Ana G. Petrovic (Columbia University, U.S.A) and the result are shown 
in Figure 3.13. 
 
Figure 3.13. Experimental ORD spectra of (P,P,P,P)-MC[142] (black solid line) and its enantiomer 
(M,M,M,M)-MC[142] (black dashed line) measured in chloroform in a 1 cm quarzt cell. 
The calculated ORD values (CAM-B3LYP 6-31G(d) level of theory) for the three possible 
conformers of (P,P,P,P)- MC[142] (cis, trans and twist) along with the experimental one 
are reported in Figure 3.14. 
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Figure 3.14. Experimental ORD spectrum (scaled by 40000) measured in CHCl3 (black line) and theorethical 
ORD spectrum (), CAM-B3LYP 6-31G(d) level of theory, for the three possible conformations of 
(P,P,P,P)-MC[142]: twist (green line), cis (red line) and trans (blue line). In order to facilitate the 
calculations, the optical rotation values were calculated for the macrocycle with methyl groups instead or 
tert-butyl groups. 
Generally, the comparison between experimental and theoretical ORD profiles is 
qualitative, which means that the sign and the curvature of the trend line are the relevant 
criteria for finding the optimal agreement. In comparing the calculated and measured ORD 
curves, CAM-B3LYP spectra indicate a scarce population of cis and trans conformers and 
suggest that the twist conformer is the predominant. 
In view of these results, and taking into account the theoretical results in the ECD spectra, 
we can presume that the twist conformer is the prevalent conformer in solution. 
Moreover, preliminary molecular dynamic simulations91 point towards the twist conformer 
as the dominant in solution.  
                                                 
91 The main parameters of MD simulations are: a time step of 2 fs since the Shake algoritm is activated; for 
the thermostat it was used Langevin dynamics; a general AMBER force field (gaff) was employed to 
describe the system. 
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3.4 Solvent Effects 
The chemical and physical properties of compounds in solution are strongly affected by the 
solvent or the solvent mixture involved. For this reason, several attempts have been carried 
out to characterize the so-called solvent effect. This solvent effect usually is understood in 
terms of the solvent polarity, which is defined, in general, as the solvation power.  
3.4.1 Empirical Scales of Solvent Polarity 
The term “solvent polarity” lacks an exact definition, but it is generally used to cover all 
the intermolecular interactions between solvent and solute molecules.92 
In order to understand solvent effects on chemical reactions and physical absorptions in a 
more quantitative way, a multitude of empirical single- and multi-parameter solvent 
polarity scales, derived from various physicochemical processes, have been proposed 
during the past century. 
Probably the most well-known empirical scale of solvent polarity supported on a kinetic 
measurement is the Y scale developed by Grunwald and Winstein,93 based on the solvolysis 
of tert-butyl chloride.  
In contrast to these empirical polarity scales based on kinetic measurements, there are also 
scales based on spectroscopic measurements. A major advantage of using spectroscopic 
methods is that the measurement may be made quickly and easily, while kinetic 
experiments require a series of measurements to arrive at a single polarity value for a given 
solvent. Of these scales, the easiest to determine are those based on the solvatochromic 
method. Among them, the scales based on a single parameter approaches include Dimroth-
Richardt´s ET(30),
94 Brownstein´s S,95 Kosower´s Z,96 Dubois-Bienvenue´s Φ,97 Kamlet, 
Abboud and Taft´s π*, 98  and Drago´s unified polarity scale S'. 99  In addition, some 
multiparametric correlation equations (either by the combination of two or more existing 
scales or by postulating specific parameters to relation distinct types of effects) have been 
                                                 
92 Katritzky, A. R.; Fara, D. C,; Hong, Y; Tamm, K.; Tamm, T.; Karelson, M. Chem. Rev. 2004, 104, 175. 
93 Grunwald, E.; Winstein, S. J. Am. Chem. Soc. 1948, 70, 846. 
94 Dimroth, K.; Reichardt, C.; Siepmann, T.; Bohlmann, F. Liebigs Ann. Chem. 1963, 1,661. 
95 Brownstein, S. Can. J. Chem. 1960, 38, 1590 
96 Kosower, E. M. J. Am. Chem. Soc. 1958, 80, 3253. 
97 Dubois, J. E.; Bienvenûe, A. J. Chem Phys. 1968, 65, 1259. 
98 Kamlet, M. J.; Abboud, J.-L.; Taft, R. W. J. Am. Chem. Soc. 1977, 99, 6027. 
99 Drago, R. S. J. Chem. Soc., Perkin Trans. 1992, 2, 1827. 
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proposed. The introduction of multiparameter equations is due to the observation that 
solute-solvent interactions, responsible for the solvent influence on equilibria, rates, and 
absorptions, are caused by a multitude of nonspecific (ion/dipole, dipole/dipole, 
dipole/induced dipole, instantaneous dipole/induced dipole) and specific (H bonding, 
electron pair donor/ electron pair acceptor interaction) intermolecular forces between 
solute and solvent molecules. One of these multiparameter equations was described by 
Kamlet and Taft and was called linear solvation energy relationship (LSER).100 
In addition, in 1995, Catalán and coworkers reported the solvent polarity/polarizability 
(SPP) scale, based on UV/Vis measurements of the 2-dimethylamino-7-nitrofluorene/2-
fluoro-7-nitrofluorene probe–homomorph couple.101 More recently, Catalán and Hopf have 
proposed an empirical solvent polarizability (SP) scale, by using 3,20-di-tert-butyl-
2,2,21,21-tetramethyl-3,5,7,9,11,13,15,17,19-docosanonaene as a suitable probe of 
inductive and dispersive interactions of solvents.102 
On the other hand, computational approaches consisting on quantitative structure–property 
relationships (QSPR) have been employed to describe empirical solvent polarity scales in 
terms of molecular properties. 
The application of empirical parameters of solvent polarity has its inherent weaknesses and 
limitations. The establishment of a universal, generally valid solvent polarity scale seems 
to be impossible because, solute/solvent interactions depend on the solvent structure and 
also on the chemical structure of the probe solute.  
3.4.2 Solvatochromism 
The change in shape, intensity and/or position of the UV/Vis absorption or emission 
spectrum of a chromophore or fluorophore induced by the solvent was termed 
solvatochromism by Hantzsch in 1922. 103  Solvatochromism is caused by differential 
solvation of the ground and excited state of the light-absorbing molecule (or its 
chromophore). If the excitated state is more polar than the ground state, it will be better 
stabilized with increasing solvent polarity and its energy lowered so that the transition will 
                                                 
100 Kamlet, M. J.; Abboud, J.-L. M.; Abraham, M. H.; Taft, R. W. J. Org. Chem. 1983, 48, 2877. 
101 a) Catalán, J. in: G. Wypych (Ed.), Handbook of Solvents: Solvent effects based on pure solvent scales, 
William Andrew, Inc. and ChemTec Publishing, Toronto-New York, 2001, p.p. 583. b) Catalán, J.; López, 
V.; Pérez, P.; Martín-Villamil, R.; Rodriguez, J.-G. Liebigs Ann. 1995, 241. 
102 Catalan, J.; Hopf, H. Eur. J. Org. Chem. 2004, 22, 4694. 
103 Hantzsch, A. Ber. Dtsch. Chem. Ges. 1922, 55, 953. 
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occur at longer wavelength, i.e. there will be a bathochromic (red) shift, that it is usually 
called positive solvatochromism. On the other hand, better stabilization of the ground state 
relative to the excitate state with increasing solvent polarity, will results in a hypsochromic 
(blue) shift will result, which is termed negative solvatochromism (Figure 3.15).104  
 
Figure 3.15. Solvatochromism: red shift (top) and blue shift (bottom). 
The change in the intensity is described as hypochromism, when there is an anomalous 
enhancement of the absorbance of a sample, or hyperchromism, which describes the 
opposite effect, an anomalous decrease in absorbance.  
The observed solvatochromism depends on the chemical structure and physical properties 
of the chromophore as well as the solvent molecules, which determine the strength of the 
intermolecular solute/solvent interactions in the equilibrium in the ground state and in the 
excited state. For these reasons, solvatochromic shifts are important for the description of 
the relative energies of electronic states of molecules, for the experimental determination 
of some important physical properties (dipole moment, polarizability and higher multipole 
moments of molecules) and moreover, they often provide information about specific 
interactions such as hydrogen bonding.  
                                                 
104 a) Jhonson, B. P.; Khaledi, M. G.; Dorsery, J. G. Anal. Chem. 1986, 58, 2354. b) Reichardt, C. Chem. Rev. 
1994, 94, 2319. c) Suppan, P.; Ghoneim, N. Solvatochromism, The Royal Society of Chemistry, 1997. 
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3.4.3 UV/Vis and Electronic Circular Dichroism Measurements 
When the UV/Vis and ECD spectra of (P,P,P,P)-MC[142] and its enantiomer were 
measured in hexane and chloroform it was observed that the shape and the intensity of the 
spectra were different (Figure 3.16). 
 
 
Figure 3.16. UV/Vis and CD spectra of (P,P,P,P)-MC[142] (black solid line) and its enantiomer 
(M,M,M,M)-MC[142] recorded in CHCl3 (top) and hexane (bottom). 
A similar result was obtained in the case of the other chiral isomer, (P,P,M,P)-MC[142] 
and (M,M,P,M)-MC[142] (Figure 3.17). 
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Figure 3.17. UV/Vis and CD spectra of the first (black solid line) and second (black dashed line) fractions of 
the isomer (P,P,M,P)- MC[142] (M,M,P,M)-MC[142] recorded in CHCl3 (top) and hexane (botton). 
Intermolecular aggregates at 10–610–5 M in CHCl3 and hexane are discarded since 
absorbance measurements follow the Beer’s law at 317 nm (Figure 3.18). 
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Figure 3.18. Beer´s plot of absorbance at 317 nm vs concentration of MC[142] in CHCl3 (left) and in hexane 
(right). 
For this reason, the UV/Vis and ECD spectra of (P,P,P,P)-MC[142] were measured in 
different solvents in order to study the effect of the solvent in this system (Figure 3.19). 
(P,P,P,P)-MC[142] is soluble in chloroform, scarcely soluble in tetrachloroethane, hexane 
and methanol and totally insoluble in water. 
 
Figure 3.19. UV/Vis and CD spectra of (P,P,P,P)-MC[142] measured in CHCl3 (blue), hexane (red), CCl4 
(grey) and MeOH (purple). 
The region bellow 280 nm correspond to solvent absorption so we do not take it into 
account.  
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The absorption spectra present three main bands between 350 and 280 nm. These bands are 
due to the vibronic structure of acetylene groups, as was previously mentioned.  
With respect to the CD spectra, there are three main dichroic peaks. In order to view more 
clearly the effect of the solvent in the CD spectra, the max of this dichroic peaks 
(P,P,P,P)-MC[142] in the four different solvents, ordered according to decreasing the 
value of solvent polarity/polarizability (SPP)101 (MeOH (0.857), CHCl3 (0.786), CCl4 
(0.632), Hexane (0.519)) are compiled in Table 3.4. 
Solvent λmax (nm)  (Lmol–1cm–1) 
MeOH 
333          
314          
295 
-111.625                    
6.517                 
55.474                     
CHCl3 
336           
313 
302 
-125,287           
31.892                         
-24.249 
CCl4 
331           
308             
297                    
-112.992                     
-0.866                
53.483                     
Hexane 
329            
308          
292         
-111.952                        
-3.921               
32.762 
 
Table 3.4. Values of max of (P,P,P,P)-MC[142] in different solvents.  
As we can observe, CD spectra measure in hexane and CCl4, apolar aprotic solvents, and 
MeOH, polar protic solvent, present a similar shape. Moreover, there is a slightly red shift 
from hexane (λmax = 329 nm) to MeOH (λmax = 333 nm) that could be due to the solvent 
polarity/polarizability. However, when comparing the CD spectra measured in the last 
solvent with the spectra in chloroform, we found that the intensity and the position of the 
Cotton effects in the spectrum (that don´t correlate with solvent polarity/polarizability) are 
different. 
For this reason and since the crystal structure of the achiral isomer (P,M,M,P)-MC[142] 
shows weak hydrogen bonds with chloroform molecules, we believe that a similar 
complexation may occur between (P,P,P,P)-MC[142] and chloroform. 
3.4.3.1 The Chloroform, an Uninvited Guest 
A typically hydrogen bonding is formed between a X–H donor and a Y acceptor where X 
and Y are electronegative atoms (often nitrogen or oxygen). Despite the C–H bond will not 
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usually take part in hydrogen bonding, in a molecule like chloroform it behaves as a proton 
donor. Numerous studies have shown that weak hydrogen bonds can be formed between 
the hydrogen of chloroform and the nitrogen of pyridine.105 Two types of hydrogen bonds 
between the proton donor of CHCl3 and the pyridine can be formed, one is with the 
nitrogen lone pair electrons (C–H...N) and the other is with the acceptor  orbital (C–
H…).  
Howard and coworkers published in 1963 the association constant and NMR association 
shifts for the complex chloroform-pyridine.105a They obtained that the association constant 
(corrected for self- and solvent association) of chloroform to pyridine at 25 ºC using CCl4 
as solvent is 1.90 ± 0.04 (mol fraction)
–1. One year later, Berkeley and Hanna reported that 
the system chloroform-pyridine have a standard enthalpy of association (–Hº) of 2.1 
kcal/mol.105b This standard enthalpy of formation was obtained from the temperature 
variation of equilibrium constants determined from NMR measurements.  
In our case, the NMR of the crystals of (P,P,P,P)-MC[142] showed a residual peak at 6.26 
ppm, which correspond to CHCl3 (C6D6, 7.27 ppm) shifted 5.4 Hz from the regular 
chemical shift of CHCl3 in benzene (purple and green line in Figure 3.20). Integration of 
this signal revealed a stoichiometry of 1 (P,P,P,P)-MC[142] X 2 CHCl3. This 
stoichiometry was observed previously in the X-ray analysis of the achiral isomer 
(P,M,M,P)-MC[142]. 
                                                 
105 a) Howard, B. B.; Jumper, C. F.; Emerson, M. T. J. Mol. Spectrosc. 1963, 10, 117. b) Berkeley, P. J.; 
Hanna, M. W. J. Chem. Phys. 1964, 41, 2530. c) Findlay, T. J. V.; Keniry, J. S.; Kidman, A. D.; Pickles, V. 
A. Calorimetric and NMR studies of Hydrogen Bonding Involving C-H Bonds. Part 1. Chloroform and 
Pyridine, 1966. d) Fan, H.; Moliva A, C. D.; Eliason, J. K.; Olson, J. L.; Green, D. D.; Gealy, M. W.; Ulness, 
D. J. Chem. Phys. Lett. 2009, 479, 43. 
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Figure 3.20. Top: NMR spectra of (P,P,P,P)-MC[142] crystals in C6D6. Bottom: comparison between 
CHCl3-MC[142] (purple NMR spectrum) and free CHCl3 (green NMR spectrum) in C6D6. 
The amount of residual solvent in a sample of (P,P,P,P)-MC[142] decreases exceptionally 
slowly once the stoichiometry of 1 (P,P,P,P)-MC[142] X 2 CHCl3 is reached. 
1H NMR in 
C6D6 of (P,P,P,P)-MC[142] indicated the presence of CHCl3, even when the sample was 
drying under reduce pressure (10–1 mbar) at 298 K during 12 h or, after bubbling argon 
through a benzene solution of the macrocycle for 5 h. Only when a big excess of 
trifluoroacetic acid (TFA) (8200 equiv.) was added to a solution of the allenophane in 
C6D6 followed by evaporation of the solvent under reduce pressure and then, neutralization 
with Et3N (the same equivalents than TFA), evaporation of the solvent under reduce 
pressure, filtration through a silica pad using dichloromethane as solvent and finally 
evaporation of the solvent, gave the macrocycle (P,P,P,P)-MC[142] without any solvent 
(Figure 3.21). 
CHCl3 
5.4 Hz 
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Figure 3.21. Top: NMR spectrum of CHCl3-(P,P,P,P)-MC[142]. Bottom: NMR spectrum of free (P,P,P,P)-
MC[142].  
All this information let us to believe in a complexation of chloroform with (P,P,P,P)-
MC[142]. However, all the attempts to calculate the association constant by NMR were 
unfruitful due to the small amount of sample available and the scarce solubility of 
(P,P,P,P)-MC[142]. Moreover, the study of complexation (P,P,P,P)-MC[142]-CHCl3 by 
ECD and UV/Vis spectroscopy, showed that we need approximately 30000 equiv. of 
CHCl3 with respect to the macrocycle to observe a noticeable change in the spectra. 
3.5 Reaction of (P,P,P,P)-MC[142] with TFA 
The allenophane (P,P,P,P)-MC[142] present two pyridine rings in its structure and 
therefore it is prone to behave as a base. Thus, the behaviour of (P,P,P,P)-MC[142] with 
trifluoroacetic acid (pKa (H2O) = 0.23) in two different solvents, chloroform and hexane 
was studied. 
Protons can be transferred from Brönsted acids, A–H, to bases, |B, via the hydrogen-
bonded covalent and ionic complexes a and b, depending on both the relative acidity and 
the relative basicity of A–H and |B respectively, and the solvation capability of the 
surrounding medium.106 
 
                                                 
106 Reichardt, C. Solvent and Solvent effects in Organic Chemistry 3rd Ed.; Willey-VCH, Weinheim, 2003. 
CHCl3 
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The solvent can influence the association, the proton transfer and the dissociation steps. 
The main factor which determines the position of this acid/base equilibrium is the 
solvation of the covalent and the ionic hydrogen–bonded complexes a and b. 
With increasing solvent polarity the proton transfer equilibrium is shifted to the ionic 
structure b. 
The proton transfer in rather concentrated solution can be coupled with aggregation 
processes via formation of complexes with various stoichiometric ratios (1:2, 2:1 or even 
higher). These species have been recognized in NMR and IR spectra of some pyridine-acid 
systems,107 and found theoretical support by theoretical calculations.108 
One example is given with the 1H NMR studies in CDCl3 of proton transfer in Schiff base 
and mineral acids such as HCl, HBr and HI, or trichloroacetic, monochloroacetic and 
propionic carboxylic acids. 109  With mineral acids only 1:1 structures are formed and 
protonation is always complete and the equilibrium is shifted to the right. However, with 
carboxylic acids 1:1, 1:2 and bigger structures are present in rapid equilibrium (Scheme 
3.11). 
 
Scheme 3.11. Possible complexes that can be occurred between a Shift base and a carboxylic acid.109 
Another example is the reported by Gordon M. Barrow where he studies the reaction of 
pyridine with different carboxylic acids in chloroform.107a In this paper he concludes that 
                                                 
107 a) Barrow, G. M. J. Am. Chem. Soc. 1956, 78, 5802. b) Dega-Szafran, Z.; Dulewicz, E. Org. Magn. 
Reson. 1981, 16, 214 c) Barczynski, P.; Dega-Szafran, Z.; Szafran, M. J. Chem. Soc., Perkin Trans. 2 1985, 
765. d) Smirnov, S. S.; Golubev, N. S.; Denisov, G. S.; Benedict, H.; Schah-Mohammedi, P.; Limbach, H. H. 
J. Am. Chem. Soc. 1996, 118, 4094. e) Balevicius, V.; Bariseviciute, R.; Aidas, K.; Svoboda, I.; Ehrenberg, 
H.; Fuess, H. Phys. Chem. Chem. Phys. 2007, 9, 3181. 
108 Fernandez-Berridi, M. J.; Iruin, J. J.; Irusta, L.; Mercero, J. M.; Ugalde, J. M. J. Phys.Chem. A 2002, 106, 
4187. 
109 Vocelle, D.; Le-Thanh. Can. J. Chem. 1990, 68, 1909. 
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the reaction of protonic acids in non dissociating solvent leads, for acids and bases of 
sufficient strength, to the formation of an ion-pair associated through a hydrogen bond. For 
instance, titration of a CHCl3 solution of pyridine by TFA leads to the formation of a specie 
[pyridine–(HA)2] (Figure 3.22) that shows in the IR spectrum absorptions bands 
corresponding to the presence of a carbonyl group and a carboxylate group, which 
corroborate the proton transfer process and the presence of an ion-pair species.  
 
Figure 3.22. 2:1 reaction product of stronger carboxylic acids with pyridine.107a 
In our case, the UV/Vis and CD spectra of (P,P,P,P)-MC[142] in CHCl3 (Figure 3.23) and 
in hexane (Figure 3.24) changed its shape spectacularly upon the addition of TFA. 
 
Figure 3.23. Change of the UV/Vis and CD spectra of (P,P,P,P)-MC[142] (3.12x10–06 M in CHCl3) upon 
addition of TFA. [TFA] = 0 (blue solid line) to 0.38 M (red solid line). Light path length 10 mm. (The arrow 
represent from 0 to 0.34 M of TFA) 
The neutral (P,P,P,P)-MC[142] in chloroform shows three main bands in the CD spectra 
centered at λ = 336 nm,  = 125.29 Lmol–1cm–1, λ = 313 nm,  = 31.892 Lmol–1cm–
1and λ = 302 nm,  = 24.25 Lmol–1cm–1. Upon addition of TFA in ratios of 1:1000 until 
1:60000, this three bands gradually convert into a single band centered at λ = 314 nm,  = 
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130.08 Lmol–1cm–1 and new two red-shifted negative bands centered at λ = 369 nm,  = 
28.53 Lmol–1cm–1 and λ = 400 nm,  = 72.88 Lmol–1cm–1 appeared. When a very large 
excess of TFA was used (1:90000) the band centered at λ = 369 nm disappeared and the 
band centered at λ = 400 nm increased.110  
With respect to the UV/Vis spectra, a new red-shifted band centered at λ = 372 nm,  = 
52219.87 Lmol–1cm–1appeared and was assigned to the pyridinium ion. 
When the reaction was carried out in hexane, less amount of TFA (approximately 20 times 
less to reach the maximum in absorption at 372 nm) was needed to observe the same 
effect. This result was not the expected, because chloroform is more polar (D = 4.81) than 
hexane (D = 1.89), and, as we mentioned before, the proton transfer equilibrium would be 
shifted to the ionic structure b when increasing the polarity of the solvent. This result could 
be explained in terms of solvation, the macrocycle (P,P,P,P)-MC[142] is better solvated by 
chloroform molecules than by hexane and therefore, the equilibria is shifted to the left. 
The shape of the CD and UV/Vis spectra, when TFA was added to a hexane solution of 
(P,P,P,P)-MC[142], was similar to the ones in CHCl3 with the exception that at low 
concentration of TFA there is a positive dichroic peak at 400nm that eventually 
disappeared and at higher concentrations a negative dichroic peak at 380 nm appeared 
(Figure 3.24). 
                                                 
110 With bigger amounts of TFA the CD began to diminish, which eventually disappeared. 
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Figure 3.24. Change of the UV/Vis and CD spectra of (P,P,P,P)-MC[142] (8.86 x 10–06 M in hexane) upon 
addition of TFA. [TFA] = 0 (blue solid line) to 0.765 M (red solid line). Light path length 10 mm. (The arrow 
represent from 0 to 0.41 M of TFA). 
To shed light at this results, an experiment was also carried out with (M,M)-HT-H and 
TFA in chloroform (Figure 3.25 top) and in hexane (Figure 3.25 bottom). 
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Figure 3.25. Top: Change of the UV/Vis and CD spectra of (M,M)-HT-H (1.82 x10–05 M in CHCl3) upon 
addition of TFA. [TFA] = 0 (blue solid line) to 0.35 M (red solid line) Bottom: Change of the UV/Vis and 
CD spectra of HT-H (1.82 x10–05 M in hexane) upon addition of TFA. [TFA] = 0 (blue solid line) to 0.018 M 
(red solid line). 
The shape of the UV/Vis and CD spectra of (M,M)-HT-H in both solvents changed in a 
similar way. As for (P,P,P,P)-MC[142], for the titration of HT-H in hexane less amount of 
TFA (~ 20 times less) was needed to reach the maximum of absorbance at 370 nm. 
To obtain a more clear result about what happen when TFA is added to a solution of  
(P,P,P,P)-MC[142] or (M,M)-HT-H, the curves for the absorbance at λ = 370 nm as a 
function of the concentration of TFA were drawn (Figure 3.26).  
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Figure 3.26. Graphs of the reaction of (P,P,P,P)-MC[142] (top) and (M,M)-HT-H (bottom) with TFA. The 
lines are theoretical curves by iterative curve-fitting.  
For each curve we obtain an “equivalent point” (like in a typical titration curve, volume vs 
pH) that are shown in Table 3.5. 
 
Compound Equivalent point 
 [TFA] molL–1 
MC[142] in CHCl3 0.082 
MC[142] in hexane 0.015 
HT-H in CHCl3 0.064 
HT-H in hexane 0.003 
Table 3.5. 
As we can observe, when the titration was carried out in chloroform bigger amount of TFA 
were needed, and as we mention before, this could be due to a better solvation of the 
system in chloroform than in hexane. 
With respect to the differences between the macrocycle and the heterotrimer, we can 
postulate that the electron pair of the nitrogen in the macrocycle are more hindered than in 
the case of the heterotrimer, and for this reason we need more amount of TFA in the 
titration of the macrocycle. Attempts to know what happens in the macrocycle system, i.e., 
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if a proton transfer of the TFA with the two pyridine moieties is occurring, were 
unsuccessful because high amounts of TFA were needed to observe an effect.  
All these results point to an interaction of the chloroform with the macrocycle, and 
moreover, with the heterotrimer.  
Interestingly, when triethylamine (Et3N) was added to the protonate (P,P,P,P)-MC[142] 
the original CD and UV/Vis spectra were recovered (Figure 3.27).  
 
Figure 3.27. UV/Vis and CD spectra: blue solid line: neutral (P,P,P,P)-MC[142]; dotted black line: 
protonated (P,P,P,P)-MC[142]; red solid line: protonated (P,P,P,P)-MC[142] after addition of Et3N. 
Taking this into account, (P,P,P,P)-MC[142] is a potential pH-induced chiral molecular 
switch whose switching can be monitored by CD and UV/Vis spectroscopy. The basic 
requirement for a molecular switch is bistability, i.e., two distinct forms of a molecule can 
be interconverted reversibly by the application of an external stimulus such as light, heat, 
pressure, magnetic or electric fields, pH change, or chemical reactions.111 The development 
of molecular switches is of great interest in view of their possible use in many applications, 
such as drug release, new sensor techniques or information storage and transmission. 
 
                                                 
111 Feringa, B. L. J. Org. Chem. 2007, 72, 6635. 
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Indolizines are a class of heteroaromatic compounds containing a six-membered ring fused 
to a five membered ring and a bridging nitrogen atom (Figure 4.1). 
 
Figure 4.1. General structure of indolizine nucleus. 
In nature the reduced derivatives (indolizidines) are frequently encountered instead of the 
aromatic indolizine core. Many indolizine derivatives have been isolated from plants, 
insects, animals, marine lives and microbes.112 Some examples are (–)-swainsonine and 
camptothecin (Figure 4.2). 
 
Figure 4.2. a) (–)-Swainsonine. b) Camptothecin 
The indolizine nucleus is present in a variety of compounds with relevant biological 
properties, including anti-inflammatory,113 muscular relaxant,114 and antioxidant,115 and as a 
chromophore it has shown potential usage in dyes and fluorophores.116  
Although a variety of methods for their synthesis have emerged,117 there is still significant 
need for more direct methods to afford functionalized indolizinyl derivatives. 
                                                 
112 Michael, J. P. Natural product reports, 2008, 25,139. 
113 a) Gubin, J.; Vogealer, H.; Inion, H.; Houben, C.; Luchetti, J.; Mahaux, J.; Roesseels, M. P.; Clinet, M.; 
Polster, P.; Chatelain, P. J. Med. Chem. 1993, 36, 1425. b) Kitadokoro, K.; Hagishita, S.; Sato, T.; Ohtani, 
M.; Miki, K. J. Biochem. 1998, 123, 619. c) Oslund, R. C.; Cermak, N.; Gelb, M. H. J. Med. Chem. 2008, 51, 
4708. 
114 a) Hagishita, S.; Yamada, M.; Shirahase, K.; Okada, T.; Murakami, Y.; Ito, Y.; Matsuura, T.; Wada, M.; 
Kato, T.; Ueno, M.; Chikazawa, Y.; Yamada, K.; Ono, T.; Teshirogi, I.; Ohtani, M. J. Med. Chem. 1996, 39, 
3636. b) Gupta, S. P.; Mathur, A. N.; Nagappa, A. N.; Kumar, D.; Kumaran, S. Eur. J. Med. Chem. 2003, 38, 
867. 
115 Østby, O. B.; Dalhus, B.; Gundersen, L.-L.; Rise, F.; Bast, A.; Haenen, G. R. M. M. Eur. J. Org. Chem. 
2000, 3763. 
116 a) Delattre, F.; Woisel, P.; Surpateanu, G.; Cazier, F.; Blach, P. Tetrahedron 2005, 61, 3939. b) Retaru, A. 
V.; Druta, L. D.; Deser, T.; Mueller, T. J. Helv. Chim. Acta 2005, 88, 1798. c) Surpateanu, G. G.; Becuwe, 
M.; Lungu, N. C.; Dron, P. I.; Fourmentin, S.; Landy, D.; Surpateanu, G. J. Photochem. Photobiol. A 2007, 
185, 312. d) Kim, E.; Koh, M.; Ryu, J.; Park, S. B. J. Am. Chem. Soc. 2008, 130, 12206. 
117 a) Seregin, I. V.; Ryabova, V.; Gevorgyan, V. J. Am. Chem. Soc. 2007, 129, 7742. b) Niyomura, O.; 
Yamaguchi, Y.; Sakao, R.; Minoura, M.; Okamoto, Y. Heterocycles 2008, 75, 297. c) Basavaiah, D.; 
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Thus, we designed indolizynil-allenophanes MC-In, and proposed a similar synthetic 
scheme to the one we used in the previous chapter, being this, Sonogashira cross-coupling 
reactions between the enantiopure allene (P)-DEA-OH and the indolizinyl aromatic spacer 
followed by intermolecular macrocyclization of the deprotected hetero-oligomer that 
should give the desire indolizinyl-allenophane. 
Scheme 4.1. Retrosynthetic scheme of indolizinil-allenophane MC-In. 
The first target of this project is the synthesis of the indolizinyl aromatic spacers from 2-
enynylpyridines. Incorporation of a halogen atom at position 5 of indolizine,118 would lead 
to the halogenated anchor. 
4.1 Synthesis of 2-Enynylpyridines 
During the synthesis of the ocular pigment A2E,119 when dibromoolefin 4.2 was treated 
whit LDA in high excess in THF at –78 ºC, enynylpyridine E-4.1a was obtained in good 
yield. However, when t-BuOK was used as base at 25 ºC, a more apolar fluorescent 
                                                                                                                                                    
Devendar, B.; Lenin, D. V.; Satyarayana, T. Synlett 2009, 411. d) Barluenga, J.; Lonzi, G.; Riesgo, L.; 
López, L. A.; Tomás, M. J. Am. Chem. Soc. 2010, 132, 13200. 
118 Kuznetsov, A. G.; Bush, A. A.; Babaev, E. V.; Tetrahedron 2008, 64, 749.  
119 Sicre, C.; Cid, M. M. Org. Lett. 2005, 7, 5737. 
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compound was obtained. Exhaustive spectroscopic analysis (1H, 13C, COSY, HSQC and 
HMBC spectra) led to the indolizine-skeleton In-4.1a-TMS (Scheme 4.2). 
 
Scheme 4.2. Influence of reactions conditions in the preparation of 2-enynylpyridine E-4.1a-TMS from 
dibromodienylpyridine 4.2.119 
Thus, in order to know more about this process, first, we carried out the synthesis of 
different enynylpyridines to yield the corresponding indolizines (Figure 4.3). 
 
Figure 4.3. Enynylpyridines E-4.1b, E-4.1c and Z-4.1c-TMS. 
The synthesis of enynylpyridine E-4.1b is depicted in Scheme 4.3. Horner-Wadsworth-
Emmons (HWE) of 2-formylpyridine with the phosphonate anion, obtained by reaction of 
ethyl 2-(diethoxyphosphin)propanoate with NaH, afforded the pyridinacrylate E-4.3 in 
67% yield along with the (Z)-2-methyl-3-(pyridin-2-yl)acrylate in 6% yield. Then, 
reduction of E-4.3 with DIBAL-H in DCM followed by oxidation employing the Dess-
Martin periodinane and subsequent Corey-Fuchs reaction gave the dibromopyridine E-4.6 
in 63% yield. Finally, reaction of E-4.6 with LDA at –78 ºC provided the enynylpyridine 
E-4.1b in 70% yield. 
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Scheme 4.3. Synthesis of enynylpyridine E-4.1b. 
The synthesis of enynylpyridine E-4.1c started with a Corey-Fuchs reaction of 2-
formylpyridine that led to 2-(2’,2’-dibromovinyl)pyridine 4.7 in 90% yield. Then reduction 
of 4.7 with LiAlH4 gave (E)-2-(2´-bromovinyl)pyridine E-4.8 in 43% yield along with 2-
ethynylpyridine (7%). Sonogashira cross-coupling ([Pd(PPh3)2Cl2], CuI, Et3N) between E-
4.8 and trimethylsilylacetylene afforded the enynylpiridine E-4.1c-TMS in a 51% yield. 
Finally, deprotection of E-4.1c-TMS employing K2CO3 in MeOH gave the desire 
enynylpiridine E-4.1c in 95% yield (Scheme 4.4). 
 
Scheme 4.4. Synthesis of enynylpyridine E-4.1c. 
On the other hand, the synthesis of enynylpyridine Z-4.1c-TMS started with a Wittig 
bromoolefination reaction of 2-formylpyridine with bromomethyltriphenylphosphonium 
bromide, NaHDMS as base at –78 °C during 3 h to give (Z)-2-(2´-bromovinyl)pyridine Z-
4.8 in 87% yield and E-4.8 in 8% yield. Then, Sonogashira cross-coupling reaction 
([Pd(PPh3)2Cl2], CuI, Et3N) with trimethylsilylacetylene afford the desired (Z)-
enynylpyridine Z-4.1c-TMS in 72% yield among a compound identified as the 1,1'-
biindolizine 4.9 in 15% yield (Scheme 4.5). 
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Scheme 4.5. Shynthesis of of enynylpyridine Z-4.1c-TMS. 
 
Once the enynylpyridines were obtained, they were submitted to cyclization conditions to 
yield the corresponding indolizine. 
4.2 Synthesis of Indolizines from 2-Enynylpyridines 
To shed light on the mechanism responsible of the transformation of (E)-enynylpyridines 
into the corresponding indolizines we carried out an experimental and computational120 
reactivity study on the enynylpyridines E-4.1a, E-4.1b and E-4.1c.121  
 
Scheme 4.6. Reactivity of different substituted enynylpyridines. 
When tBuOK was added in large excess at 25 C, enynylpyridine E-4.1a yielded a single 
fluorescent product, indolizine In-4.1a.119 Enynylpyridine E-4.1b also yielded the 
indolizine product In-4.1b although it required higher temperature (65 C). On the 
contrary, E-4.1c proved nonreactive. Different attempts to activate the reaction, such as 
thermal (115 C in toluene), nucleophilicity enhancement of the MeO– anion by adding a 
crown ether to capture the base counterion (15-crown-5), or activation of the alkyne with 
iodine, were unsuccessful. 
                                                 
120  The theoretical calculations were performed by Dr. Carlos Silva López and Dr. Armando Navarro-
Vázquez (Universidade de Vigo, Spain). 
121 Lahoz, I. R.; Sicre, C.; Navarro-Vázquez, A.; Silva López, C.; Cid, M. M. Org. Lett. 2009, 11, 4802. 
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Preliminary studies by Kaloko and Hayford122 reported the formation of indolyzinyl ethers 
via treatment of silylated (Z)-2-enynyl pyridines with cesium or potassium fluoride in the 
presence of different alcohols as solvents or cosolvents. A mechanistic pathway involving 
a Michael type addition to the vinylacetylene and subsequent six electron electrocyclic ring 
closure to afford the indolizine was proposed (Scheme 4.7). 
 
Scheme 4.7. Preliminary studies by Hayford and Kaloko. Preparation of indolizines from (Z)-2-pyridine- and 
quinolinesilylated vinylacetylenes (top). Proposed mechanism for the formation of indolizinas from 
enynylpyridines (bottom).122 
However, Haley and Herges propose that similar heterocyclic structures undergo 
cyclization via a pseudocoarctate process,123 which can be conveniently identified by a 
disconnection in the anisotropy of the current-induced density (ACID).124  
First of all, it is necessary to define what are the differences between a pericyclic and a 
coarctate reaction; a pericyclic reaction is a concerted reaction that proceeds by a 
simultaneous breaking and formation of only one bond at each atom involved in the 
reaction in a cyclic array. When the cyclic delocalization of electrons in the transition state 
is interrupted (disconnected) due to the presence of orthogonal orbitals involved in the 
delocalized system, the reactions are pseudopericyclic. 
On the other hand, a coarctate reaction takes place when there is at least one atom at which 
two bonds are made and two bonds are broken simultaneously. Coarctate reactions do not 
                                                 
122 Kaloko, J.; Hayford, A. Organic Lett. 2005, 7, 4305. 
123 a) Herges, R. Angew. Chem., Int. Ed. 1994, 33, 255. b) Kimball, D. B.; Herges, R.; Haley, M. M. J. Am. 
Chem. Soc. 2002, 124, 1572. c) Kimball, D. B.; Weakley, T. J. R.; Herges, R.; Haley, M. M. J. Am. Chem. 
Soc. 2002, 124, 13463. 
124 Herges, R.; Geuenich, D. J. Phys. Chem. A 2001, 105, 3214. 
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follow a cyclic path. Disconnections can also occur in coarctate reactions and we term 
these reactions pseudocoarctate. 
The ACID method is a useful tool to distinguish between pericyclic/pseudopericyclic and 
coarctate/pseudocoarctate mechanisms. The ACID scalar field is interpreted as the density 
of delocalized electrons. A cyclic topology in an ACID plot indicates a pericyclic reaction, 
and a noncyclic but contiguous delocalized system (constricted or coarctate cycle) 
indicates a coarctate system. Disconnections that are characteristic for pseudopericyclic 
and pseudocoarctate processes are immediately visible by a disconnection in the bonding 
path. 
The next example, reported by Haley, Herges and coworkers,123c shows the difference 
between an ACID plot of a pseudocoarctate and a coarctate reaction (Scheme 4.8). 
 
Scheme 4.8. Left: The ACID plot shows a disconnection between the C and N atoms at which the new C–N 
bond is formed. The current density vectors (green arrows with red tips) do not exhibit a closed circle in the 
five-membered ring. Therefore, the transition state is pseudocoarctate. Right: The current density vectors, 
which are plotted onto the ACID isosurface, indicate the coarctate nature of the transition state.123c 
In our case, the ACID isosurface at the transition state (TS) leading from (Z)-2-
enynylpyridine to the corresponding indolizine exhibits a disconnection between the C and 
N atoms at which the new C–N bond is formed and, moreover, show a non-cyclic 
delocalized system; consequently the reaction is pseudocoarctate (Scheme 4.9). 
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Scheme 4.9. ACID plot of the transition state of the cyclization of (Z)-2-enynylpyridines to indolizine.121 
The energy landscapes of two different mechanisms for the formation of these indolizines 
from the corresponding 2-enynylpyridines were also studied on the basis of B3LYP DFT 
computations: concerted and neutral vs nucleophilic and highly charged.  
The concerted and neutral mechanistic alternative indicates that the double-bond 
isomerization previous to the pseudocoarctate cyclization involves a very high activation 
barrier (41.9, 41.8, and 45.5 kcal/mol for E-4.1a, E-4.1b and E-4.1c, respectively (Figure 
4.4). The remaining steps show activation energies considerably lower. Accessible barriers 
at working temperature can be observed for E-4.1a and E-4.1b (the rate-limiting step 
would involve an activation energy of ∼22 kcal/mol), whereas E-4.1c seems to be less 
prone to undergo both, the pseudocoarctate cyclization (27.3 kcal/mol) and the carbene 
insertion (29.0 kcal/mol). The energy profiles for this pathway, thus, are quite consistent 
with the experimentally observed trends if a low energy alternative for the double-bond 
isomerization of the (E)-enynylpyridines can be found. 
 
Figure 4.4. Free energy profile (kcal/mol, 298 K) for the concerted pathway from enynylpiridines E-4.1a, E-
4.1b, and E-4.1c to the corresponding indolizines. The base was modeled as MeOLi to reduce computational 
cost.121 
E-4.1a R1 = Me R2 = CCH
E-4.1b R1 =Me  R2 = H
E-4.1c R1 = H    R2 = H
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The nucleophilic mechanistic alternative does seem compatible with the double-bond 
isomerization. After the deprotection of the TMS group, the first and key step in this 
mechanism proposed by Hayford and Kaloko is the addition of the alkoxide to the enyne. 
This step takes place with a low barrier of ∼18 kcal/mol to give an intermediate complex. 
According to the energy profile, double-bond isomerization is accessible for E-4.1a and E-
4.1b (rate limiting steps of ∼25 kcal/mol) whereas it is significantly higher in energy for E-
4.1c (29.6 kcal/mol). The final cyclization step follows, approximately, the same trend and 
similar reaction barriers (Figure 4.5). 
 
Figure 4.5. Free energy profile (kcal/mol, 298 K) for the nucleophilic pathway from enynylpiridines E-4.1a, 
E-4.1b, and E-4.1c to the corresponding indolizines.121 
A qualitative comparison between both profiles, concerted and nucleophilic, indicates that 
the lowest energy pathway available to the (E)-enynylpyridine substrate combines both 
mechanisms: the nucleophile assisted E-Z isomerization followed by a pseudocoarctate 
cyclization that leads to an intermediate indolizinyl carbine, which in the presence of 
alcohols, undergoes fast formal insertion onto the OH bond to yield the corresponding 
ether derivative (Figure 4.6). 
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Figure 4.6. Free energy profile (kcal/mol, 298 K) for the proposed mechanism for the formation of indolizine 
derivatives from enynylpiridines E-4.1a, E-4.1b, and E-4.1c.121 
 
In order to verify these theoretical results, an intermolecular and intramolecular trapping of 
the indolizinyl carbene intermediate was carried out.125 
a) Intermolecular Carbene Trapping 
The reactivity of the indolizinyl carbene 4.10 towards electron-rich and electron-poor 
alkenes was investigated in order to classify its nucleophilic or electrophilic nature. When 
2-enynylpyridine Z-4.1c was heated in ethyl acrylate, electron-poor alkene, the cyclopropyl 
derivative 4.11-cis was obtained as a single diastereoisomer in 32% yield. On the other 
hand, when Z-4.1c was heated in neat dimethylbutene, electron-rich alkene, the expected 
cyclopropyl derivative was not obtained; instead, ether 4.12 was identified as a product 
(Scheme 4.10). A plausible explanation for this result is the formal insertion of carbene 
4.10 into the OH bond of 2,3-dimethyl-3-butenol, which is a dimethylbutene oxidation 
subproduct. 
                                                 
125 Lahoz, I. R.; Silva López, C.; Navarro-Vázquez, A.; Cid, M. M. J. Org. Chem. 2011, 76, 3266. 
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Scheme 4.10. Intermolecular trapping of the indolizinyl carbene 4.10.121 
In light of these experimental results and with the help of theoretical calculations, we 
propose that enynylpyridines undergo a stereoselective addition to ethyl acrylate through 
the formation of a transient nucleophilic singlet carbene to give cis-cyclopropylindolizines. 
It is worth nothing that indolizine 4.11-cis upon standing on CDCl3 gradually converted to 
a new isomeric compound, in which the originally observed complex multiplet at 3.76 
ppm, arising from strong couplings of the diastereotopic CH2 protons of the carbethoxy 
group, transforms into a 1:3:3:1 quartet at 4.25 ppm, suggesting that the original product 
should correspond to the 4.11-cis form, in which the indolizine moiety is closer to the CH2 
group. Consequently, the newly formed compound should be the trans isomer, 4.11-trans, 
with the indolizine ring lying away from the diastereotopic methylene protons, which 
become nearly chemically equivalent (Scheme 4.11). This transformation likely proceeds 
through enol formation catalyzed by traces of hydrochloric acid in the CDCl3 solvent. In 
fact, 4.11-cis is much more stable in deuterated benzene and, when using activated alumina 
treated CDCl3, isomerization rates were appreciably lowered. Computations have shown 
that the 4.11-trans product is more stable than 4.11-cis by 2.3 kcal/mol, in agreement with 
the NMR observations. 
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1H-NMR (CHCl3) -CO2CH2CH3: 
 
Scheme 4.11. Isomerization of 4.11-cis to 4.11-trans in CDCl3 (top). 1H-NMR of the diastereotopic CH2 
protons of the carbethoxy group of 4.11-cis and 4.11-trans (bottom).125 
Verification of this stereochemical assignment was based on the observed NOE 
enhancement pattern obtained in DPFGSE 1D NOESY experiments, using a mixing time 
of 500 ms. The spin system of both isomers was characterized on the basis of HSQC and 
HMBC experiments. Irradiation of H2' leads to an NOE enhancement of 2.4% in H1', in 
4.11-cis, that falls to 0.6% in 4.11-trans. In addition, a long-range NOE (0.6%) is observed 
for the indolizinyl proton H5 upon H2' irradiation in 4.11-cis. Irradiation of H1' led to the 
observation of 2.0 and 1.8% NOE, in 4.11-cis and 4.11-trans respectively, with one of the 
methylenic protons which was, accordingly, assigned as H3'b (Figure 4.7). 
 
Figure 4.7. Observed NOE increments for the cis and trans forms of cylopropylindolizine 4.11.125 
4.11-cis 
4.11-trans 
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When indolizine 4.11-trans stand in CDCl3 solution, its H1 proton signal slightly broadens 
until the signal completely disappear. We attribute this behavior to progressive deuteration 
of the C1 position of the indolizine nucleus due to the presence of DCl in the CDCl3 
solution. In fact, after filtering the indolizine CDCl3 solution through dry CaCO3, a sharp 
doublet was observed again for the C1 proton. 
b) Intramolecular Carbene Trapping 
Sonogashira coss-coupling between 2-enynylpyridine Z-4.1c and 2-bromovinylpyridine 
afforded bis(pyridylenyl)yne 4.13, that undergoes a spontaneous reaction giving the 
biindolizine 4.9 in 60% yield (Scheme 4.12). 
 
Scheme 4.12. Synthesis of biindolizine 4.9.125 
Biindolizine 4.9 had been previously obtained as a side product in the Sonogashira reaction 
to obtain the compound Z-4.1c-TMS. 
According to M06/6-31+G** computations, biindolizine 4.9 presents two possible 
conformations of C2 symmetry, s-cis and s-trans, with N–C–C–N dihedral angles of 64 and 
134º, respectively, the trans form being slightly higher in energy (0.7 kcal/mol) than the 
cis. 
Dipyridylene-yne 4.13 may present several conformations due to rotation around the two 
pyridyl-alkene bonds, which we noted as s-trans or s-cis, and also by rotation about C–
CC bond, what will result in transoid or cisoid conformations. According to M06 
computations the most stable form is the transoid s-trans/s-trans form where the nitrogen 
lone pair points away from the alkyne moiety (Figure 4.8). 
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Figure 4.8. Relative energies (kcal/mol) for all conformations of dypyridylene-yne 4.13.125 
The cyclization reaction of the dipyridylene-yne 4.13 proceeds either from the transoid 
(cisoid) s-trans/s-cis or s-cis/s-cis conformers. Interestingly, both conformers undergo 
cyclization through nearly isoenergetic transition structures (20.7 kcal/mol, ΔG298.15K). In 
the case of the s-cis/s-cis transition structure, the final product 4.9 is obtained in a single 
step with no intermediate transition state for the formation of the second C–N bond. 
However reaction from the s-cis/s-trans isomer proceeds through formation of an 
intermediate carbine although both reaction paths are almost energetically degenerated 
(Figure 4.9). 
A C2-symmetric structure of formal coarctate nature, corresponding to synchronous 
formation of the two C–N bonds, is a second-order saddle point higher in energy (ΔG298.15K 
= 28.4 kcal/mol) than the asynchronous transition state and therefore is not relevant in the 
reaction pathway. 
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Figure 4.9. Potential free energy surface for biscyclization of bispyridine 4.13.125 
 
In summary, computational and experimental evidence supports that a combination of 
nucleophile assisted E-Z isomerization followed by a pseudocoarctate cyclization that leads 
to a nucleophilic singlet carbene, is responsible for the transformation of enynylpyridines 
into the corresponding indolizines. 
With the indolizines in hand, halogenation reactions and subsequent Sonogashira cross-
coupling reaction with DEA followed by macrocyclization under Breslow conditions will 
render the corresponding indolizinyl-allenophane MC-In. This work will be carried out in 
due course. 
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A new (2,6)pyrido[142]allenoacetylenyc cyclophane MC[142] was prepared by two routes: 
 
 The first route involved the synthesis of MC[142] from the diethynyallene (±)-
DEA-TIPS. This allenophane was obtained as a mixture of two pairs of enantiomers 
(P,P,P,P)/(M,M,M,M)-MC[142] and (P,P,M,P)/(M,M,P,M)-MC[142] and three achiral 
isomers (P,M,M,P)-MC[142], (P,M,P,M)-MC[142] and (P,P,M,M)-MC[142] in a 1:4:1:1:1 
predicted statistical distribution. This mixture was resolved by HPLC and the relative 
configuration of the different stereoisomers could be assigned thanks to their symmetry 
and chirality by NMR, HPLC in a chiral stationary phase, dichroism circular spectroscopy 
X-Ray analysis and theoretical calculations. 
 
 The second route involved the resolution of the starting material, the 
diethynylallene DEA-OH, by HPLC in a chiral stationary phase. Subsequent reactions and 
the conservation of the enantiomeric purity provided the macrocycle (P,P,P,P)-MC[142] 
and its enantiomer enantiomerically pure.  
(P,P,P,P)-MC[142] can present three possible conformations: cis, trans and twist. In solid 
phase, this macrocycle presents a geometry close to the theoretical twist conformation.  
To discern which conformation is present in solution or if the allenophane is better 
described as an average of them, it was carried out an experimental and theoretical study 
(CAM-B3LYP 6-31G(d) level of theory) of its chiroptical propertiers (ECD, VCD and 
ORD). The comparison of experimental and theoretical ECD and ORD spectra strongly 
suggests the twist conformation as the predominant in solution.  
The study of the solvent effect in this system show that chloroform solvent molecules can 
establish weak hydrogen bonds with the pyridine ring of the macrocycle.  
The chiral macrocycle presents bistability. The two possible states reversibility exchanged 
by addition of TFA or Et3N and present very different quiroptical responses, therefore 
opening access to novel chiral molecular switches. 
 
 Finally, incorporation of new aromatic spacers into the macrocycle, such as 
idolizinyl moieties, offers the possibility of new systems with fascinating properties.  
The indolizinyl aromatic spacer was synthesised from 2-enynylpyridines. To shed light 
about this process computational and experimental reactivity studies were performed. 
These studies support that a nucleophile assisted E-Z isomerization followed by a 
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pseudocoarctate cyclization that leads to a nucleophilic singlet carbene is responsible for 
the transformation of (E)-enynylpyridines into the corresponding indolizines.  
 
Chiral alleno-acetylenic macrocycles are fascinating and interesting structures in modern 
organic chemistry. This interest arises from their application in supramolecular chemistry, 
material science, and theoretical chemistry. Their applications, include the formation of 
discotic liquid crystals, extended tubular channels, porous organic solids, aggregates on 
surfaces, and hostguest complexes. Moreover, alleno-acetylenic macrocycles are of high 
interest due to their chiroptical properties when they are obtained in enantiopure form. 
These chiral properties can be further combined with other properties to furnish new 
functional materials, such as chiral molecular switches, chiral magnets, chiral 
semiconductors or fluorophores exhibiting circularly polarized luminescence.  
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 General procedures. Solvents were dried according to published methods and distilled 
before use.126 THF, for reactions were dried by distillation over sodium/benzophenone. 
Dichloromethane, dichloroethane, Et3N, pyridine, and methanol were distilled over 
calcium hydride immediately before use. All other reagents were commercial compounds 
of the highest purity available. All reactions were carried out under argon atmosphere, and 
those not involving aqueous reagents were carried out in oven-dried glassware for at least 
12 hours to 140 ºC. All solvents and anhydrous solutions were transferred through syringes 
and cannulae previously dried in the oven for at least 12 h and kept in a dessicator with 
KOH. For reactions at low temperature, icewater or CO2/acetone systems were used. 
Flash column chromatography (FC) was carried out using Merck Kieselgel 60 (230-400 
mesh) under pressure. Analytical thin layer chromatography (TLC) was performed on 
aluminium plates with Merck Kieselgel 60F254 and visualized by UV irradiation (254 nm) 
or by staining with a solution of phosphomolibdic acid. HPLC: Waters 510 pump 
controlled by PMC pump controller, with U6K injector and UV detector. The used 
solvents were HPLC grade and degassed with He. UV/Vis and ECD spectra were recorded 
on a Jasco J-815 spectropolarimeter at 25 ºC. 1H NMR spectra were recorded in CDCl3, 
C6D6 or acetone at ambient temperature on a Bruker AMX-400 spectrometer at 400 MHz 
or 600 MHz with residual protic solvent as the internal reference [CDCl3, H = 7.26 ppm; 
(CD3)2CO, H = 2.05 ppm; C6D6, H = 7.16 ppm]; chemical shifts () are given in parts per 
million (ppm), and coupling constants (J) are given in Hertz (Hz). The proton spectra are 
reported as follows:  (multiplicity, coupling constant J, number of protons, assignment). 
13C NMR spectra were recorded in CDCl3 and C6D6 at ambient temperature on the same 
spectrometer,r at 100 MHz, with the central peak of CDCl3 (C = 77.16 ppm), C6D6 (C = 
128.06 ppm) as the internal reference. The DEPT135 pulse sequence was used to aid in the 
assignment of signals in the 13C NMR spectra. IR spectra were recorded on a JASCO 
FT/IR-4200 infrared spectrometer from a thin film deposited onto a NaCl glass plate Peaks 
are quoted in wave numbers (cm-1). Mass spectra were obtained on a Hewlett-Packard 
HP59970 instrument operating at 70 eV by electron ionization and on an APEX III FT-ICR 
MS (Bruker Daltonics, Billerica, MA) equipped with a 7T actively shielded magnet. Ions 
were generated using an Apollo API electrospray ionization (ESI) source, with a voltage 
between 1800 and 2200 V (to optimize ionization efficiency) applied to the needle, and a 
counter voltage of 450 V applied to the capillary. Samples were prepared by adding a spray 
                                                 
126 Perrin, D.; Armarego, W. Purification of Laboratory Chemicals; Pergamon Press: Oxford, 1998. 
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solution of 70:29.9:0.1 (v/v/v) CH3OH/water/formic acid to a solution of the sample at a 
v/v ratio of 1 to 5% to give the best signal-to-noise ratio. High-resolution mass spectra 
were taken on a VG Autospec instrument.  
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2,2,6,6-Tetramethyl-hepta-4-yn-3-one (2.1).44b 
 
 
 
n-BuLi (1.8 mL of a 2.5 M solution in hexane, 4.5 mmol) was added dropwise under argon 
atmosphere at 0 °C to 3,3-dimethylbut-1-yne (500 µL, 4.0 mmol) in THF (4 mL). After 1 
h, CuI (764 mg, 4.0 mmol) was added in small amounts over a period of 30 min (orange-
red). Then a solution of tert-BuCOCl (500 µL, 4.0 mmol) in THF was added dropwise at 0 
°C. The mixture was stirred for 1 h at this temperature and then, warmed up to room 
temperature (yellow). Saturated aqueous NH4Cl solution was added, and the mixture was 
extracted with Et2O. The combined organic phases were dried with MgSO4. Evaporation in 
vacuo and purification by flash chromatography (SiO2; ciclohexane/AcOEt 20:1) gave a 
clear volatile oil, 2,2,6,6-tetramethyl-hepta-4-yn-3-one (2.1) (334 mg, 50%). 
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 1.29 (s, 9H), 1.18 (s, 9H). 13C-NMR (100 MHz, 
CDCl3) δ (ppm) 194.9, 103.2, 77.3, 44.9, 30.3, 28.0, 26.32. 
 
 
 (±)-3-tert-Butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-diyn-3-ol ((±)-2.2).44b 
 
 
 
 
 
 
n-BuLi (1.3 mL of a 2.5 M solution in hexane, 3.25 mmol) was added dropwise under 
argon atmosphere at –78 °C to a solution of ethynyltriisopropylsilane (660 µL, 536.6 
mmol) in THF (3.6 mL). After stirring for 1 h, ynone 2.1 (314 mg, 2.17 mmol) in THF (1.5 
mL) was added dropwise. After 30 min, the mixture was allowed to warm to room 
temperature. Saturated aqueous NH4Cl solution was added, and the mixture was extracted 
with Et2O. The combined organic phases were dried with MgSO4. Evaporation in vacuo 
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and purification by flash chromatography (SiO2; ciclohexane/AcOEt 20:1, and then 
ciclohexane/AcOEt 10:1) gave 3-tert-butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-
diyn-3-ol ((±)-2.2) as a clear volatile oil (563 mg, 62%).  
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 1.21 (s, 9H), 1.12 (s, 9H), 1.08 (s, 21H). 13C-NMR 
(100 MHz, CDCl3) δ (ppm) 108.1, 93.0, 84.8, 79.1, 71.4, 40.1, 31.1, 27.8, 25.2, 19.0, 11.7. 
 
 
(±)-3-tert-Butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-diyn-3-yl-acetate ((±)-3.2)) 
 
 
 
To a solution of the alcohol (±)-2.2 (120 mg, 0.34 mmol) in DCM (860 µL) in a Schlenk 
tube, were added Et3N (240 µL, 1.7 mmol), Ac2O (80 µL, 0.7 mmol) and DMAP (18 mg, 
0.14 mmol). The mixture was stirred at 40 °C for 24 h. After cooling to room temperature, 
the mixture was partitioned between saturated aqueous NaHCO3 solution and DCM, the 
aqueous phase was extracted with DCM, and the combined organic phases were dried with 
MgSO4. Evaporation in vacuo and purification by flash cromatography (SiO2, 
ciclohexane/AcOEt 20:1) gave 3-tert-butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-
diyn-3-yl-acetate ((±)-3.2) (78 mg, 58%) as a white solid. 
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 2.05 (s, 3H), 1.22 (s, 9H), 1.16 (s, 9H), 1.10 (s, 
21H). 13C-NMR (100 MHz, CDCl3) δ (ppm) 167.6, 103.8, 94.0, 86.3, 75.4, 74.4, 40.2, 
30.7, 27.6, 24.9, 21.6, 18.7, 11.4. MS (EI+) m/z (%) 390 ([M]+, 18%), 173 (100). HRMS 
(EI+) m/z calc. for C24H42O2Si 390.2954; found 390.29486. 
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Kinetic resolution of (±)-3-tert-butyl-6,6-dimethyl-1-(tri propylsilyl)hepta-1,4-diyn-3-
yl-acetate ((±)-3.2) catalyzed by Lipases. 
 
 
 
General procedure: racemic acetate (±)-3.2 was dissolved in THF (0.4 M) and sodium 
phosphate buffer [0.1 M; pH = 7] (0.02 M). Then lipase was added in small amounts and 
the reaction mixture was vigorously stirred at room temperature. The conversion of the 
reaction was followed by TLC and GC analysis. The reaction mixture was then partitioned 
between distilled water and Et2O. The aqueous phase was extracted with Et2O. The 
combined organic phases were dried (MgSO4) and the solvent removed under reduced 
pressure. 
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Candida antarctica inmobilized in Sol-Gel-AK 0.003 38 24 — — 
Candida antarctica inmobilized in Sol-Gel-AK 0.003 158 24 — — 
Candida cylindracea 2.4 40 24 — — 
Candida cylindracea 2.4 151 24 — — 
Hog pancreas 21 50 24 — — 
Rhizopus niveus 0.0026 125 96 — — 
Rhizopus niveus 0.0026 168 24 — — 
Mucor miehei 1.6 74 96 — — 
Aspergilus niger 1.4 62 96 — — 
Rhizopus arrhizus 0.002 163 24 — — 
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(±)-3-tert-Butyl-6,6-dimethylhepta-1,4-diyn-3-yl acetate ((±)-3.3). 
 
 
 
TBAF (260 µL of a solution 1 M in THF, 0.26 mmol) was added to a solution of the 
acetate (±)-3.2 (80 mg, 0.23 mmol) in THF (7.5 mL) and the mixture was stirred at 25 °C 
for 3 h. Purification by flash chromatography (SiO2; pentane/Et2O 10:1→10:1.5) gave (±)-
3-tert-butyl-6,6-dimethylhepta-1,4-diyn-3-yl acetate ((±)-3.3) (35 mg, 64%) as a white 
solid. 
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 2.55 (s, 1H), 2.06 (s, 3H), 1,22 (s, 9H), 1.14 (s, 9H). 
13C-NMR (100 MHz, CDCl3) δ (ppm) 168.3, 94.4, 80.3, 74.7, 73.8, 73.3, 40.5, 30.7, 27.6, 
24.8, 21.7. 
 
 
Kinetic resolution of (±)-3-tert-butyl-6,6-dimethylhepta-1,4-diyn-3-yl acetate ((±)-3.3) 
catalyzed by Lipases 
 
 
 
The results of the kinetic resolution of (±)-3.3 catalyzed by lipases following the same 
procedure described for the resolution of compound (±)-3.2 are showed in the next table: 
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Candida antarctica inmobilized in Sol-Gel-AK 0.003 50 6 — — 
Candida antarctica inmobilized in Sol-Gel-AK 0.003 55 26 — — 
Candida cylindracea 2.4 50 6 — — 
Candida cylindracea 2.4 48 26 — — 
Candida cylindracea 2.4 150 48 — — 
Rhizopus niveus 0.0026 150 48 — — 
Rhizopus arrhizus 0.002 60 48 — — 
 
 
(±)-1-(tert-Butyl)-4,4-dimethyl-1-[(triisopropylsilyl)ethynyl]pent-2-yn-1-ylpentafluoro 
benzoate ((±)-2.3).43, 44 
 
 
 
n-BuLi (3.6 mL of a solution 1.5 M in THF, 5.4 mmol) was added dropwise to a solution 
of bis(trimethylsilyl)amine (1.05 g, 6.5 mmol) in THF (24 mL) at 0 °C. After 1 h, this 
solution (LHDMS) was added dropwise at 0 °C to alcohol (±)-2.2 (1.4 g, 5.4 mmol) in 
THF (11 mL) and stirred for 30 min at this temperature. ClCOC6F5 was added via syringe 
and the solution was stirred at 0 °C for 1 h. Then the mixture was warmed up to 25 °C and 
partitioned between a saturated aqueous NH4Cl solution and Et2O. The aqueous phase was 
extracted with Et2O, and the combined organic phases were dried with Na2SO4. 
Evaporation in vacuo give 2.76 g of a yellow oil, (±)-1-(tert-butyl)-4,4-dimethyl-1-
[(triisopropylsilyl)ethynyl]pent-2-yn-1-ylpentafluoro benzoate ((±)-2.3) which was used 
without further purification. 
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1H-NMR (400 MHz, CDCl3) (ppm) δ 1.22 (s, 9H), 1.18 (s, 9H), 1.08 (s, 21H). 13C NMR 
(100 MHz, CDCl3) δ (ppm) 155.9, 147.1, 144.8, 143.8, 141.4, 139.5, 136.1, 102.3, 95.8, 
88.3, 78.0, 74.4, 40.5, 30.6, 27.7, 24.9, 18.7, 11.4. 19F NMR (282 MHz, CDCl3) δ (ppm) -
139.2 (m, 2F), -150.2 (m, 1F), -161.2 (m, 2F). 
 
 
 (±)-3,5-Di(tert-butyl)-1-(triisopropylsilyl)hepta-3,4-diene-1,6-diyne ((±)-DEA-TIPS).44 
 
 
 
Two solutions were prepared: 
a: a solution of (±)-2.3 (922 mg, 1.7 mmol) in CH4Cl2 (6.5 mL) in a Schlenk tube; 
b: a solution of [Pd(PPh3)4] (98 mg, 0.085 mmol) in CH4Cl2 (10 mL); 
Both solutions were degassed with Ar. CuI (32 mg, 0.17 mmol) was added to solution b 
and this solution was further sparged with Ar. iPr2NH (480 µL, 3.5 mmol) and TMS-
acetylene (480 µL, 3.4 mmol) were added to solution a. Solution b was transferred via 
canula to a, after further sparging with Ar, the reaction was stirred at 25 °C for 22 h. Then 
the reaction mixture was partitioned between saturated aqueous NH4Cl solution and 
dichloromethane. The aqueous phase was extracted with dichloromethane. The combined 
organic phases were dried (Na2SO4) and the solvent was removed under reduced pressure. 
The crude obtained was then redissolved in THF (5.0 mL) and MeOH (5.0 mL), K2CO3 
(90 mg, 0.65 mmol) was added and the mixture was stirred at 25 °C for 3 h under Ar 
atmosphere. Then, the reaction mixture was partitioned between saturated aqueous NH4Cl 
solution and hexane. The aqueous phase was extracted with hexane. The combined organic 
phases were dried (Na2SO4) and the solvent was removed under reduced pressure. 
Purification by flash chromatography (SiO2; hexane) gave (±)-3,5-di(tert-butyl)-1-
(triisopropylsilyl)hepta-3,4-diene-1,6-diyne ((±)-DEA-TIPS) (460 mg, 76%) as a pale 
yellow oil.  
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1H-NMR (400 MHz, CDCl3) δ (ppm) 3.01 (s, 1H), 1.17 (s, 9H), 1.16 (s, 10H), 1.10 (s, 
21H). 13C NMR (100 MHz, CDCl3) δ (ppm) 212.7, 104.3, 101.9, 100.1, 94.5, 80.3, 77.8, 
35.5 35.4, 29.0, 28.9, 18.8, 11.5. 
 
 
(±)-5,7-Di(tert-butyl)-2-methyl-9-(triisopropylsilyl)nona-5,6-dien-3,8-diyn-2-ol ((±)-
DEA-DP).47 
 
 
 
Two solutions were prepared: 
a: a solution of (±)-2.3 (1.3 g, 2.39 mmol) in CH4Cl2 (10 mL) in a Schlenk tube; 
b: a solution of [Pd(PPh3)4] (135 mg, 0.117 mmol) in (CH2Cl)2 (10 mL); 
Both solutions were degassed with Ar. CuI (45 mg, 0.24 mmol) was added to solution b 
and this solution was further sparged with Ar. iPr2NH (880 µL, 5 mmol) and acetylene 
(460 µL, 4.75 mmol) were added to solution a. Solution b was transferred via canula to a. 
After further sparging with Ar, the reaction was stirred at 60 °C for 22.5 h. Then the 
reaction mixture was partitioned between saturated aqueous NH4Cl solution and 
dichloromethane. The aqueous phase was extracted with dichloromethane. The combined 
organic phases were dried with Na2SO4. Removal of the solvent under reduced pressure 
followed by purification by flash chromatography (SiO2; hexane/dichloromethane 1:1) 
gave (±)-5,7-di(tert-butyl)-2-methyl-9-(triisopropylsilyl)nona-5,6-dien-3,8-diyn-2-ol ((±)-
DEA-DP) (455 mg, 46 %) as a yellow oil. 
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 1.56 (s, 6H), 1.13 (s, 9H), 1.10 (s, 9H), 1.08 (s, 
21H). 13C NMR (100 MHz, CDCl3) δ (ppm) 211.8, 103.8, 102.2, 100.5, 96.9, 94.1, 76.1, 
65.9, 35.73 35.4, 31.7, 29.0, 18.8, 11.5. 
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5,7-Di-tert-butyl-2-methylnona-5,6-diene-3,8-diyn-2-ol (DEA-OH).47 
 
 
 
To a solution of (±)-DEA-DP (380 mg, 0.91 mmol) in THF (15 mL), TBAF (1 mL of a 1 
M solution in THF, 1.0 mmol) was added, and the mixture was stirred at 25 °C under Ar 
atmosphere for 5 h. Then the reaction mixture was partitioned between saturated aqueous 
NH4Cl solution and hexane. The aqueous phase was extracted with hexane. The combined 
organic phases were dried (Na2SO4) and the solvent was removed under reduced pressure. 
Purification by flash chromatography (SiO2; hexane/AcOEt 9:1) gave (±)-5,7-di-tert-butyl-
2-methylnona-5,6-diene-3,8-diyn-2-ol ((±)-DEA-OH) (184 mg, 78%) as a yellow oil. 
Compound (±)-DEA-OH was resolved by semipreparative HPLC whit an e.r. up to 99% 
using a chiral stationary phase, Chiralpack IA column (particle size of 5 µm; 10 mm Ø x 
250 mm). Elution was done with a mixture of hexane: isopropanol 99.2:0.8 at a flow rate 
of 2.5 mL/ min. Under these conditions a sample of (±)-DEA-OH (5 mg dissolved in 100 
µL of n-hexane; injection 100 µL) can be resolved into its enantiomers with a retention 
time (tR) of: 
   Enantiomer (P)-DEA-OH: tR = 17.8 min. 
   Enantiomer (M)-DEA-OH: tR  = 21.1 min. 
 
1H-NMR (400 MHz, CDCl3) δ (ppm) 2.98 (s, 1H), 1.54 (s, 6H), 1.12 (s, 9H), 1.11 (s, 9H). 
13C NMR (100 MHz, CDCl3) δ (ppm) 211.7, 103.1, 102.3, 97.5, 80.4, 77.7, 75.7, 65.8, 
35.6, 35.3, 31.6, 29.0, 28.9. 
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2,6-Bis[3,5-di-(tert-butyl)-7-(triisopropylsilyl)hepta-3,4-diene-1,6-diynyl)pyridine 
(HT-TIPS). 
 
 
 
Two solutions were prepared: 
a: a solution of (±)-DEA-TIPS (410 mg, 1.15 mmol) in toluene (6.5 mL) in a Schlenk 
tube; 
b: a solution of [PdCl2(PPh3)2] (18 mg, 0.026 mmol) and commercial 2,6-dibromopyridine 
(124 mg, 0.523 mmol) in toluene (6.5 mL). 
Both solutions were degassed with argon. CuI (10 mg, 0.052 mmol) was added to solution 
b, and the solution was further degassed with argon. TMEDA (182 mg, 1.57 mmol) was 
added to solution a. Then solution b was transferred via canula to solution a. After 
sparging with Ar, the reaction was stirred at reflux (110 °C) under Ar for 24 h. The 
reaction mixture was partitioned between saturated aqueous NH4Cl solution and hexane. 
The aqueous phase was extracted with hexane. The combined organic phases were dried 
(Na2SO4) and the solvent was removed under reduced pressure. Purification by flash 
chromatography on silica gel (hexane→hexane/DCM 9:1) afforded 2,6-bis[3,5-di-(tert-
butyl)-7-(triisopropylsilyl)hepta-3,4-diene-1,6-diynyl)]pyridine (HT-TIPS) (340 mg, 83%) 
as a yellow oil and as a diasteromeric mixture. 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.56 (t, J = 7.8, 1H), 7.33 (d, J = 7.8, 2H), 1.17 (s, 
18H), 1.14 (s, 18H), 1.06 (s, 42H). 13C NMR (100 MHz, CDCl3) δ (ppm) 213.2, 144.3, 
136.2, 126.4, 104.6, 102.4, 100.1, 94.9, 91.5, 84.2, 36.0, 35.6, 29.3, 29.1, 18.9, 11.5. 
HRMS-ESI: m/z calc. for C53H82NSi2
+ 788.59564; found 788.59803. 
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(P,P)-9,9'-(Pyridine-2,6-diyl)bis(5,7-di-tert-butyl-2-methylnona-5,6-dien-3,8-diyn-2-ol) 
((P,P)-HT-OH). 
 
 
 
Two solutions were prepared: 
a: a solution of (P)-DEA-OH (115 mg, 0.44 mmol) in toluene (5 mL) in a Schlenk tube; 
b: a solution of [PdCl2(PPh3)2] (8 mg, 0.011 mmol) and commercial 2,6-dibromopyridine 
(48 mg, 0.20 mmol) in toluene (5 mL). 
Both solutions were degassed with argon. CuI (4 mg, 0.02 mmol) was added to solution b 
and this solution was further degassed with argon. TMEDA (71 mg, 0.61 mmol) was added 
to solution a. Then solution b was transferred via canula to solution a. After sparging the 
reaction mixture, it was stirred at reflux (110 °C) under Ar for 20 h. The reaction mixture 
was then partitioned between saturated aqueous NH4Cl solution and hexane. The aqueous 
phase was extracted with hexane. The combined organic phases were dried (Na2SO4) and 
the solvent was removed under reduced pressure followed by purification by flash 
chromatography on silica gel (hexane/AcOEt 70:30) afforded (P,P)-9,9'-(pyridine-2,6-
diyl)bis(5,7-di-tert-butyl-2-methylnona-5,6-dien-3,8-diyn-2-ol) (P,P)-HT-OH (95 mg, 
79%) as a yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.58 (t, J= 7.8, 1H), 7.34 (d, J= 7.8, 2H), 1.55 (s, 
12H), 1.19 (s, 18H), 1,13 (s, 18H). 13C NMR (100 MHz, CDCl3) δ (ppm) 212.1, 144.2, 
136.2, 126.3, 126.3, 103.5, 102.7, 97.9, 91.5, 84.1, 75.7, 65.8, 35.8, 35.6, 31.6, 29.2, 29.0. 
IR-TF (NaCl) ν 3361, 2965, 2929, 2901, 2866, 2206, 1557, 1444 cm-1. UV/Vis (CHCl3): 
λmax () = 317 nm (20872 Lmol–1cm–1), 289 nm (22990 Lmol–1cm–1). HRMS-ESI: m/z 
calc. for C41H54NO2
+ 592.4149; found 592.4156. [α]D20 = +463 (c = 5 E–4 g/mL, CHCl3) 
 
The enantiomer (M,M)-HT-OH was obtained in a similar manner: HRMS-ESI: m/z calc. 
for C41H54NO2
+ 592.4149; found 592.4162. [α]D20 = 487 (c = 6.2 E–4 g/mL, CHCl3). 
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2,6-Bis[3,5-di-(tert-butyl)-hepta-3,4-diene-1,6-diynyl)]pyridine (HT-H). 
 
 
 
To a solution of HT-TIPS (330 mg, 0.42 mmol) in dry THF (60 mL), TBAF (920 µL of a 
1M solution in THF, 0.920 mmol) was added under Ar atmosphere. After stirring for 5 h at 
25 °C, saturated aqueous NH4Cl solution was added, and the mixture was extracted with 
hexane. The combined organic phases were dried with Na2SO4. Evaporation in vacuo and 
purification by flash chromatography on silica gel (hexane/AcOEt 95:5) afforded 2,6-
bis[3,5-di-(tert-butyl)-hepta-3,4-diene-1,6-diynyl)]pyridine (HT-H) (178 mg, 89%) as a 
white solid and as a diasteromeric mixture. 
 
 
2,6-Bis[(P)-3,5-di-tert-butylhepta-3,4-dien-1,6-diyn-1-yl)]pyridine ((P,P)-HT-H). 
 
 
 
Pulverized NaOH (732 mg, 18.26 mmol) was placed in a round-bottom flask, and dried 
with a heat gun under vacuum (101 Pa) and then, filled with Ar. Enantiopure (P,P)-HT-
OH (60 mg, 0.10 mmol) was dissolved in dry toluene (4 mL), and the solution was 
transferred to the round-bottom flask. The mixture was refluxed at 110 °C for 2 h. Then 
saturated aqueous NH4Cl solution was added, and the mixture was extracted with hexane. 
The combined organic phases were dried with Na2SO4. Evaporation in vacuo and 
purification by flash chromatography on silica gel (hexane/AcOEt 8:2) afforded 2,6-
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bis((P)-3,5-di-tert-butylhepta-3,4-dien-1,6-diyn-1-yl)pyridine (P,P)-HT-H (39 mg, 80%) 
as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.56 (t, J = 7.8, 1H), 7.32 (d, J = 7.8, 2H), 2.99 (s, 
2H), 1.18 (s, 18H), 1.13 (s, 18H). 13C NMR (100 MHz, CDCl3) δ (ppm) 212.8, 144.1, 
136.2, 126.5, 103.2, 103.1, 91.8, 83.7, 81.1, 77.3, 35.9, 35.5, 29.2, 29.0. IR-TF (NaCl) ν 
3309, 2965, 2930, 2903, 2867, 1571, 1557, 1443, 1363, 1239, 1201 cm-1. HRMS-ESI 
(HT-H): m/z calc. for C35H42N
+ 476.3312; found 476.3299. UV/Vis (CHCl3): λ () = 317 
nm (16917 Lmol–1cm–1), 283 nm (18779 Lmol–1cm–1) 
 
   Enantiomer (P,P)-HT-H: HRMS-ESI: m/z calc. for C35H42N
+ 476.3312; 
found.476,3317. [α]D20 = + 284 (c = 4.75 E–4 g/mL, CHCl3) 
   Enantiomer (M,M)-HT-H: HRMS-ESI: m/z calc. for C35H42N
+ 476.3312; found 
476.3317. [α]D20 =  289 (c = 4.73 E–4 g/mL, CHCl3) 
 
 
Data for (P)-5,7-di-tert-butyl-9-(6-((P)-3,5-di-tert-butylhepta-3,4-dien-1,6-diyn-1-
yl)pyridin-2-yl)-2-methylnona-5,6-dien-3,8-diyn-2-ol ((P,P)-HT-MP). 
 
 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.60 (t, J = 7.8, 1H), 7.36 (d, J = 7.8, 2H), 3.02 (s, 
1H), 1.56 (s, 6H), 1.21 (s, 9H), 1.20 (s, 9H), 1.16 (s, 9H), 1.13 (s, 9H). 13C NMR (100 
MHz, CDCl3) δ (ppm) 212.8, 212.1, 144.1, 144.1, 136.3, 126.4, 103.4, 103.2, 103.1, 102.7, 
97.8, 91.8, 91.5, 84.2, 83.8, 81.1, 75.7, 65.9, 35.9, 35.8, 35.7, 35.5, 31.6, 29.3, 29.2, 29.0, 
28.9. IR-TF (NaCl) ν 3377, 3311, 2964, 2929, 2903, 2866, 2209, 1574, 1557, 1459, 1443, 
1363 cm–1. HRMS-ESI: m/z calc. for C38H48NO
+ 534.3730; found 534.3727. UV/Vis 
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(CHCl3): λ ()= 319 nm (29523 Lmol–1cm–1), 287 nm (32933 Lmol–1cm–1). [α]D20 = + 416 
(c = 1,92 E–3 g/mL, CHCl3). 
 
 
(P,P,P,P)-6,6'-(3,5,10,12-Tetra-tert-butyltetradeca-3,4,10,11-tetraen-1,6,8,13-tetrayne-
1,14-diyl)bis(5,7-di-tert-butyl-2-methylnona-5,6-dien-3,8-diyn-2-ol)pyridine) 
((P,P,P,P)-D-OH) 
 
 
 
Compound (P,P)-HT-MP (10 mg, 0.019 mmol) was dissolved in toluene (1 mL) in a 
Schlenk tube. To this solution [PdCl2(PPh3)2] (2.5 mg, 3.5 mol), CuI (1 mg, 5.23 mol) 
and TMEDA (8 mg, 0.07 mmol) were added, and the mixture was stirred at reflux (110 °C) 
under air atmosphere for 28 h. The reaction mixture was partitioned between saturated 
aqueous NH4Cl solution and dichloromethane. The aqueous phase was extracted with 
dichloromethane. The combined organic phases were dried (Na2SO4) and the solvent was 
removed under reduced pressure. Purification by flash chromatography on silica gel 
(hexane/AcOEt 70:30) afforded (P,P,P,P)-D-OH (6 mg, 62%) as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.59 (t, J = 7.8, 1H), 7.36 (d, J = 7.8, 2H), 1.56 (s, 
12H), 1.21 (s, 9H), 1.20 (s, 9H), 1.17 (s, 9H), 1.13 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 
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(ppm) 214.4, 212.1, 144.1, 144.0, 136.3, 126.5, 103.7, 103.7, 103.4, 102.7, 97.8, 92.1, 
91.5, 84.2, 83.5, 77.8, 75.7, 75.3, 65.9, 36.1, 36.1, 35.8, 35.6, 31.6, 29.2, 29.2, 29.2, 29.0. 
HRMS-ESI: m/z calc. for C76H93N2O2
+ 1065.7231; found 1065.7219. UV-Vis (CHCl3): λ 
()= 324 nm (62673 Lmol–1cm–1), 283 nm (63694 Lmol–1cm–1). [α]D20 = + 1090 (c = 1,12 
E–3 g/mL, CHCl3). 
 
 
4,6,11,13,19,21,26,28-Octa-tert-butyl-1,16(2,6)dipyridinecyclotriacontaphane-
4,5,11,12,19,20,26,27-octaen-2,7,9,14,17,22,24,29-octayne (MC[142]). 
 
 
 
Breslow method. 
 
CuCl (134 mg, 1.35 mmol) and CuCl2 (27 mg, 0.198 mmol) were dissolved in dry pyridine 
(8 mL), and the solution was degassed by bubbling Ar for 60 min. A solution of HT-H (9 
mg, 0.018 mmol) in dry pyridine (10 mL) was added over a period of 20 h. After 72 h, the 
solvent was removed under reduced pressure; the remaining solid was dissolved in DCM 
and washed with a saturated aqueous EDTA solution. The aqueous phase was extracted 
with DCM, dried over Na2SO4 and evaporated to dryness. The obtained solid was purified 
by flash chromatography (SiO2; hexane/DCM 70:30) affording MC[142] (5 mg, 63 %) as a 
white solid. 
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Hay method: 
 
A round-bottom flask was flame dried under a flow of dry argon. To the flask, CuI (25mg, 
0.123 mmol), TMEDA (40 mg, 0.34 mmol) and dichloroethane (3 mL) were added. Air 
was bubbled into the solution for 1 h at ambient temperature afforded Hay catalyst. Next, 
in other round-bottom flask a solution of HT-H (8 mg, 0.017 mmol) in dichloroethane (6 
mL) was prepared. The solution was stirred at ambient temperature while air was bubbled 
from an inlet tube. The solution of HT-H was added dropwise via a syringe pump to the 
Hay catalyst over a period of 6 h. After stirring the reaction for additional 264 h, the 
dichloromethane was evaporated under reduced pressure and the residue was washed with 
EDTA. The aqueous layers were extracted with DCM and the combined organic layers 
were washed with water, dried with Na2SO4, filtered and concentrated in vacuo. 
Purification by flash column chromatography on silica gel (hexane/DCM 70:30) afforded 
the desire compound MC[142] (5 mg, 68%) and another compounds identified by mass 
spectroscopy as 2,6-bis-(3,5-di-tert-butyl-7-iodohepta-3,4-dien-1,6-diyn-1-yl)pyridine HT-
I and 6,6'-(3,5,10,12-tetra-tert-butyltetradeca-3,4,10,11-tetraen-1,6,8,13-tetrayne-1,14-
diyl)bis(2-3,5-di-tert-butyl-7-iodohepta-3,4-dien-1,6-diyn-1-yl)pyridine) D-I. 
 
Pd/Cu method. 
 
Two solutions were prepared: 
a: a solution of Pd(PPh3)2Cl2 (8 mg, 0.011 mmol), CuI (4.0 mg, 0.021 mmol) and TMEDA 
(253 mg, 2.2 mmol) in toluene (15 mL).  
b: a solution of HT-H (50 mg, 0.109 mmol) in toluene (40 mL). 
Both solutions were bubbled with air for 1 h at ambient temperature. The solution a was 
heated at 60 °C and then, the solution b was added dropwise via a syringe pump over a 
period of 26 h. After stirring the reaction for additional 48 h, the toluene was evaporated 
and the residue was washed with KCN. The aqueous layers were extracted with DCM and 
the combined organic layers were washed with water, dried with Na2SO4, filtered and 
concentrated in vacuo. Purification by flash column chromatography on silica gel 
(hexane/DCM 70:30) afforded the desire compound MC[142] (29 mg, 56%) along with the 
diiodo compound HT-I (14%) and the diiodo dimer D-I (identified by mass spectroscopy). 
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MC[142] was obtained as a mixture of five different stereoisomers, which was separated 
by HPLC on the stationary phase Rexchrom ‘BucKyclutcher 1’ Preparative, 10 µm 100Å 
Trident-TriDNP, 50 cm X 21.1 mm ID (DCM/hexane 80:20; 5 mLmin–1). 
 
General data of MC[142]: IR-TF (NaCl) ν 3309, 2964, 2929, 2902, 2866, 2112, 1922, 
1729, 1574, 1557, 1444, 1363, 1220, 770 cm-1. 
 
Data for (P,M,M,P)-MC[142] 
 
1H NMR (400 MHz, C6D6) δ (ppm) 6.83 (d, J = 7.8, 4H), 6.63 (t, J = 7.6, 2H), 1.12 (s, 36 
H), 1.09 (s, 36 H). 13C NMR (100 MHz, C6D6) δ (ppm) 215.1, 144.3, 135.6, 125.9, 104.4, 
104.3, 93.6, 82.9, 78.7, 75.9, 36.1, 35.8, 29.1, 29.0. HRMS-ESI: m/z calc. for C70H79N2
+ 
947.6238; found 947.62335.  
 
Data for (P,P,P,P)-/(M,M,M,M)-MC[142] 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.58 (t, J = 7.8, 2H), 7.32 (d, J = 7.8, 4H), 1.19 (s, 
36H), 1.16 (s, 36H). 13C NMR (100 MHz, CDCl3) δ (ppm) 214.8, 144.0, 136.1, 126.2, 
103.9, 103.4, 92.1, 83.5, 78.1, 75.3, 36.1, 35.9, 29.2, 29.1. UV/Vis (CHCl3): λ ()= 321 nm 
(71685 Lmol–1cm–1), 300 nm (91791 Lmol–1cm–1), 284 nm (83578 Lmol–1cm–1). 
 
   Enantiomer (P,P,P,P)-MC[142]: HRMS-ESI: m/z calc. for C70H49N2
+ 947.6238; found 
947.6231. 
   Enantiomer (M,M,M,M)-MC[142]: HRMS-ESI: m/z calc. for C70H49N2
+ 947.6238; found 
947.6237. 
 
Data for (P,P,M,P)-/(M,M,P,M)-MC[142] 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.57 (t, J =7.7, 2H), 7.33 (d, J = 7.64, 4H), 1.19 (m, 
72H). 13C NMR (100 MHz, CDCl3)
 δ (ppm) 214.9, 214.4, 214.2, 144.1, 144.0, 136.2, 
126.3, 126.2, 126.1, 104.0, 103.7, 103.7, 103.5, 103.4, 92.3, 92.1, 91.9, 83.6, 83.4, 78.0, 
78.0, 77.9, 75.1, 75.0, 36.2, 36.1, 36.0, 36.0, 35.8, 29.2, 29.2. HRMS-ESI: m/z calc. for 
C70H79N2
+ 947.6238; found 947.6194. UV/Vis (CHCl3): λ ()= 320 (29677 Lmol–1cm–1), 
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296 (39563 Lmol–1cm–1), 281 nm (44453 Lmol–1cm–1). [α]D20 (compound C1)= 50.10 (c 
= 1,65 E–3 g/mL, CHCl3). [α]D20 (compound C2)= due to the low amount of sample it was 
not possible the measure.  
 
Data for (P,P,M,M)-MC[142]. 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.64 (t, J =7.8, 2H), 7.39 (d, J =7.8, 4H), 1.28 (s, 
36H), 1.22 (s, 36H). 13C NMR (100 MHz, CDCl3)
 δ (ppm) 214.7, 144.1, 136.1, 126.3, 
103.9, 103.4, 92.3, 83.5, 78.0, 75.1, 36.1, 35.9, 29.2, 29.1. HRMS-ESI: m/z calc. for 
C70H79N2
+ 947.6238; found 947.6232. 
 
Data for (P,M,P,M)-MC[142] 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.59 (t, J = 7.8, 2H), 7.34 (d, J = 7.8, 4H), 1.22 (s, 
36H), 1.19 (s, 36H). 13C NMR (100 MHz, CDCl3)
 δ (ppm) 214.8, 144.0, 136.3, 126.2, 
104.0, 103.5, 92.2, 83.9, 78.0, 75.0, 36.1, 36.0, 29.3, 29.2. HRMS-ESI: m/z calc. for 
C70H79N2
+ 947.6238; found 947.6215. 
 
 
Data for 2,6-Bis[(±)-3,5-di-(tert-butyl)-7-iodohepta-3,4-diene-1,6-diynyl)]pyridine 
(HT-I).  
 
   
 
1H NMR (400 MHz, CDCl3) δ (ppm) 7.57 (t, J = 7.8, 1H), 7.33 (d, J = 7.8, 2H), 1.18 (s, 
18H), 1.12 (s, 18H). 13C NMR (100 MHz, CDCl3) δ (ppm) 213.8, 144.1, 136.3, 126.6, 
104.7, 103.5, 91.8, 87.3, 81.1, 77.4, 36.1, 36.0, 29.3, 29.1. HRMS-ESI: m/z calc. for 
C35H40I2N
+ 728.1244; found 728.1215. 
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Data for 6,6'-(3,5,10,12-Tetra-tert-butyltetradeca-3,4,10,11-tetraen-1,6,8,13-tetrayne-
1,14-diyl)bis(2-3,5-di-tert-butyl-7-iodohepta-3,4-dien-1,6-diyn-1-yl)pyridine) (D-I).  
 
 
 
HRMS-ESI: m/z calc. for C70H79N2
+ 1201.4327; found 1201.4323. 
 
 
Data for 4,6,11,13,19,21,26,28-dodeca-tert-butyl-
1,16,31(2,6)tripyridinecyclopentatetracontaphane-4,5,11,12,19,20,26,27,34,35,41,42-
dodecaen-2,7,9,14,17,22,24,29,32,37,39,44-dodecayne MC[143]. 
 
 
 
1H NMR (400 MHz, CDCl3):  (ppm) 7.56 (td, J = 7.8, 3.0, 3H), 7.33 (dd, J = 7.8, 1.4, 
6H), 1.18 (s, 54H), 1.13 (s, 54H). 13C NMR (100 MHz, CDCl3):  (ppm) 214.5, 144.0, 
136.0, 126.4, 103.6, 92.1, 83.3, 77.7, 75.2, 35.9, 29.1, 29.0. HRMS-ESI: m/z calc. for 
C105H118N3
+ 1420.9320; found 1420.9327. 
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(E)-Ethyl-2-methyl-3-(pyridine-2-yl)acrylate (E-4.3). 
 
 
 
A solution of ethyl 2-(diethoxyphosphoryl)propanoate (1.67 g, 7 mmol) in DMF (12 mL) 
was slowly added over a suspension of NaH (168 mg, 7 mmol; 60% in mineral oil) in 
THF. Then 2-formylpyridine (500 mg, 4.7 mmol) was added. The solution was stirred for 
30 min at 25 °C and then heated at 90 °C for 25 h. The mixture was extracted with DCM, 
the organic layer was washed with water, dried over Na2SO4, filtered and concentrated in 
vacuo. Purification by flash chromatography on silica gel (hexane/AcOEt 70:30) afforded 
594 mg (67%) of (E)-ethyl-2-methyl-3-(pyridine-2-yl)acrylate (E-4.3) and 58 mg (6%) of 
the Z-isomer.  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.65 (d, J = 4.7, 1H, H6), 7.67 (dt, J = 1.8, 7.7, 1H, 
H4), 7.61 (s,1H, H1'), 7.34 (d, J = 7.9, 1H, H3), 7.16 (ddd, J = 1.1, 4.8, 7.6, 1H, H5), 4.25 (q, 
J = 7.1, 2H, CO2-CH2-CH3), 2.30 (s, 3H, CH3-C2'), 1.32 (t, J = 7.1, 3H, CO2-CH2-CH3). 
13C  NMR (100 MHz, CDCl3): δ (ppm) 168.6 (C), 155.2 (C), 149.5 (CH), 136.6 (CH), 
136.1 (CH), 132.4 (C), 125.7 (CH), 122.4 (CH), 61.0 (CH2, CO2-CH2-CH3), 14.2 (CH3, 
CH3-C2'), 14.1 (CH3, CO2-CH2-CH3 ). IR-TF (NaCl) ν 1709 (CO) cm-1. MS (EI+) m/z (%) 
191 ([M+], 15), 119 (10), 118 (51), 117 (100), 146 (10), 145 (22). HRMS (EI+) m/z calc. 
for C11H13NO2 191.0946; found 191.0955. 
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(E)-2-Methyl-3-(pyridin-2-yl)prop-2-en-1-ol (E-4.4). 
 
 
 
To a solution of E-4.3 (248 mg, 1.3 mmol) in DCM (6.5 mL) DIBAL-H (1 M solution in 
hexane, 4 mL, 4 mmol) was added dropwise at –78 °C. The solution was stirred at –78 °C 
for 8 h. Then the temperature was allowed to warm to 0 °C and quenched at this 
temperature by adding consecutively MeOH (10 mL), MeOH/water (20 mL) (3% v/v) and 
water (10 mL) with the subsequent formation of a white emulsion. A saturated aqueous 
Rochelle´s salt solution (30 mL) was added and the temperature was allowed to warm to 
25 °C overnight. The mixture was extracted with DCM, dried over Na2SO4, filtered and 
concentrated in vacuo. Purification by flash chromatography on silica gel (AcOEt) gave 
163 mg (84%) of (E)-2-methyl-3-(pyridin-2-yl)prop-2-en-1-ol (E-4.4). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.47 (d, J = 4.9, 1H, H6 ), 7.55 (dt, J =1.8, 7.7, 1H, 
H4), 7.16 (d, J = 7.9, 1H, H3), 7.01 (m, 1H, H5), 6.60 (s, 1H, H1'), 4.12 (s, 2H, H3'), 1.91 (s, 
3H, CH3-C1'). 13C NMR (100 MHz, CDCl3): δ (ppm) 156.7 (C, C2), 148.6 (CH, C6), 143.2 
(C, C2'), 136.1 (CH, C), 123.9 (CH, C), 122.7 (CH, C), 120.8 (CH, C), 67.4 ( CH2, C3'), 
15.3 (CH3-C2'). IR-TF (NaCl) ν 3500-3000 (broad,-OH) cm-1. MS (EI+) m/z (%) 149 
([M+], 44), 148 (25), 130 (100), 117 (58). HRMS (EI+) m/z calc. for C9H11NO 149.0841; 
found 149.0845. 
 
 
2-[(1'E)-2'-Formyl-2'-methylprop-1'-en-1'-yl]pyridine (E-4.5).  
 
 
 
A solution of E-4.4 (378 mg, 2.54 mmol) in DCM (3 mL) was added via canula to a stirred 
solution of Dess-Martin periodinane (1625 mg, 3.83 mmol) and pyridine (500 µL) in DCM 
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(7 mL) at 0 °C. After stirring for 2 h at 0 °C, saturated aqueous Na2S2O3 and saturated 
aqueous NaHCO3 were consecutively added. The mixture was extracted with DCM. The 
organic layer was dried over Na2SO4, filtered and concentrated in vacuo. Purification by 
flash chromatography on activated alumina 3% (hexane/AcOEt 85:15) gave 284 mg (76 
%) of 2-[(1'E)-2'-formyl-2'-methylprop-1'-en-1'-yl]pyridine (E-4.5). 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 9.63 (s, 1H, H3'), 8.72 (d, J = 4.0, 1H, H6), 7.75 (dt, 
J = 1.8, 7.7, 1H, H4), 7.49 (d, J = 7.8, 1H, H3), 7.23 (m, 2H, H5 y H1'), 2.15 (s, 3H, CH3-
C2'). 13C NMR (100 MHz, CDCl3): δ (ppm) 195.8 (CH), 154.4 (C), 150.0 (CH), 147.5 
(CH), 141.5 (C), 136.4 (CH), 125.9 (CH), 123.3 (CH, C), 11.0 (CH3-C2'). IR-TF (NaCl) ν 
1680 (C=O) cm-1. MS (EI+) m/z (%) 147 ([M+], 50), 118 (96), 83 (100). HRMS (EI+) m/z 
calc. for C9H9NO 147.0684; found 147.0691. 
 
 
 (E)-2-(4',4'-Dibromo-2-methylbuta-1',3'-dienyl)pyridine (E-4.6). 
 
 
 
To a solution of carbon tetrabromide (1509 mg, 4.55 mmol) in DCM (18 mL) was added 
via canula a solution of PPh3 (2389 mg, 9.11 mmol) in DCM (22 mL) at 0 °C. The solution 
was stirred for 30 min at 0 °C. Then, was added via canula, a solution of E-4.5 (335 mg, 
2.28 mmol) in DCM (8 mL) at 0 °C. After 1 h, the mixture was extracted with DCM. The 
organic layer was dried over Na2SO4, filtered and concentrated in vacuo. Purification by 
flash chromatography on silica gel (DCM) gave 539 mg (77%) of (E)-2-(4',4'-dibromo-2-
methylbuta-1',3'-dienyl)pyridine (E-4.6).  
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.6 (d, J = 4.3, 1H, H6), 7.65 (td, J = 1.9, 7.7, 1H, 
H4), 7.26 (d, J = 8.2, 1H, H3), 7.1 (m, 2H, H5 y H2'), 6.66 (s, 1H, H1'), 2.34 (s, 3H, CH3-
C2'). 13C NMR (100 MHz, CDCl3): δ (ppm) 155.9 (C), 149.4 (CH), 140.9 (CH), 137.5 (C), 
136.0 (CH), 132.1 (CH), 124.8 (CH), 121.5 (CH), 88.9 (C), 17.4 (CH3-C2'). MS (EI+) m/z 
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(%) 305 (5), 303 (12), 302 (7), 301 ([M+], 6) 224 (90), 222 (100), 143 (60), 142 (45). 
HRMS (EI+) m/z calc. for C10H9Br2N 300.9102; found 300.9106. 
 
 
(E)-2-(2'-Methyl-but-1'-en-3'-ynyl)pyridine (E-4.1b). 
 
 
 
To a solution of diisopropylamine (275 µL, 2 mmol) in THF (4 mL) was added dropwise 
n-BuLi (1.5 M solution in hexane, 1.25 mL, 1.87 mmol) at 0 °C. After 30 min at 0 °C, the 
resulting solution of LDA was cooled to –78 °C and was added via canula to a solution of 
E-4.6 (93 mg, 0.31 mmol) in THF (1 mL) at –78 °C. 45 min later, MeOH (1 mL) was 
added and the temperature was allowed to warm to 25 °C. Purification by flash 
chromatography on silica gel (hexane/Et3N 98:2 and then, hexane/AcOEt 95:5) gave 31 
mg (70 %) of (E)-2-(2'-methyl-but-1'-en-3'-ynyl)pyridine (E-4.1b) as a volatile and 
unstable oil. 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.60 (d, J =4.5, 1H, H6), 7.62 (td, J = 1.8, 7.7, 1H, 
H4), 7.19 (d, J = 7.8, 1H, H3), 7.1 (m, 1H, H5), 6.85 (s, 1H, H1'), 3.02 (s, 1H, H4'), 2.30 (s, 
3H, CH3-C2'). 13C NMR (100 MHz, CDCl3): δ (ppm) 155.5, 149.3, 136.1, 135.7, 124.8, 
121.7, 87.3, 19.30. IR-TF (NaCl) ν 2089 (C≡C) cm1. MS (EI+) m/z (%) 144 (100), 143 
([M+], 27). HRMS (EI+) m/z calc. for C10H9N 143.0735; found 143.0735. 
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2-(2',2'-Dibromovinyl)pyridine (4.7). 
 
 
 
To a solution of carbon tetrabromide (1745 mg, 5.25 mmol) in DCM (21 mL) at 0 ºC was 
added via canula a solution of PPh3 (2760 mg, 10.51 mmol) in DCM (13mL) at 0 °C. The 
solution was stirred for 45 min at 0 °C. Then was added, via canula, a solution of 2-
formylpyridine (281 mg, 2.63 mmol) in DCM (7 mL) at 0 °C. After 1 h, the mixture was 
extracted with DCM. The organic layer was dried over Na2SO4, filtered and concentrated 
in vacuo. Purification by flash chromatography on silica gel (DCM) gave 618 mg (90 %) 
of an oil identified as 2-(2',2'-dibromovinyl)pyridine (4.7). 
 
1H NMR (400 MHz, (CD3)2CO) δ (ppm) 8.62 (d, J = 4.2, 1H, H6), 7.86 (td, J =1.6,7.8, 1H, 
H4), 7.76 (d, J = 8.2, 2H, H3 and H1’), 7.36 (m, 1H, H5). 13C NMR (100 MHz, CDCl3) δ 
(ppm) 153.8 (C), 149.5 (CH), 137.1 (CH), 136.2 (CH), 123.5 (CH), 122.9 (CH), 93.1 (C). 
IR-TF (NaCl) ν 3052, 3005, 2923, 2853, 1585, 1462, 1432, 873, 771, 682 cm1. HRMS 
(EI+) m/z (%) 265 (11), 263 ([M+], 19), 261 (9), 185 (14), 182 (100), 104 (18), 103 (32). 
 
 
 (E)-2-(2'-Bromovinyl)pyridine (E-4.8).127 
 
 
To a solution of 4.7 (676 mg, 2.59 mmol) and dry AcOEt (510 µL, 5.2 mmol) in THF (8 
mL) was slowly added LiAlH4 (197 mg, 5.2 mmol) at –40 ºC. After 4 hours at this 
temperature under argon atmosphere, the reaction was quenched with acetone HPLC grade 
(1.4 mL, 20.72 mmol) and Na2SO4 10H2O (2.5 mL, 10.36 mmol) and a white precipitate 
                                                 
127 Horibe, H.; Kazuhiro, K.; Okuno, H.; Aoyama, T. Synthesis 2004, 7, 986. 
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was formed. It was stirred during 1 hour at 25 ºC and then, filtered through Celite and 
washed with Et2O. Purification by flash chromatography on silica gel (hexane/AcOEt 
70:30) gave 200 mg (90%) of an oil identified as (E)-2-(2'-dibromovinyl)pyridine (E-4.8) 
among 2-ethynylpyridine (20 mg, 7 %) and 2-vinylpyridine (30 mg, 11 %). 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.53 (d, J = 4.2, 1H, H6), 7.76 (td, J = 1.8, 7.7, 1H, 
H4), 7.49 (d, J = 13.6, 1H, H1´), 7.39 (d, J = 7.8, 1H, H3), 7.28 (m, 1H, H5), 7.24 (d, J = 
13.7, 1H, H2’). 13C NMR (100 MHz, CDCl3) δ (ppm) 153.9 (C, C2), 149.6 (CH, C6), 136.6 
(CH, C1´), 136.4 (CH, C4), 122.7 (CH, C5), 121.6 (CH, C3), 112.6 (CH,C2´). MS (EI+) m/z 
(%) 184 (92), 183 ([M+], 8), 182 (100), 104 (5), 103 (27), 102 (6). 
 
 
(E)-2-(4'-Trimethylsilyl-but-1'-en-3'-ynyl)pyridine (E-4.1c-TMS).128 
 
 
 
A solution of E-4.8 (200 mg, 1.64 mmol) in dry triethylamine (3.5 mL) was sparged with 
argon. Pd(PPh3)2Cl2 (15mg, 21µmol), CuI (12 mg, 63 µmol) were added sequentially with 
further sparging with argon after each addition. Then ethynyltrimethylsilane (186 µL, 1.31 
mmol) was added and the mixture was stirred for 20 h at 25 °C. After evaporation of the 
solvent under reduce pressure, the residue was purified by flash chromatography on silica 
gel (hexane/AcOEt 85:15) giving 112 mg (51%) of (E)-2-(4'-trimethylsilyl-but-1'-en-3'-
ynyl)pyridine (E-4.1c-TMS). 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.53 (d, J = 4.7, 1H, H6), 7.61 (td, J = 1.8, 7.7, 1H, 
H4), 7.19 (d, J = 7.8, 1H, H3), 7.15 (ddd, J = 1.0, 4.8, 7.5, 1H, H5), 6.99 (d, J = 15.9, 1H, 
H1´), 6.72 (d, J = 15.9, 1H, H2´), 0.23 (s, 9H, Si(CH3)3). 13C NMR (100 MHz, CDCl3) δ 
(ppm) 154.0 (C, C2), 149.9 (CH, C6), 141.2 (CH, C1´), 136.7 (CH, C4), 123.2 (CH, C3), 
                                                 
128 Eberbach, W.; Maier, W. Tetrahedron Lett. 1989, 30, 5591. 
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122.5 (CH, C5), 112.5 (CH, C2´), 104.1 (C, C3’), 99.2 (C, C4’), 0.02 (CH3, Si(CH3)3). IR-TF 
(NaCl) ν 2959 (C≡C) cm-1. HRMS (EI+) m/z (%) 203 (4), 202 (12), 201([M+], 52), 186 
(100) 
 
 
(E)-2-(But-1'-en-3'-ynyl)pyridine (E-4.1c).129 
 
 
 
To a solution of E-4.1c-TMS (70 mg, 0.34 mmol) in MeOH (3.5 mL), K2CO3 (48 mg, 
0.347 mmol) was added at 25 °C. After 30 min at 25 °C, the mixture was filtered and 
concentrated in vacuo. Purification by flash chromatography on silica gel (hexane/Et3N 2% 
→ hexane/AcOEt 95:5) gave 42 mg (95%) of an solid identified as (E)-2-(but-1'-en-3'-
ynyl)pyridine (E-4.1c). 
 
1H NMR (400 MHz, CDCl3) δ (ppm) 8.56 (d, J = 4.7, 1H , H6), 7.64 (dt, J = 1.8, 7.7, 1H, 
H4), 7.23 (d, J = 7.8, 1H, H3), 7.18 (ddd, J = 1.1, 4.8, 7.6, 1H, H5), 7.05 (d, J = 16.0, 1H, 
H1'), 6.71 (dd, J = 2.4, 16.0, 1H, H2'), 3.15 (d, J = 2.4, 1H, H4'). 13C NMR (100 MHz, 
CDCl3): δ (ppm) 153.6 (C, C2'), 149.8 (CH, C6'), 141.9 (CH, C1'), 136.7 (CH, C4), 123.3 
(CH, C3), 122.4 (CH, C5), 111.4 (CH, C2'), 82.5 (C, C3'), 81.1(CH, C4'). IR-TF (NaCl) ν 
2094 (C≡C) cm1. 
 
  
                                                 
129 Campbell, M. M.; Cosford, N. D. P.; Rae, D. R.; Sainsbury, M. J. Chem. Soc. Perkin Trans. 1, 1991, 765. 
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(Z)-2-(2'-Bromovinyl)pyridine (Z-4.8).130 
 
 
 
To a suspension of bromomethyltriphenylphosphonium bromide (344 mg, 0.79 mmol) in 
THF (2 mL) was slowly added NaHDMS (1 M solution in THF, 790 µL, 0.79 mmol) at 25 
°C. Then the yellow solution was cooled to –78 °C before addition of DMPU (0.5 mL). 
The solution was stirred for 1.5 h at –78 °C. Then, 2-formylpyridine (50 µL, 0.525 mmol) 
was added and 3h later, the solvent was removed under vacuum and the residue was 
extracted with DCM, dried over Na2SO4, filtered, and concentrated in vacuo. Purification 
by flash chromatography on silica gel (hexane/AcOEt 70:30) gave 84 mg (87%) of (Z)-2-
(2'-bromovinyl)pyridine (Z-4.8) and the corresponding E-isomer (8 mg, 8%).  
 
1H NMR (400 MHz, CDCl3: δ (ppm) 8.64 (d, J = 3.9, 1H, H6), 8.04 (d, J = 7.9, 1H, H3), 
7.73 (t, J = 7.7, 1H, H4), 7.27 (m, 2H, H5 y H2'), 6.68 (d, J = 7.2, 1H, H1'). 13C NMR (100 
MHz, CDCl3): δ (ppm) 153.9 (C), 149.5 (CH), 136.0 (CH), 133.2 (CH), 123.7 (CH), 122.8 
(CH), 109.2 (CH).  
 
 
 (Z)-2-(4'-Trimethylsilyl-but-1'-en-3'-ynyl)pyridine (Z-4.1c-TMS).122 
 
 
 
                                                 
130 Uenishi, J.; Kawahama, R.; Yonemitsu, O. J. Org. Chem. 1998, 63, 8965. 
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A solution of Z-4.8 (300 mg, 1.64 mmol) in dry triethylamine (6.5 mL) was sparged with 
argon. Pd(PPh3)2Cl2 (23 mg, 32 µmol), CuI (18 mg, 94 µmmol) were added sequentially 
with further sparging with argon after each addition. Then ethynyltimethylsilane (464 µL, 
3.28 mmol) was added and the mixture was stirred for 39h at 25 °C. After evaporation of 
the solvent under reduce pressure, the residue was purified by flash chromatography on 
silica gel (hexane/ AcOEt 85:15) gaving 241 mg (72%) of (Z)-2-(4'-trimethylsilyl-but-1'-
en-3'-ynyl)pyridine (Z-4.1c-TMS) and 50 mg (15 %) of a compound identified as the 3,3'-
biindolizine. 
 
1H NMR (400 MHz, CDCl3): δ (ppm) 8.58 (d, J = 4.7, 1H, H6), 8.45 (d, J = 8.1, 1H, H3), 
7.66 (dt, J = 1.8, 7.9, 1H, H4), 7.16 (ddd, J = 1.9, 4.9, 7.3, 1H, H5), 6.86 (d, J = 12.3, 1H, 
H1'), 5.93 (d, J = 12.3, 1H, H2'), 0.24 (s, 9H, Si(CH3)3). 13C NMR (100 MHz, CDCl3): δ 
(ppm) 154.9 (C), 149.3 (CH), 140.6 (CH), 135.8 (CH), 122.9 (CH), 122.8 (CH), 110.8 
(CH), 103.9 (C), 102.9 (C), -0.30 (CH3, Si(CH3)3). MS (EI+) m/z (%) 201 ([M
+], 15), 200 
(46), 69 (100). 
 
 
3-(tert-Butoxymethyl)-2-methylindolizine (In-4.1b).  
 
 
 
To a solution of E-4.1b (16 mg, 0.112 mmol) in THF (2 mL) was added t-BuOK (63 mg, 
0.56 mmol). The mixture was refluxed for 7.5 h. Then THF was removed under reduced 
pressure and the crude residue was dissolved in hexane and washed with water. The 
organic layer was dried over Na2SO4, filtered and concentrated in vacuo. Purification by 
flash chromatography on activated alumina 3% (hexane/AcOEt 95:5) gave 16 mg (66%) of 
3-(tert-butoxymethyl)-2-methylindolizine (In-4.1b) as an unstable compound (it 
decompose on standing in days, and in solution, such as in CDCl3, in minutes)  
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1H NMR (400 MHz, CDCl3): δ (ppm) 7.94 (d, J = 6.8, 1H, H5),.7.26 (d, J = 8.2 , 1H, H8), 
6.63 (t, J= 6.7, 1H, H7), 6.45 (t, J = 6.7, 1H, H6), 6.21 (s, 1H, H1), 4.65 (s, 2H, H1'), 2.31 (s, 
3H, C2-CH3), 1.31 (s, 9H, t-Bu). 13C NMR (100 MHz, C6D6): δ (ppm) 133.3 (C, C9), 123.8 
(C, C2), 123.6 (CH, C5), 119.5 (C, C3), 118.9 (CH, C8), 117.1 (CH,C6), 109.8 (CH, C7), 
100.7(CH, C1), 73.1 (C, C-t-Bu), 54.3 (CH2, C1') 27.8 (CH3, CH3-t-Bu), 12.2 (CH3, -Me). 
HRMS-ESI: calc. for C14H20NO
+ [M+H]+ 218.15356; found 218.1539. 
 
 
3, 3'-Biindolizine (4.9).  
 
 
 
To a solution of Z-4.1c-TMS (68 mg, 0.335 mmol) in THF:MeOH (20:1) (3.5 mL) TBAF 
(1 M solution in THF, 670 µL, 670 mmol) was added at 25 °C. After 15 min at 25 °C, the 
mixture was partitioned between hexane and a saturated aqueous NaHCO3 solution, the 
organic phase was washed with saturated aqueous NaHCO3 solution, followed by brine and 
water, dried over Na2SO4 and concentrated in vacuo. The resultant oil (Z)-2-(But-1'-en-3'-
ynyl)pyridine (Z-4.1c) was taken up in Et3N (0.5 mL) and then, a degassed solution of 
Pd(PPh3)2Cl2 (1.3 mg, 1.86 µmmol), CuI (1.2 mg, 6.28 µmmol) and Z-bromovinilpyridine 
Z-4.8 (17 mg, 0.09 mmol) in Et3N (1mL) was added. The mixture was stirred at 25 °C for 
19 h. After evaporation of the solvent under reduce pressure, the residue was purified by 
flash chromatography on silica gel (hexane/AcOEt 85:15) giving 13 mg (60 %) of 3,3'-
biindolizine (4.9). 
 
1H NMR (400 MHz, C6D6): δ (ppm) 7.31 (d, J = 7.0, 1H, H5), 7.23 (d, J = 9.0, 1H, H8), 
6,91 (d, J =3.8, 1H, H2), 6.58 (d, J =3.7, 1H, H1), 6.41 (t, J= 7.68, 1H, H7), 6.0 (t, J= 7.68, 
1H, H6). 13C NMR (100 MHz, CDCl3): δ (ppm) 133.8 (C, C9), 123.3 (CH, C5), 119.6 (CH, 
C8), 117.5 (CH, C7), 115.9 (CH, C2), 115.3 (C, C3), 110.8 (CH, C6), 99.5 (CH, C1). MS 
(EI+) m/z (%) 233 (15), 232 ([M+], 100), 231 (49), 230 (20), 229 (10), 155 (6), 154 (47), 
153(7), 152 (5). HRMS (EI+) m/z calc. for C16H12N2 232.1000; found 232.1003. 
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(1'RS, 2'SR)-Ethyl 2-(indolizin-3-yl)cyclopropanecarboxylate (4.11-cis). 
 
 
 
To a solution of Z-4.1c-TMS (240 mg, 1.18 mmol) in ethyl acrylate (5 mL) was added CsF 
(270 mg, 1.77 mmol) and MeOH (38 mg, 1.18 mmol). The mixture was stirred for 4.5 h at 
70 °C under argon. Then, ethyl acrylate was removed under reduced pressure and the crude 
residue was dissolved in ethyl acetate and washed with water. The organic layer was dried 
over Na2SO4, filtered and concentrated in vacuo. Purification by flash chromatography on 
SiO2 (hexane/AcOEt 90:10) gave 64 mg (23%) of ethyl 2-(indolizin-3-
yl)cyclopropanecarboxylate (4.11-cis) and 11 mg (6 %) of 3-methoxymethylindolizine, 
among other indolizines that were not characterized.  
 
1H NMR (600 MHz, CDCl3) δ (ppm) 7.95 (dd, J = 0.9, 7.1, 1H, H5), 7.31 (dt, J = 1.2, 8.9, 
1H, H8), 6.65 (dd, J = 0.4, 3.9, 1H, H2), 6.61 (ddd, J = 0.9, 6.4, 8.9, 1H, H7), 6.49 (td, J = 
1.3, 6.9, 1H, H6), 6.35 (d, J = 3.9, 1H, H1), 3.76 (m, 2H, -CO2CH2CH3), 2.46 (q, J = 7.9, 
16.1, 1H, H1'), 2.18 (dt, J=5.8, 8.0, 1H, H2'), 1.77 (ddd, J = 4.8, 5.7, 7.0, 1H, H3'b), 1.48 (dt, 
J=4.8, 8.0, 1H, H3'a), 0.79 (t, J = 7.1, 3H, -CO2CH2CH3). 13C NMR (100 MHz, C6D6) δ 
(ppm) 169.8 (C, -CO2Et), 133.4 (C, C9), 122.4 (CH, C5), 120.4 (C, C3), 119.6 (CH, C8), 
116.0 (CH, C7), 114.9 (CH, C1), 110.0 (CH, C6), 98.8 (CH, C2), 60.0 (CH2, -OCH2CH3), 
20.9 (CH, C2'), 16.3 (CH, C1'), 13.7 (CH3, -OCH2CH3), 11.1 (CH2, C3'). MS (EI+) m/z (%) 
230 (6), 229 ([M+], 35), 228 (4), 157 (16), 156 (100), 154 (81). HRMS (EI+) m/z calc. for 
C14H15NO2 229.1103; found 229.1104. 
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(1'RS, 2'RS)-Ethyl 2-(indolizin-3-yl)cyclopropanecarboxylate (4.11-trans). 
 
 
 
When 4.11-cis was allowed to stand in CDCl3 for several days, it underwent an 
isomerization reaction and (1'RS, 2'RS)-Ethyl 2-(indolizin-3-yl)cyclopropanecarboxylate 
(4.11-trans) was obtained. 
 
1H NMR (600 MHz, CDCl3) δ (ppm) 7.91 (d, J= 7.1, 1H, H5), 7.34 (dt, J=1.1, 9.0, 1H, 
H8), 6.66 (ddd, J= 1.0, 6.5, 8.9, 1H, H7), 6.54 (td, J= 1.1, 6.9, 1H, H6), 6.51 (s, 1H, H2), 
6.33 (s, 1H, H1), 4.25 (q, J= 7.1, 2H, -CO2CH2CH3), 2.52 (ddd, J= 4.2, 6.4, 9.2, 1H, H1'), 
1.81 (ddd, J= 4.2, 5.0, 8.4, 1H, H2'), 1.63 (ddd, J= 4.2, 5.0, 9.2, 1H, H3'b), 1.35 (ddd, J= 4.3, 
6.4, 8.4, 1H, H3'a ), 1.30 (t, J= 7.1, 3H, -CO2CH2CH3). 13C NMR (100 MHz, CDCl3) 173.6 
(C, -CO2Et), 133.3 (C, C4), 122.7 (C, C3), 122.3 (CH, C5), 119.5 (CH, C8), 116.7 (CH, C7), 
111.8 (CH, C2), 110.6 (CH, C6), 98.0 (CH, C1), 61.1 (CH2, -O-CH2-CH3), 21.7 (CH, C2'), 
17.5 (CH, C1'), 14.9 (CH2, C3'), 14.5 .(CH3, -O-CH2-CH3). HRMS (EI+) m/z calc. for 
C14H15NO2 229.1103; found 229.1111. 
 
 
3-(3',3',4'-Trimethyl-2'-oxapent-4'-en-1'-yl)indolizina (4.12). 
 
 
 
To a solution of Z-4.1c-TMS (150 mg, 0.74 mmol) in THF:MeOH (20:1) (10 mL), TBAF 
(1 M solution in THF, 1.5 mL, 1.5. mmol) was added at 25 °C. After 15 min at 25 °C, the 
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mixture was partitioned between hexane and a saturated aqueous NaHCO3 solution, the 
phases were separated, and the organic phase was washed with saturated aqueous NaHCO3 
solution, saturated aqueous NaCl solution and water, dried over Na2SO4 and concentrated 
in vacuo. The resultant oil Z-4.1c was washed with bencene, purged under argon 
atmosphere (15 min) and redissolved in dimethylbut-2-ene (2 mL). The mixture was stirred 
for 21 h at 75 °C. Then the solvent was removed under reduce pressure, the crude residue 
was dissolved in AcOEt, and the solution was washed with water. The organic layer was 
dried over Na2SO4, filtered and concentrated in vacuo. Purification by flash 
chromatography on SiO2 (hexane/AcOEt 95:5) gave 42 mg (35%) of 3-[(2,3-dimethylbut-
3-en-2-yloxy)methyl]indolizine (4.12), among other uncharacterized products. 
 
1H NMR (400 MHz, C6D6) δ (ppm) 7.98 (d, J = 7.0, 1H, H5), 7.20 (d, J = 9.0, 1H, H8), 
6.72 (d, J = 3.8, 1H, H1), 6.46 (d, J = 3.8, 1H, H2), 6.44-6.37 (m, J = 6.5, 8.1, 1H, H7), 6.21 
(t, J = 6.7, 1H, H6), 5.00–4.84 (m, 2H), 4.38 (s, 2H), 1.69 (d, J = 9.0, 3H), 1.23 (s, 6H). 
13C NMR (100 MHz, C6D6) δ (ppm) 148.9 (C, C4'), 134.0 (C, C9), 123.5 (CH, C5), 122.1 
(C, C3), 119.5 (CH, C8), 116.7 (CH, C7), 114.4 (CH, C2), 112.3 (CH2, C4'-CH2), 110.1 
(CH,C6), 98.8 (CH, C1), 77.4 (C, C3'), 57.1 (CH2, C1'), 25.8 (CH3, C3'-(Me)2), 18.7 (CH3, 
C4'-Me). MS (EI+) m/z (%) 230 (3), 229 ([M
+], 23), 146 (11), 145 (57), 131 (18), 130 
(100), 117 (23), 116 (4). HRMS (EI+) m/z calc. for C15H19NO 229.1467; found 229.1476. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Resumo 
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Os macrociclos acetilénicos configuracionalmente estables son importantes unidades 
estruturais na química supramolecular, na ciencia dos materiais, e na química teórica; 
sendo utilizados nunha gama moi ampla de aplicacións, como a formación de cristais 
líquidos, canais tubulares, sólidos orgánicos porosos, agregados en superficies, receptores 
artificiais. Tamén son obxecto de estudo o seu comportamento óptico lineal e non lineal, a 
súa florescencia, así como as súas propiedades electroquímicas. 
7.1 Alenofanos e Macrociclos Aleno-acetilénicos 
A química dos ciclofanos ten crecido e avanzado moito durante este último século dando 
lugar a unha gran variedade de novas estruturas. Unha das clases de ciclofanos que máis 
son estudadas son aquelas que conteñen unidades acetilénicas. Estes ciclofanos, tamén 
chamados deshidroanulenos, presentan propiedades moleculares únicas, como por 
exemplo, complexación, agregación e novedosas propiedades electrónicas.  
Sen embargo, os ciclofanos que conteñen unidades alénicas (1,2-propadienos), chamados 
tamén alenofanos, non foron moi estudados, debido probablemente a dificultade da súa 
síntese e a gran reactividade das unidades alénicas.  
Os alenos, debido a súa quiralidade axial intrínseca, cando se incorporan a un composto fai 
que éste adquira unha estrutura tridimensional e así mesmo, outórganlle quiralidade axial a 
molécula. 
A primeira síntese dun alenofano “real” foi publicada por Krause e colaboradores en 1999 
(Figura 7.1). Este ciclofano foi obtido como unha mestura de catro diasterómeros, os cales 
non puideron ser separados e polo tanto, as súas propiedades físicas e quiroópticas non 
foron estudadas. 
 
Figura 7.1. [34]alenofano sintetizado por Krause e colaboradores. 
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En colaboración co grupo do profesor Diederich (ETH-Zürich), o noso grupo sintetizou 
unha serie de macrociclos acetilénicos quirais levando como unidades estruturais 1,3-
dietinilalenos (DEAs) e diferentes unidades aromáticas, como o antraceno e a piridina 
disustituida nas posicións 2 e 5 (Figura 7.2). Estes alenofanos foron obtidos como unha 
mezcla de estereoisómeros os cales foron separados por HPLC e totalmente caracterizados.  
 
Figura 7.2. Antraceno-alenofano (esquerda) e (2,5)pirido-alenofanos (dereita). 
7.2 Alenofanos Quirais 
Nos últimos anos, o interese na síntese de macrociclos aleno-acetilénicos enantiopuros está 
aumentando, e vese reflectido tanto no incremento de publicacións neste eido, así como no 
uso da espectroscopía quiróptica para determinar a conformación e a configuración 
absoluta destas moléculas quirais. 
Éstes métodos espectroscópicos inclúen: dicroísmo circular electrónico (ECD), dispersión 
óptica rotatoria (ORD), espectroscopía Ramman e dicroísmo circular vibracional (VCD).  
 
No ano 2005, Clay e Fallis presentaron a primeira síntese enantiomérica dun alenofano 
acetilénico (Figura 7.3). A súa estrutura quiral foi corroborada mediante espectroscopía de 
dicroismo circular (CD) e modulado molecular. 
Resumo 
165 
 
 
Figura 7.3. Alenofano quiral sintetizado por Clay e Fallis. 
Uns cantos anos mais tarde, no 2008, o mesmo grupo, Lecleré e Fallis, publicaron a 
primeira síntese de dous alenofanos “reais” enantiopuros (Figura 7.4). Sen embargo, 
debido a inestabilidade destes dous compostos, unicamente se puido medir o seu espectro 
de CD en hexano. 
 
Figura 7.4. Tris-meta-alenofano (esquerda) e tetrakis-meta-alenofano (dereita) sintetizados por Lecleré e 
Fallis. 
No ano 2009, Diederich e colaboradores, sintetizaron o primeiro macrociclo aleno-
acetilénico enantiopuro (Figura 7.5). As súas propiedades estruturais, quirópticas e 
electrónicas foron estudadas experimental e teoricamente. É importante sinalar que este 
macrociclo quiral presenta excepcionais intensidades de CD, o valor de  da banda de CD 
a 252 nm é un dos maiores valores que se teñen publicado para moléculas orgánicas.  
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Figura 7.5. Macrociclo aleno-acetilénico enantiopuro sintetizado por Diederich e colaboradores. 
Un dos últimos traballos publicados recentemente polo mesmo grupo de Diederich, 
describe a síntese e o estudo teórico e experimental das propiedades quirópticas (ECD, 
ORD, espectroscopía Ramman e VCD) dunha serie de ciclooligómeros aleno-acetilénicos 
quirais (Figura 7.6). 
 
Figura 7.6. Ciclooligómeros quirais sintetizados por Diederich e colaboradores. 
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7.3 Obxectivos 
O obxectivo deste traballo é a síntese, caracterización e estudo das propiedades quirópticas 
de pirido-alenofanos [142]. A sinerxía entre a síntese e as predicións da mecánica cuántica 
farán que este traballo se desenvolva de forma efectiva. 
Inserción de cromóforos aromáticos (espazadores) entre dúas unidades de 1,2-dietinilaleno 
(DEA) dará lugar a oligómeros híbridos os cales presentarán interesantes propiedades 
electrónicas e fotónicas. Por este motivo, no noso grupo levouse previamente a cabo a 
síntese e o estudio das propiedades electroquímicas, fotoquímicas e fotofísicas de 
diferentes oligómeros híbridos (Figura 7.7). 
 
Figura 7.7. Oligómeros híbridos obtidos mediante incorporación de diferentes espazadores entre dúas 
unidades de DEA. 
Nesta tese levarase a cabo, como continuación dos traballos previamente realizados, a 
síntese de heterotrímeros cunha piridina meta-sustituída como espazador, os cales serán 
precursores do correspondente alenofano. 
A incorporación dun espazador meta-substituído dará lugar a macrociclos con menos 
flexibilidade conformacional. Así mesmo, a presenza do nitróxeno na piridina ofrece a 
oportunidade para a formación de complexos hospedador-hóspede con metais e pequenas 
moléculas orgánicas. 
A estratexia para a síntese destes alenofanos amósase no Esquema 7.1: 
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Esquema 7.1. Esquema retrosintético para a síntese dos alenofanos. 
A síntese proposta está baseada nunha reacción de Sonogashira de acoplamento cruzado 
entre unidades de dietinilalenos (DEAs) e o correspondente espazador. Desprotección do 
heterotrímero obtido e posterior acoplamento intermolecular dará lugar o alenofano 
desexado. 
A síntese dos alenofanos será levada a cabo mediante dous camiños diferentes: 
- Síntese do piridoalenofano a partir de (±)-DEA. A mestura obtida de esteroisómeros 
será resolta por HPLC e así mesmo, asignados por HPLC en fase estacionaria quiral, 
RMN, dicroismo circular e raios-X. 
- Síntese do piridoalenofano a partir do DEA enantiopuro. Unha vez obtido este 
alenofano enantiopuro, levarase acabo o estudo das súas propiedades quiropticas, así 
como o efecto do disolvente e da protonación.  
7.4 Síntese e Caracterización de Pirido-alenofanos a partir de (±)-1,3-
Dietinilalenos 
Reacción de Sonoghasira de acoplamento cruzado do composto comercial 2,6-
dibromopiridina con 2.2 equiv. do dietinilaleno (±)-DEA-TIPS, 2 mol% de 
[PdCl2(PPh3)2], e 5 mol % de CuI en tolueno empregando N,N,N',N'-
tetramethylethylenediamine (TMEDA) como base a 110 ºC renden o hetero-oligómero 
HT-TIPS como unha mestura de estereoisómeros nun 83% de rendemento. 
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Homoacoplamento intermolecular acetilénico entre dúas unidades do HT-H, obtido a 
partir da total desprotección do HT-TIPS empregando para tal fin nBu4NF (TBAF) en 
THF a 25 ºC, deu lugar ao [142]-piridoalenofano MC[142] como unha mestura de cinco 
posibles esteroisómeros (Esquema 7.2) 
Esquema 7.2. Síntese do MC[142]. 
A síntese do MC[142] foi levada a cabo empregando un homoacoplamento intermolecular 
baixo as condicións de Breslow, e como alternativa a estas condicións, co fin de evitar o 
uso do tóxico disolvente piridina, tamén se levou a cabo a síntese do macrociclo 
empregando as condicións baseadas na modificación do método estándar de Hay e na 
reacción catalizada por Pd/Cu. Na Táboa 7.1 recóllense os resultados obtidos: 
 
Método Condicións 
Rendemento 
(%) 
Breslow 
CuCl, CuCl2, py, 25 ºC, Ar, 20 h de adición (F.R.: 1 mL/h),[a] 
3 días de reacción[b] 
63 
Hay 
CuI, TMEDA, CH2Cl2, 25 ºC, aire, 6 h de adición (F.R.: 0,5 mL/h ) 
11 días de reacción 
68 
Pd/Cu 
[Pd(PPh3)2Cl2], CuI, TMEDA, tolueno, 60 ºC, aire, 12 h de adición 
(F.R.: 1,5 mL), 5 días de reacción 
 
51 
Táboa 7.1. [a] Unha disolución do HT-H é engadida mediante unha xiringa automática, programada cunha 
determinada velocidade de fluxo (F.R.), ao medio de reacción.[b] A partir da adición completa da disolución 
do HT-H . 
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Cando a reacción de macrociclación lévase a cabo empregando as condición de Hay ou as 
de Pd/Cu obsérvase a formación de oligómeros diiodados así como, a formación do 
macrociclo con tres unidades piridina MC[143] (no caso de empregar a macrociclación 
catalizada por Pd/Cu) que en moitos casos son o único produto obtido ou o maioritario 
(Esquema 7.3). Para evitar a formación destes compostos diiodados sustituiuse o CuI por 
CuCl, sen embargo outro composto sen identificar foi obtido despois de 5 días de reacción. 
Así mesmo, o emprego de I2 como oxidante, en vez do O2, soamente conduciu a 
recuperación do composto de partida. 
Esquema 7.3. Produtos obtidos na macrociclación cando son empregadas as condicións de Hay ou Pd/Cu. 
 
A formación destes oligómeros diiodados pode ter orixe nunha transmetalación de cobre 
por iodo durante a formación do intermedio cobre-acetiluro, como propón Zhang e 
colaboradores.  
 
Figura 7.8. Posible explicación para a formación dos compostos diiodados. 
O emprego do aleno racémico (±)-DEA-TIPS como material de partida para a síntese do 
ciclofano (2,6)pirido[142]alenoacetilénico MC[142] ten como consecuencia que este 
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macrociclo sexa obtido coma unha mestura de dous pares de enantiómeros 
(P,P,P,P)/(M,M,M,M)-MC[142] e (P,P,M,P)/(M,M,P,M)-MC[142] e tres isómeros aquirais 
(P,M,M,P)-MC[142], (P,M,P,M)-MC[142] e (P,P,M,M)-MC[142] nunha distribución 
estatística teórica 1:4:1:1:1. 
Ésta mestura de diasterómeros resolveuse mediante HPLC usando como fase estacionaria 
unha ‘Buckyclutcher 1’ e como eluinte CH2Cl2/hexano 80:20 nun fluxo de 5 mL/min. Cabe 
mencionar que no cromatograma soamente aparecen catro dos cinco diasterómeros teóricos 
(Figura 7.9).  
 
Figura 7.9. Cromatograma obtido da resolución por HPLC da mezcla de estereoisoméros do MC[142]. Os 
picos do cromatograma que aparecen sen etiquetar corresponden os compostos diiodados. 
Comparando a área por debaixo dos picos do cromatograma ca distribución estadística dos 
distintos estereoisómeros, podemos predicir que o pico C posiblemente equivalla ó isómero 
quiral (P,P,M,P)-MC[142] e ó seu enantiómero (M,M,P,M)-MC[142]. 
Cando se realizou o RMN de 1H e 13C dos distintos compostos resoltos por HPLC obtívose 
o seguinte resultado:  
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Figura 7.10. Cromatograma e RMN de 1H e 13C dos distintos isómeros do MC[142]. 
Todos os compostos do cromatograma presentan dous sinais no espectro de RMN de 1H 
correspondente ós tert-butilos e un sinal entre 214-216 ppm correspondente os carbonos 
cumulénicos, agás un, o composto C. Sen embargo por RMN nesta fracción asemella haber 
2 isómeros. Por este motivo esta fracción C volveuse inxectar no HPLC empregando unha 
fase estacionaria chiral, ChiralPack IA, e como eluínte hexano/tert-butil-dimetil eter 
(TBDME) (83:17), e cómo esperábamos esta fracción resolveuse en tres picos (Figura 
7.11). 
 
Figura 7.11. Cromatograma do pico C resolta por HPLC chiral. 
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Para estudar máis en profundidade este sistema e para corroborar que os compostos C1 e 
C2 corresponde o isómero quiral (P,P,M,P)-MC[142] e ao seu enantiómero (M,M,P,M)-
MC[142], levouse a cabo o estudo da quiralidade e simetría dos diferentes isómeros co fin 
de asignar a configuración relativa tendo en conta o número de carbonos cumulénicos no 
espectro de 13C RMN e os tert-butilos no espectro de 1H-RMN non-equivalentes. Para elo, 
previamente levouse a cabo una búsqueda conformacional para cada diasteroisómero. 
Grazas a este estudio e que os compostos C1 e C2 presentan o espectro de dicroismo 
circular como unha imaxe especular, podemos asignar esta fracción ao isómero quiral 
(P,P,M,P)-MC[142] e o seu enantiómero (M,M,P,M)-MC[142].  
Así mesmo, a fracción B foi inxectada en HPLC reciclado con unha fase estacionaria 
quiral (Chiralpack IA) e como eluinte hexano/TBDME (83:17) Despois de 4 ciclos a 
fracción B deu lugar a 2 picos, B1 e B2, os cales presentan espectros de dicroismo circular 
que son imaxes especulares, o que nos permite asignar ó pico B ó outro isómero chiral 
(P,P,P,P)-MC[142] e o seu enantiómero (M,M,M,M)-MC[142]. 
A estrutura do isómero correspondente o composto A puido ser asignada ó isómero achiral 
(P,M,M,P)-MC-14 grazas a obtención de cristais adecuados para a difracción por raios-X. 
Cabe destacar, que a estrutura obtida por raios-X presenta dúas moléculas de cloroformo 
por macrociclo. A distancia de interacción entre o nitróxeno do macrociclo, o cal actúa 
como aceptor, e o cloroformo o cal actúa como doador, é de 3,254 (6) Å, o que indica a 
presenza dun enlace de hidróxeno N…H–CCl3 débil (Figura 7.12) 
 
Figura 7.12. ORTEP do enlace de hidróxeno C-H…N entre o CHCl3 e o macrociclo (P,M,M,P)-MC[142].  
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Así mesmo, tamén se obtiveron cristais adecuados para o análise por raios-X do composto 
C3 do cromatograma que foi asignado ó isómero quiral (P,P,M,M)-MC[142]. 
Finalmente, a estrutura do isómero correspondente ao pico D do cromatograma foi 
asignado por descarte, ó isómero (P,M,P,M)-MC[142]. 
Na Figura 7.12 amósase o cromatograma de HPLC así como o asinamento de cada 
diasteroisómero. 
 
Figure 7.12. Asignamento dos distintos diasteroisómeros do MC[142]. 
7.5 Síntese e Caracterización de Pirido-alenofanos a partir de 1,2-Dietinilalenos 
Enantiopuros 
Como vimos no anterior capítulo, a síntese do piridoalenofano MC[142] a partir da mestura 
racémica do DEA (±)-DEA-TIPS da lugar a unha mestura de tres isómeros aquirais e dous 
pares de enantiómeros que foi resolta por HPLC, sen embargo esta metodoloxía está 
limitada en gran parte pola cantidade obtida de cada isómero. 
Por outra parte, a síntese de (P,P,P,P)-MC[142] a partir do DEA (P)-DEA-OH da lugar o 
producto final, MC[142], con total pureza enantiómerica en un bo rendemento. A 
limitación desta metodoloxía é a obtención dos precursores do macrociclo enantiopuros. 
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Nun primeiro momento intentouse levar a cabo unha resolución cinética do acetylalcohol 
(±)-3.2 catalizada por lipasas como unha maneira sinxela para obter o DEA enantiopuro 
(Esquema 7.4). 
Esquema 7.4. Resolución cinética catalizada por lipasas do acetil acetylalcohol (±)-3.2. 
Sen embargo, a pesar de que se levaron a cabo distintos ensaios, ben modificando o 
sustrato, probando con un rango amplo de lipasas, cambiando as condicións de reacción, 
nunca se chegou a observar a resolución do acetilalcochol (±)-3.2. 
Por este motivo, o aleno (±)-DEA-OH foi resolto nos correspondentes enantiómeros (P)-
DEA-OH e (M)-DEA-OH mediante HPLC usando como fase estacionaria ChiralPack IA 
e como eluinte hexano/iPrOH 99.8:0.2  
Unha vez obtido o DEA enantiopuro, levouse a cabo a síntese do allenofano quiral 
(P,P,P,P)-MC[142] e do seu enantiómero (M,M,M,M)-MC[142] seguindo o mesmo 
procedemento que no caso da síntese partindo da mestura racémica do aleno (Esquema 
7.5). 
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Esquema 7.5. Síntese do macrociclo enantiopuro (P,P,P,P)-MC[142]. 
 
Mediante difracción de raios-X corroborouse a estrutura e asignación do macrociclo quiral 
(P,P,P,P)-MC[142]. 
 
Co macrociclo enantiopuro en man, procedeuse ó estudo das súas propiedades quirópticas 
por dicroísmo circular electrónico (ECD), vibracional (VCD) e polarimetría (ORD). 
O alenofano quiral (P,P,P,P)-MC[142], pode presentar tres posibles conformacións: cis, 
trans e twist cunha enerxía relativa semellante (Figura 7.13) 
 
Figura 7.13. Confórmeros de (P,P,P,P)-MC[142]: a) cis; b) trans; c) twist. 
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Para saber cal conformación adopta o (P,P,P,P)-MC[142] en disolución ou si está presente 
unha mestura, calculouse o espectro de CD teórico (DFT, CAM-B3LYP; 6-31G(d)) de 
cada unha das posibles conformacións e comparouse co espectro de CD experimental 
(Figura 7.14). Sen embargo, como podemos observar os espectros teóricos de cada unha 
das conformacións e incluso a media non se asemella en absoluto ó espectro experimental.  
 
Figura 7.14. Espectro de CD e UV/Vis do (P,P,P,P)-MC[142]: liña negra: espectro experimental medido en 
hexano; liña vermella, espectro teórico do confórmero cis; liña azul, espectro teórico do confórmero trans; 
liña verde, espectro teórico do confórmero plano, liña punteada negra, media dos tres posibles confórmeros. 
Unha posible explicación a isto pode ser o acoplamento vibrónico, debido a que no 
espectro de UV/Vis aparece o típico patrón de picos cunha separación de aproximadamente 
2200 cm-1que corresponde ca frecuencia das bandas de tensión do grupo –CC–.  
Por este motivo levouse a cabo no grupo de investigación de Fabrizio Santoro (CNR-
Istituto di Chimica dei Composti Organo Metallici, Pisa; Italia) cálculos máis exhaustivos 
incluíndo o acoplamento vibrónico. Mediante este estudo parece que o confórmero que 
predomina en disolución e o confórmero twist. Sen embargo, non se pode descartar unha 
mestura co confórmero trans. Desafortunadamente as medidas de VCD realizadas pola 
Dra. Ana G. Petrovic (Universidade de Columbia, Estados Unidos) non deron ningún 
resultado concluinte. Sen embargo cando se comparou o espectro experimental e o teórico 
(CAM-B3LYP, 6-31G(d)) de ORD observouse, que o confórmero predominante en 
disolución é o twist (Figura 7.15). 
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Figura 7.15. Espectro experimental de ORD (escalado por 40000) medido en CHCl3 (liña negra) e espectro 
de ORD teórico (), CAM-B3LYP 6-31G(d), para os tres posibles confórmeros do MC[142]: twist (liña 
verde), cis (liña vermella) e trans (liña azul). Para facilitar os cálculos teóricos, sustituíronse os tert-butilos do 
macrociclo por metilos. 
O espectro de ECD do MC[142] se mediu en distintos disolventes, MeOH (0.857), CHCl3 
(0.786), CCl4 (0.632) e hexano (0.519) (ordenados de forma decrecente en canto o valor de 
polaridade/polarizabilidade (SPP)), observouse que o ECD medido en CHCl3 non seguía o 
patrón establecido (Figura 7.16). 
 
Figura 7.16. Espectro de UV/Vis e CD de (P,P,P,P)-MC[142] medidos en CHCl3 (azul), hexano (vermello), 
CCl4 (gris) e MeOH (violeta). 
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Tendo en conta isto, e ademáis, que o isómero aquiral (P,M,M,P)-MC[142] presenta na súa 
estrutura de raios-X un enlace feble de hidróxeno entre o nitróxeno da piridina e o 
hidróxeno do cloroformo, que o RMN de 1H en C6D6 dos cristais obtidos do isómero 
(P,P,P,P)-MC[142] presentan unha relación cloroformo-macrocilo 2:1 (Figura 7.17) a cal 
non diminúe a pesar de burbullar argon ou concentrar a alto baleiro durante varias horas, 
unha posible complexación do cloroformo co macrociclo pode estar acontecendo. Sen 
embargo, tódolos intentos de calcular a constante de asociación cloroformo-macrociclo 
foron infrutuosos. 
 
Figura 7.17. Espectro de RMN de 1H medido en C6D6 dos cristais do macrociclo (P,P,P,P)-MC[142]. Na 
figura superior, macrociclo con CHCl3. Na figura inferior: comparativa de CHCl3 libre (espectro verde) e 
posiblemente complexado co macrociclo (espectro violeta). 
Así mesmo, cando se levou a cabo a protonación do macrociclo (P,P,P,P)-MC[142] con 
TFA en cloroformo e en hexano, observouse que se necesitaban máis equivalentes de TFA 
en cloroformo que en hexano, cando en teoría, os disolventes máis polares favorecen o 
equilibrio de transferencia de protón do ácido á base de Brönsted. Unha posible 
explicación a isto pode ser que, o macrociclo en cloroformo estea altamente solvatado 
dificultando desta maneira a súa protonación. 
Cando se engade Et3N a unha disolución do macrociclo con TFA, obsérvase que se 
recupera o espectro orixinal de ECD (Figura 7.18). Esta é unha interesante propiedade do 
macrociclo posto que é a base dos “switchers” moleculares inducidos por un cambio de 
pH. 
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Figura 7.18. Espectro de UV/Vis e CD: liña sólida azul: MC[142] neutro; liña punteada negra: MC[142] con 
TFA; liña sólida vermella: MC[142] protonado despois da addición de Et3N. 
7.6 Síntese de Indolizinas a partir de 2-Eninilpiridinas. 
As indolizinas son uns interesantes candidatos para a síntese de novos alenofanos debido 
as súas propiedades biolóxicas e sobre todo a súa potencial aplicación para complexacións 
hospedador-hóspede. 
Aínda non se levou acabo a síntese destes alenofanos, pero si a síntese e o estudo do 
mecanismo polo cal se obteñen as indolizinas a partir de 2-eninilpiridinas (Esquema 7.6). 
 
Esquema 7.6. Síntese de indolizinas a partir de 2-eninilpiridinas. 
A eninilpiridina E-4.1a da lugar a indolizina correspondente a temperatura ambiente. Para 
formación da indolizina In-4.1b a partir da eninilpiridina E-4.1b requírese unha 
temperatura maior (65 ºC). Sen embargo, a eninilpiridina E-4.1c non da lugar a 
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correspondente indolizina a pesar de levar a cabo a reacción a maior temperatura (115 ºC 
en tolueno), aumento do carácter nucleófilo do anión MeO– mediante a captura do seu 
contraión por o éter coroa 15-C-5, activación do alquino con iodo. 
Por este motivo decidiuse levar a cabo un estudio teórico e experimental para entender cal 
é o mecanismo polo cal se obteñen as indolizinas a partir de 2-eninilpiridinas. 
Mediante cálculos teóricos utilizando B3LYP DFT proponse un mecanismo no cal ten 
lugar unha isomerización E-Z da eninilpiridina promovida pola base nucleófila presente no 
medio (t-BuO– ou MeO–). O Z-enino formado da lugar mediante unha ciclación 5-exo-dig 
a un indolizinil carbeno intermedio. Mediante ACID demostrouse que esta ciclación ten 
unha natureza pseudocoartada. Finalmente, na presenza de alcohois, ocorre a adición do 
carbeno o enlace OH, obténdose desta maneira o correspondente éter (Esquema 7.7). 
 
Esquema 7.7. Mecanismo proposto para a ciclación de 2-eninilpiridinas. 
Para verificar estes resultados teóricos, levouse a cabo un atrapamento intermolecular e 
intramolecular do indolizinil carbeno intermedio. 
O atrapamento intermolecular do carbeno 4.10 levouse a cabo na presenza de acrilato de 
etilo un alqueno pobre en electróns, obténdose o ciclopropano correspondente 4.11. Sen 
embargo na presenza de dimetilbutano, un alqueno rico en electróns, non se obtén o 
ciclopropano correspondente se non que se obtén o eter 4.12, o cal púidose formar por a 
inserción do carbeno o enlace O–H do 2,3-dimetil-3-butenol, o cal é un subproduto obtido 
pola oxidación do dimetilbuteno. Polo tanto, isto confirma a presenza dun carbeno 
nucleófilo intermedio (Esquema 7.8). 
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Esquema 7.8. Atrapamento intermolecular do indolizinil carbeno intermedio 4.10. 
O atrapamento intramolecular do carbeno deu lugar a biindolizina 4.9 mediante unha 
reacción “one-pot” na cal tres enlaces son formados secuencialmente (Esquema 7.9).  
 
 
Esquema 7.9. Síntese da biindolizina 4.9. 
7.7 Conclusións 
O ciclofano (2,6)pirido[142]alenoacetilénico MC[142] foi sintetizado a partir de dúas rutas: 
 
 Na primeira ruta, a síntese do MC[142] levouse a cabo a partir do dietinilaleno (±)-
DEA-TIPS. Por este motivo, o alenofano foi obtido como unha mestura de dous pares de 
enantiómeros (P,P,P,P)/(M,M,M,M)-MC[142] e (P,P,M,P)/(M,M,P,M)-MC[142] e tres 
isómeros aquirais (P,M,M,P)-MC[142], (P,M,P,M)-MC[142] e (P,P,M,M)-MC[142] nunha 
distribución estatística 1:4:1:1:1. Esta mestura foi resolta por HPLC e, grazas o estudo da 
simetría e a quiralidade dos estereoisómeros, a configuración relativa destes puido ser 
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asignada por RMN, HPLC cunha fase estacionaria quiral, espectroscopía de dicroísmo 
circular e análise de raios-X. 
 
 A segunda ruta consistiu na resolución por HPLC cunha fase estacionaria quiral, da 
mestura racémica do dietinilaleno DEA-OH, o que deu lugar, tras unha serie de reaccións, 
á obtención do macrociclo (P,P,P,P)-MC[142] e o seu enantiómero enantioméricamente 
puros. 
O MC[142] pode presentar tres conformacións: cis, trans e twist. En fase sólida, o 
macrociclo (P,P,P,P)-MC[142] presenta unha xeometría semellante a conformación twist 
teórica. Para discernir cal das conformacións está presente en disolución, ou se esta 
presente unha media de ámbalas tres, levouse acabo un estudo teórico (CAM-B3LYP 6-
31G(d) nivel de teoría) e experimental das súas propiedades quirópticas (ECD, VCD, 
ORD). A comparación dos espectros teóricos e experimental de ORD e ECD suxiren que a 
conformación twist é a predominante en disolución.  
O estudo do efecto do disolvente neste sistema amosa que o cloroformo pode chegar a 
formar un complexo co macrociclo establecendo pontes de hidróxeno febles entre o C–H 
dador do cloroformo e o nitróxeno aceptor da piridina. 
Así mesmo, o macrociclo quiral presenta biestabilidade o que ofrece a posibilidade de 
crear novos sistemas tipo “switchers” moleculares inducidos por un cambio de pH, neste 
caso tras adición de TFA e Et3N. 
 
 A incorporación de novos espazadores aromáticos no macrociclo, como por 
exemplo unidades de indolizina, dará lugar a novos alenofanos con interesantes 
propiedades. Neste traballo, os espazadores aromáticos de indolizina foron sintetizados a 
partir de 2-eninilpiridinas. Estudos teóricos e experimentais indican que este proceso 
acontece a partir dunha isomerización E-Z asistida por un nucleófilo, seguida dunha 
ciclación pseudocoarctada que da lugar a un carbeno nucleófilo, o cal tras reacción con 
acrilato de etilo dará lugar o ciclopropano derivado correspondente ou mediante reacción 
cun alcohol dará lugar o correspondente eter derivado 
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General procedures. Solvents were dried according to published methods and distilled 
before use.
1
 THF, for reactions were dried by distillation over sodium/benzophenone. 
Dichloromethane, dichloroethane, Et3N, pyridine, and methanol were distilled over 
calcium hydride immediately before use. All other reagents were commercial 
compounds of the highest purity available. All reactions were carried out under argon 
atmosphere, and those not involving aqueous reagents were carried out in oven-dried 
glassware for at least 12 hours to 140 ºC. All solvents and anhydrous solutions were 
transferred through syringes and cannulae previously dried in the oven for at least 12 h 
and kept in a dessicator with KOH. For reactions at low temperature, icewater or 
CO2/acetone systems were used. 
Flash column chromatography (FC) was carried out using Merck Kieselgel 60 (230-400 
mesh) under pressure. Analytical thin layer chromatography (TLC) was performed on 
aluminium plates with Merck Kieselgel 60F254 and visualized by UV irradiation (254 
nm) or by staining with a solution of phosphomolibdic acid. HPLC: Waters 510 pump 
controlled by PMC pump controller, with U6K injector and UV detector. The used 
solvents were HPLC grade and degassed with He. UV/Vis and ECD spectra were 
recorded on a Jasco J-815 spectropolarimeter at 25 ºC. 
1
H NMR spectra were recorded 
in CDCl3, C6D6 or acetone at ambient temperature on a Bruker AMX-400 spectrometer 
at 400 MHz or 600 MHz with residual protic solvent as the internal reference [CDCl3, 
H = 7.26 ppm; (CD3)2CO, H = 2.05 ppm; C6D6, H = 7.16 ppm]; chemical shifts () are 
given in parts per million (ppm), and coupling constants (J) are given in Hertz (Hz). The 
proton spectra are reported as follows:  (multiplicity, coupling constant J, number of 
protons, assignment). 
13
C NMR spectra were recorded in CDCl3 and C6D6 at ambient 
temperature on the same spectrometer,r at 100 MHz, with the central peak of CDCl3 (C 
= 77.16 ppm), C6D6 (C = 128.06 ppm) as the internal reference. The DEPT135 pulse 
sequence was used to aid in the assignment of signals in the 
13
C NMR spectra. IR 
spectra were recorded on a JASCO FT/IR-4200 infrared spectrometer from a thin film 
deposited onto a NaCl glass plate Peaks are quoted in wave numbers (cm
-1
). Mass 
spectra were performed at the Cacti Universidade de Vigo by the Hewlett-Packard 
HP59970 instrument operating at 70 eV by electron ionization and on an APEX III FT-
ICR MS (Bruker Daltonics, Billerica, MA) equipped with a 7T actively shielded 
magnet. Ions were generated using an Apollo API electrospray ionization (ESI) source, 
                                                 
1
 Perrin, D.; Armarego, W. Purification of Laboratory Chemicals; Pergamon Press: Oxford, 1998. 
with a voltage between 1800 and 2200 V (to optimize ionization efficiency) applied to 
the needle, and a counter voltage of 450 V applied to the capillary. Samples were 
prepared by adding a spray solution of 70:29.9:0.1 (v/v/v) CH3OH/water/formic acid to 
a solution of the sample at a v/v ratio of 1 to 5% to give the best signal-to-noise ratio. 
High-resolution mass spectra were taken on a VG Autospec instrument.  
Computational methods: All computations were performed using Gaussian 09. The 
conformers of the different diastereoisomers of 1 were optimized at AM1 level of 
theory. These conformers were characterized as true minima by analytical computation 
of vibrational frequencies at the CAM-B3LYP/6-31G(d) level of theory. 
X-ray methods: All structures were collected on a Bruker AXS BV, 1997-2004; cell 
refinement: HKL SCALEPACK; data reduction: HKL DENZO and SCALEPACK
2
; 
The structures were solved by direct methods using the program: SHELXL97;
3
 
Drawings were produced with MERCURY
4b
 and ORTEP
4c
 programs and special 
computations for the crystal structure discussions were carried out with PLATON.
4a
  
  
                                                 
2
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Methods in Enzymology 276, Macromolecular Crystallography, part A, 1997, 307, C. W. Carter, Jr., R. 
M. Sweet, Eds., Academic Pres (New York). 
3
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2,2,6,6-Tetramethyl-hepta-4-yn-3-one (2.1).
5
  
 
C11H18O 
M.W. (g/mol): 166.14 
 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
1.29 (s, 9H, t-Bu) 
1.18 (s, 9H, t-Bu) 
 
 
194.9 (C, C=O) 
103.2 (C) 
77.3 (C) 
44.9 (C, t-Bu) 
30.3 (3xCH3, t-Bu) 
28.0 (C, t-Bu) 
26.3 (3xCH3, t-Bu) 
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 Livingsron,R.; Cox, L. R.; Odermatt, S.; Diederich, F. Helv. Chim. Act. 2002, 3052. 
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
 
  
(±)-3-tert-Butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-diyn-3-ol 
((±)-2.2).
1
 
 
C22H40OSi 
M.W. (g/mol): 348.28 
 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
1.21 (s, 9H, t-Bu) 
1,12 (s, 9H, t-Bu) 
1.08 (s, 21H, TIPS) 
 
 
108.1 (C) 
93.0 (C) 
84.8 (C) 
79.1 (C) 
71.4 (C) 
40.1 (C, t-Bu) 
31.1 (3xCH3, t-Bu) 
27.8 (C, t-Bu) 
25.2 (3xCH3, t-Bu) 
19.0 (6xCH3, TIPS) 
11.7 (3xCH, TIPS) 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
 
  
 (±)-3-tert-Butyl-6,6-dimethyl-1-(triisopropylsilyl)hepta-1,4-diyn-3-yl-
acetate ((±)-3.2).  
 
C24H42O2Si 
M.W. (g/mol): 390.67 
 
MS (EI
+
) m/z (%) 390 ([M]
+
, 18%), 173 (100) 
HRMS (EI
+
) m/z calc. for C24H42O2Si 390.2954; found 390.29486. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
2.05 (s, 3H, OAc) 
1.22 (s, 9H, t-Bu) 
1.16 (s, 9H, t-Bu) 
1.10 (s, 21H, TIPS) 
 
 
167.6 (C, -OAc) 
103.8 (C) 
94.0 (C) 
86.3 (C) 
75.4 (C) 
74.4 (C) 
40.2 (C, t-Bu) 
30.7 (3x CH3, t-Bu) 
27.6 (C, t-Bu) 
24.9 (3xCH3, t-Bu) 
21.6 (CH3, -OAc) 
18.7 (6xCH3, TIPS) 
11.4 (3xCH, TIPS) 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
  
(±)-3-tert-Butyl-6,6-dimethylhepta-1,4-diyn-3-yl acetate ((±)-3.3). 
 
C15H22O2 
M.W. (g/mol): 234.33 
 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
2.55 (s, 1H, CC-H) 
2.06 (s, 3H, OAc) 
1,22 (s, 9H, t-Bu) 
1.14 (s, 9H, t-Bu) 
 
 
 
168.3 (C, -OAc) 
94.4 (C) 
80.3 (C) 
74.7 (C) 
73.8 (C) 
73.3 (CH, CC-H) 
40.5 (C, t-Bu) 
30.7 (3xCH3, t-Bu) 
27.6 (C, t-Bu) 
24.8 (3xCH3, t-Bu) 
21.7 (CH3, OAc) 
 
 
 
 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
(±)-1-(tert-Butyl)-4,4-dimethyl-1-[(triisopropylsilyl)ethynyl]pent-2-yn-
1-ylpentafluoro benzoate ((±)-2.3).
1 
 
C29H39 F5O2Si 
M.W. (g/mol): 542.70 
 
19
F NMR (282 MHz, CDCl3) δ -139.2 (m, 2F), -150.2 (m, 1F), -161.2 (m, 2F) ppm. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
1.22 (s, 9H, t-Bu) 
1.18 (s, 9H, t-Bu) 
1.08 (s, 21H, TIPS) 
 
 
155.9 (C, -CO2C6F5) 
147.1 (C, -C6F5) 
144.8 (C, -C6F5) 
143.8 (C, -C6F5) 
141.4 (C, -C6F5) 
139.5 (C, -C6F5) 
136.1 (C, -C6F5) 
102.3 (C) 
95.8 (C) 
 
88.3 (C) 
78.0 (C) 
74.4 (C) 
40.5 (C, t-Bu) 
30.6 (3xCH3, t-Bu) 
27.7 (C, t-Bu) 
24.9 (3xCH3, t-Bu) 
18.7 (6xCH3, TIPS) 
11.4 (3xCH, TIPS) 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
F19 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
(±)-3,5-Di-(tert-butyl)-1-(triisopropylsilyl)hepta-3,4-diene-1,6-diyne 
((±)-DEA-TIPS).
1 
 
C24H40 Si 
M.W. (g/mol): 356.29 
 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
3.01 (s, 1H, -CC-H) 
1.17 (s, 9H, t-Bu) 
1.16 (s, 9H, t-Bu) 
1.10 (s, 21H, TIPS) 
 
 
212.7 (C, C=C=C) 
104.3 (C) 
101.9 (C) 
100.1 (C) 
94.5 (C) 
80.3 (CH, -CC-H) 
77.8 (C) 
35.5 (C, t-Bu) 
35.4 (C, t-Bu) 
29.0 (3xCH3, t-Bu) 
28.9 (3xCH3, t-Bu) 
18.8 (6XCH3, TIPS) 
11.5 (3XCH, TIPS) 
 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3) 
  
(±)-5,7-Di-(tert-butyl)-2-methylnona-5,6-diene-3,8-diyn-2-ol ((±)-DEA-
OH).
6
 
 
C18H26O 
M.W. (g/mol): 258,20 
 
UV-Vis (Hexane): λmax () = 225 nm (21569 Lmol
-1
cm
–1
). 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
2.98 (s, 1H, -CC-H) 
1.54 (s, 6H, -C(CH3)2OH) 
1.12 (s, 9H, t-Bu) 
1.11 (s, 9H, t-Bu) 
 
 
211.7 (C, C=C=C) 
103.1 (C) 
102.3 (C) 
97.5 (C) 
80.4 (CH, -CC-H) 
77.7 (C) 
75.7 (C) 
65.8 (C, -C(CH3)2OH) 
35.6 (C, t-Bu) 
35.3 (C, t-Bu) 
31.6 (2xCH3, -C(CH3)2OH) 
29.0 (3xCH3, t-Bu) 
28.9 (3xCH3, t-Bu) 
 
 
  
                                                 
6
 a) Alonso-Gómez, J-L; Schanen, P.; Rivera-Fuentes, P, Seiler, P.; Diederich, F. Chem. Eur. J. 2008, 
14,10564. b) Rivera-Fuentes, P.; Nieto-Ortega, B.; Schweizer, W. B.; López-Navarrete, J. T.; Casado, J.; 
Diederich, F. Chem. Eur. J. 2011, 17, 3876. 
1H-NMR (400 MHz, CDCl3)  
 
13C-NMR (100 MHz, CDCl3) 
 
Resolution of (±)-DEA-OH by HPLC on the CHIRALPACK IA chiral stationary phase 
(hexane/isopropanol 99.2:0.8; flow rate: 2.5 mLmin
–1
; concentration: 5 mg dissolved in 
100 µL of n-hexane; injection 100 µL, λ = 260 nm)  
 
 
CD and UV/Vis spectra of (P)-DEA-OH (black solid line) and (M)-DEA-OH (black 
doted line) recorded in hexane: 
2,6-Bis[3,5-di-(tert-butyl)-7-(triisopropylsilyl)hepta-3,4-diene-1,6-
diynyl)pyridine (HT-TIPS). 
 
C53H81NSi2 
M.W. (g/mol): 787.59 
 
HRMS-ESI: m/z calc. for C53H82NSi2
+ 
788.59564; found 788.59803. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.56 (t, J = 7.8, 1H) 
7.33 (d, J = 7.8, 2H) 
1.17 (s, 18H, 2xt-Bu) 
1.14 (s, 18H, 2xt-Bu) 
1.06 (s, 42H, 2xTIPS) 
 
 
213.2 (C=C=C) 
144.3 (C, py) 
136.2 (CH, py) 
126.4 (CH, py) 
104.6 (C) 
102.4 (C) 
100.1 (C) 
94.9 (C) 
91.5 (C) 
84.2 (C) 
36.0 (2xC, t-Bu) 
35.6 (2xC, t-Bu) 
29.3 (6xCH3, t-Bu) 
29.1 (6xCH3, t-Bu) 
18.9 (6xCH3, TIPS) 
11.5 (3xCH, TIPS). 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
(P,P)-/(M,M)-9,9'-(Pyridine-2,6-diyl)bis(5,7-di-tert-butyl-2-methylnona-
5,6-dien-3,8-diyn-2-ol) ((P,P)-/(M,M)-HT-OH). 
 
C41H53NO2 
M.W. (g/mol): 591.87 
 
IR-TF (NaCl) ν 3361, 2965, 2929, 2901, 2866, 2206, 1557, 1444 cm–1. 
UV-Vis (CHCl3): λmax () = 317 nm (20872 Lmol
–1
cm
–1
), 289 nm (22990 Lmol
–1
cm
–1
). 
 
 Enantiomer (P,P)-DEA-OH 
HRMS-ESI: m/z calc. for C41H54NO2
+ 
592.4149; found 592.4156. 
[α]D
20
= +463 (c= 5 E
–4 
g/mL, CHCl3) 
 
           Enantiomer (M,M)-DEA-OH 
HRMS-ESI: m/z calc. for C41H54NO2
+ 
592.4149; found 592.4162. 
[α]D
20
= -487 (c= 6.2 E
–4 
g/mL, CHCl3) 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.58 (t, J= 7.8 Hz, 1H) 
7.34 (d, J= 7.8 Hz, 2H) 
1.55 (s, 12 H, -C(CH3)2OH), 
1.19 (s, 18 H, t-Bu) 
1,13 (s, 18 H, t-Bu) 
 
 
212.1 (C, C=C=C) 
144.2 (C, py) 
136.2 (CH, py) 
126.3 (CH, py) 
103.5 (C) 
102.7 (C) 
97.9 (C) 
91.5 (C) 
 
84.1 (C) 
75.7 (C) 
65.8 (2xC, -C(CH3)2OH) 
35.8 (2xC, t-Bu) 
35.6 (2xC, t-Bu) 
31.6 (4xCH3, -C(CH3)2OH) 
29.2 (6xCH3, t-Bu) 
29.0 (6xCH3, t-Bu) 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
CD and UV/Vis spectra of (P,P)-HT-OH (black solid line) and (M,M)-HT-OH (black 
doted line) recorded in CHCl3: 
 
 
  
(P)-5,7-Di-tert-butyl-9-(6-((P)-3,5-di-tert-butylhepta-3,4-dien-1,6-diyn-
1-yl)pyridin-2-yl)-2-methylnona-5,6-dien-3,8-diyn-2-ol ((P,P)-HT-MP). 
 
C38H47NO 
M.W. (g/mol): 533.37 
 
IR-TF (NaCl) ν 3377, 3311, 2964, 2929, 2903, 2866, 2209, 1574, 1557, 1459, 1443, 
1363 cm
–1
. 
HRMS-ESI: m/z calc. for C38H48NO
+
 534.3730; found 534.3727. 
UV-Vis (CHCl3): λ ()= 319 nm (29523 Lmol
–1
cm
–1
), 287 nm (32933 Lmol
–1
cm
–1
). 
[α]D
20 
= + 416 (c = 1,92 E
–3 
g/mL, CHCl3) 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.60 (t, J = 7.8, 1H) 
7.36 (d, J = 7.8, 2H) 
3.02 (s, 1H, C C-H) 
1.56 (s, 6H, -C(CH3)2OH) 
1.21 (s, 9H, t-Bu) 
1.20 (s, 9H, t-Bu) 
1.16 (s, 9H, t-Bu) 
1.13 (s, 9H, t-Bu)
 
 
 
 
212.8 (C=C=C) 
212.1 (C=C=C) 
144.1 (C, py) 
136.3 (CH, py) 
126.4 (CH, py) 
103.4 (C) 
103.2 (C) 
103.1 (C) 
102.7 (C) 
97.8 (C) 
91.8 (C) 
91.5 (C) 
84.2 (C) 
 
83.8 (C) 
81.1 (CH, -CC-H) 
75.7 (C) 
65.9 (C, -C(CH3)2OH) 
35.9 (C, t-Bu) 
35.8 (C, t-Bu) 
35.7 (C, t-Bu) 
35.5 (C, t-Bu) 
31.6 (2xCH3, -C(CH3)2OH) 
29.3(CH3, t-Bu) 
29.2 (CH3, t-Bu) 
29.0 (CH3, t-Bu) 
28.9 (CH3, t-Bu) 
 
 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
CD and UV/Vis spectra of (P,P)-HT-MP recorded in CHCl3: 
 
 
 
  
(P,P,P,P)-6,6'-(3,5,10,12-Tetra-tert-butyltetradeca-3,4,10,11-tetraen-
1,6,8,13-tetrayne-1,14-diyl)bis(5,7-di-tert-butyl-2-methylnona-5,6-dien-
3,8-diyn-2-ol)pyridine) ((P,P,P,P)-D-OH). 
 
 
C79H92N2O2 
M.W. (g/mol): 1064.72 
 
HRMS-ESI: m/z calc. for C76H93N2O2
+
 1065.7231; found 1065.7219.  
UV-Vis (CHCl3): λ ()= 324 nm (62673 Lmol
–1
cm
–1
), 283 nm (63694 Lmol
–1
cm
–1
). 
[α]D
20 
= + 1090 (c = 1,12 E
–3 
g/mL, CHCl3). 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.59 (t, J = 7.8, 1H) 
7.36 (d, J = 7.8, 2H) 
1.56 (s, 12H, -C(CH3)2OH) 
1.21 (s, 9H, t-Bu) 
1.20 (s, 9H, t-Bu) 
1.17 (s, 9H, t-Bu) 
1.13 (s, 9H, t-Bu)
 
 
 
 
214.4 (C=C=C) 
212.1 (C=C=C) 
144.1 (C, py) 
144.0 (C, py) 
136.3 (CH, py) 
126.5 (CH, py) 
103.7 (C) 
103.7 (C) 
103.4 (C) 
102.7 (C) 
97.8 (C) 
92.1 (C) 
91.5 (C) 
84.2 (C) 
 
 
83.5 (C) 
77.8 (C) 
75.7 (C) 
75.3 (C) 
65.9 (C, -C(CH3)2OH) 
36.1 (C, t-Bu) 
36.1 (C, t-Bu) 
35.8 (C, t-Bu) 
35.6 (C, t-Bu) 
31.6 (2xCH3, -C(CH3)2OH) 
29.2(CH3, t-Bu) 
29.2 (CH3, t-Bu) 
29.2 (CH3, t-Bu) 
29.0 (CH3, t-Bu) 
  
1H-NMR (400 MHz, CDCl3) 
 
13C-NMR (100 MHz, CDCl3) 
 
 
 
CD and UV/Vis spectra of (P,P,P,P)-D-OH recorded in CHCl3: 
 
 
  
2,6-Bis[3,5-di-(tert-butyl)-hepta-3,4-diene-1,6-diynyl)pyridine (HT-H). 
 
C35H41N 
M.W. (g/mol): 475.32 
 
IR-TF (NaCl) ν 3309, 2965, 2930, 2903, 2867, 1571, 1557, 1443, 1363, 1239, 1201 
cm
1
. 
HRMS-ESI (HT-H): m/z calc. for C35H42N
+ 
476.3312; found.476.3299. 
UV-Vis (CHCl3): λ ()= 317 nm (16917 Lmol
–1
cm
–1
), 283 nm (18779 Lmol
–1
cm
–1
) 
 
 Enantiomer (P,P)-HT-H 
HRMS-ESI: m/z calc. for C35H42N
+ 
476.3312; found.476.3317. 
[α]D
20
= + 284 (c= 4.75 E
–4 
g/mL, CHCl3) 
 
            Enantiomer (M,M)-HT-H 
HRMS-ESI: m/z calc. for C35H42N
+ 
476.3312; found.476.3317. 
[α]D
20
= - 289 (c= 4.73 E
–4 
g/mL, CHCl3) 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.56 (t, J = 7.8, 1H) 
7.32 (d, J = 7.8, 2H) 
2.99 (s, 2H, C C-H) 
1.18 (s, 18H, t-Bu) 
1.13 (s, 18H, t-Bu).
 
 
 
 
 
212.8 (C=C=C) 
144.1 (C, py) 
136.2 (CH, py) 
126.5 (CH, py) 
103.2 (C) 
103.1 (C) 
91.8 (C) 
 
83.7 (C) 
81.1 (CH, -CC-H) 
77.3 (C) 
35.9 (C, t-Bu) 
35.5 (C, t-Bu) 
29.2 (CH3, t-Bu) 
29.0 (CH3, t-Bu) 
 
 
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3) 
 
CD and UV/Vis spectra of (P,P)-HT-H (black solid line) and (M,M)-HT-H (black 
dotted line) recorded in CHCl3: 
 
  
2,6-Bis[3,5-di-(tert-butyl)-7-iodohepta-3,4-diene-1,6-diynyl)pyridine 
(HT-I).  
 
C35H39I2N 
M.W. (g/mol): 727.12 
 
HRMS-ESI: m/z calc. for C35H40I2N
+ 
728.1244; found. 728.1215. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.57 (t, J = 7.8, 1H) 
7.33 (d, J = 7.8, 2H) 
1.18 (s, 18H, t-Bu) 
1.12 (s, 18H, t-Bu). 
 
 
 
 
213.8 (C, C=C=C) 
144.1 (C, py) 
136.3 (CH, py) 
126.57 (CH, py) 
104.7 (C) 
103.5 (C) 
91.8 (C) 
87.3 (C) 
84.0 (C) 
77,4 (C) 
36.1 (C, t-Bu) 
36.0 (C, t-Bu) 
29.3 (CH3, t-Bu) 
29.1 (CH3, t-Bu) 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
 
6,6'-(3,5,10,12-Tetra-tert-butyltetradeca-3,4,10,11-tetraen-1,6,8,13-
tetrayne-1,14-diyl)bis(2-3,5-di-tert-butyl-7-iodohepta-3,4-dien-1,6-diyn-
1-yl)pyridine) (D-I). 
 
C70H78I2N2 
M.W. (g/mol): 1200.43 
 
HRMS-ESI: m/z calc. for C105H118N3
+
 1201.4327; found 1201.4323. 
 
  
4,6,11,13,19,21,26,28,34,36,41,43-dodeca-tert-butyl-
1,16,31(2,6)tripyridinecyclopentatetracontaphane-
4,5,11,12,19,20,26,27,34,35,41,42-dodecaen-2,7,9, 
14,17,22,24,29,32,37,39,44-dodecayne (MC[143]). 
 
C105H117N3 
M.W. (g/mol): 1419.9 
 
HRMS-ESI: m/z calc. for C105H118N3
+
 1420.9320; found 1420.9327. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.56 (td, J=7.8, 3.0, 1H) 
7.33 (dd, J=7.8, 1.4, 2H) 
1.18 (s, 18H, t-Bu) 
1.13 (s, 18H, t-Bu) 
 
 
214.5 (C, C=C=C) 
144.0 (C, py) 
136.0 (CH, py) 
126.4 (CH, py)  
103.6 (C)  
92.1 (C)  
83.30 (C) 
77.68 (C) 
75.17 (C) 
35.92 (C, t-Bu) 
29.08 (CH3, t-Bu) 
29.03 (CH3, t-Bu) 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3) 
  
4,6,11,13,19,21,26,28-Octa-tert-butyl-
1,16(2,6)dipyridinecyclotriacontaphane-4,5,11,12,19,20,26,27-octaen-
2,7,9,10,14,17,22,24,29-octayne (MC[142]). 
 
 
C70H78N2 
M.W. (g/mol): 946.62 
 
MC[142] was obtained as a mixture of five different stereoisomers, which was separated 
by HPLC on the stationary phase Rexchrom ‘BucKyclutcher 1’ Preparative, 10 µm 
100Å Trident-TriDNP, 50 cm X 21.1 mm ID (eluent: DCM/hexane 80:20; flow rate: 5 
mLmin
–
1; 5 mg of MC[142] dissolved in 500 µL of n-hexane, λ = .320 nm) 
 
 
General data: IR-TF (NaCl) ν 3309, 2964, 2929, 2902, 2866, 2112, 1922, 1729, 1574, 
1557, 1444, 1363, 1220, 770 cm
–1
. 
Data for (P,M,M,P)-MC[142]: 
 
HRMS-ESI: m/z calc. for C70H79N2
+
 947.6238; found 947.62335. 
 
1
H NMR (400 MHz, C6D6):  (ppm) 
13
C NMR (100 MHz, C6D6):  (ppm) 
 
6.83 (d, J=7.8, 2 H) 
6,63 (t, J=7.6 1H) 
1.12 (s, 18 H, t-Bu) 
1.09 (s, 18 H, t-Bu) 
 
 
 
 
215.1 (C, C=C=C) 
144.3 (C, py) 
135.6 (CH, py) 
125,9 (CH, py) 
104.4 (C) 
104.3 (C) 
93.6 (C) 
82.9 (C) 
78.7 (C) 
75.9 (C) 
36.1 (C, t-Bu) 
35.8 (C, t-Bu) 
29.1 (CH3, t-Bu) 
29.0 (CH3, t-Bu) 
 
 
  
1H-NMR (400 MHz, C6D6) 
13C-NMR (100 MHz, C6D6): 
  
Crystal data and structure refinement for (P,M,M,P)-MC[142]. 
 
 
 
Empirical formula  C70H78N2 (CHCl3)2 
Formula weight  1186.08 
Temperature  100(2) K 
Wavelength  0.71073 Å  
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions: a = 12.3477(15) Å = 90° 
 b = 22.448(3) Å = 106.923(3)° 
 c = 12.8588(15) Å  = 90° 
Volume 3409.9(7) Å3 
Z 2 
Density (calculated) 1.155 Mg/m3 
Absorption coefficient 0.292 mm-1 
F(000) 1256 
Crystal size 0.18 x 0.13 x 0.04 mm3 
 range for data collection 1.72 to 23.23° 
Index ranges h = -13 13, k = 0 24, l =0 14 
Reflections collected 19464 
Independent reflections 4892 [R(int) = 0.1154] 
Completeness to = 23.23° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9741 and 0.8905 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4892 / 95 / 373 
Goodness-of-fit on F2 1.004 
Final R indices [I>2sigma(I)] R1 = 0.0641, wR2 = 0.1227 
R indices (all data) R1 = 0.1532, wR2 = 0.1567 
Largest diff. peak and hole max = 0.420 e.Å-3, min= -0.329 e.Å-3 
  
Data for (P,P,P,P)-/(M,M,M,M)-MC[142] 
 
General Data: UV/Vis (CHCl3): λ ()= 321 nm (71685 Lmol
–1
cm
–1
), 300 nm (91791 
Lmol
–1
cm
–1
), 284 nm (83578 Lmol
–1
cm
–1
). 
 
 Data for enantiomer (P,P,P,P)-MC[142]:  
HRMS-ESI: m/z calc. for C70H49N2
+
 947.6238; found 947.6231. 
 
 Data for enantiomer (M,M,M,M)-MC[142]:  
HRMS-ESI: m/z calc. for C70H49N2
+
 947.6238; found 947.6237. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.58 (t, J=7.8, 1H) 
7.32 (d, J=7.8, 2H) 
1.19 (s, 18H, t-Bu) 
1.16 (s, 18H, t-Bu) 
 
 
 
 
214.8 (C, C=C=C) 
144.0 (C, py) 
136.1 (CH, py) 
126.2 (CH, py) 
103.9 (C) 
103.4 (C) 
92.1 (C) 
83.5 (C) 
78.1 (C) 
75.3 (C) 
36.1 (C, t-Bu) 
35.9(C, t-Bu) 
29.2 (CH3, t-Bu) 
29.1 (CH3, t-Bu) 
 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3) 
 
CD and UV/Vis spectra of (P,P,P,P)-MC[142] (black solid line) and (M,M,M,M)-
MC[142] (black doted line) recorded in CHCl3: 
 
 
Crystal data and structure refinement for (P,M,M,P)-MC[142]. 
 
 
 
Empirical formula  C70H78N2 
Formula weight  947.34 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  C2 
Unit cell dimensions a = 33.2464(15) Å = 90°. 
 b = 6.8630(5) Å = 109.185(3)°. 
 c = 31.448(2) Å  = 90°. 
Volume 6777.0(7) Å3 
Z 4 
Density (calculated) 0.928 Mg/m3 
Absorption coefficient 0.395 mm-1 
F(000) 2048 
Crystal size 0.25 x 0.08 x 0.02 mm3 
 range for data collection 1.49 to 54.65°. 
Index ranges h= 0 34, k= 0 7, l= -33 31 
Reflections collected 51231 
Independent reflections 4573 [R(int) = 0.083] 
Completeness to  = 54.65° 98.6 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4573 / 564 / 704 
Goodness-of-fit on F2 0.930 
Final R indices [I>2sigma(I)] R1 = 0.0561, wR2 = 0.1434 
R indices (all data) R1 = 0.0911, wR2 = 0.1582 
Largest diff. peak and hole max = 0.173 e.Å-3, min = -0.160 e.Å-3 
  
Data for (P,P,M,P)-/(M,M,P,M)-MC[142] 
 
HRMS-ESI: m/z calc. for C70H79N2
+
 947.6238; found 947.6194. 
UV-Vis (CHCl3): λ ()= 320 (29677 Lmol
–1
cm
–1
), 296 (39563 Lmol
–1
cm
–1
), 281 nm (44453 
Lmol
–1
cm
–1
). 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.57 (t, J=7.7, 1H) 
7.33 (d, J=7.64, 2H) 
1.19 (m, 36H, t-Bu)
 
 
 
 
214.9 (C, C=C=C) 
214.4 (C, C=C=C) 
214.2 (C, C=C=C) 
144.1 (C, py) 
144.0 (C, py) 
136.2 (CH, py) 
126.3 (CH, py) 
126.2 (CH, py) 
126.1 (CH, py) 
104.0 (C) 
103.7 (C) 
103.7 (C)  
103.5 (C)  
103.4 (C) 
92.3 (C) 
92.1 (C) 
 
91.9 (C) 
83.6 (C) 
83.4 (C) 
78.0 (C) 
78.0 (C) 
77.9 (C) 
77.9 (C) 
75.1 (C) 
75.0 (C) 
36.2 (C, t-Bu) 
36.1 (C, t-Bu) 
36.0 (C, t-Bu) 
36.0 (C, t-Bu) 
35.9 (C, t-Bu) 
29.2 (CH3, t-Bu) 
29.2 (CH3, t-Bu) 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
CD and UV/Vis spectra of (P,P,M,P)-MC[142] and (M,M,P,M)-MC[142] recorded in 
CHCl3: 
 
  
Data for (P,P,M,M)-MC[142] 
 
HRMS-ESI: m/z calc. for C70H79N2
+
 947.6238; found 947.6232. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.64 (t, J=7.8, 1H) 
7.39 (d, J=7.8, 2H) 
1.28 (s, 18H, t-Bu) 
1.22 (s, 18H, t-Bu) 
 
 
214.7 (C, C=C=C) 
144.1 (C, py) 
136.1 (CH, py) 
126.3 (CH, py) 
103.9 (C) 
103.4 (C) 
92.3 (C) 
83.5 (C) 
78.0 (C) 
75.1 (C) 
36.1 (C, t-Bu) 
35.9 (C, t-Bu) 
29.2 (CH3, t-Bu) 
29.1 (CH3, t-Bu) 
. 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
Crystal data and structure refinement for (P,M,M,P)-MC[142]. 
 
 
 
Empirical formula  C70H78N2 
Formula weight  947.34 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 15.422(5) Å = 90° 
 b = 18.926(6) Å = 98.881(14)° 
 c = 11.672(4) Å  = 90° 
Volume 3366.1(18) Å3 
Z 2 
Density (calculated) 0.935 Mg/m3 
Absorption coefficient 0.053 mm-1 
F(000) 1024 
Crystal size 0.17 x 0.06 x 0.04 mm3 
Theta range for data collection 1.34 to 18.84° 
Index ranges h = -14 13, k = 0 17, l= 0 10 
Reflections collected 39378 
Independent reflections 2640 [R(int) = 0.0998] 
Completeness to theta = 18.84° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9925 and 0.7020 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2640 / 89 / 338 
Goodness-of-fit on F2 0.933 
Final R indices [I>2sigma(I)] R1 = 0.0759, wR2 = 0.1848 
R indices (all data) R1 = 0.1489, wR2 = 0.2168 
Extinction coefficient 0.0043(12) 
Largest diff. peak and hole max= 0.171 e.Å-3, min= -0.235 e.Å-3 
 
Data for (P,M,P,M)-MC[142] 
 
HRMS-ESI: m/z calc. for C70H79N2
+
 947.62378; found 947.6215. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 13C NMR (100 MHz, CDCl3):  (ppm) 
 
7.59 (t, J=7.8, 1H) 
7.34 (d, J=7.8, 2H) 
1.22 (s, 18H, t-Bu) 
1.19 (s, 18H, t-Bu) 
 
 
214.8 (C, C=C=C) 
144.0 (C, py) 
136.3 (CH, py) 
126.2 (CH, py) 
104.0 (C) 
103.5 (C) 
92.2 (C) 
83.9 (C) 
78.0 (C) 
75.0 (C) 
36.1 (C, t-Bu) 
36.0 (C, t-Bu) 
29.3 (CH3, t-Bu) 
29.2 (CH3, t-Bu) 
 
 
  
1H-NMR (400 MHz, CDCl3) 
13C-NMR (100 MHz, CDCl3): 
 
 
Ethyl (E)-2-Methyl-3-(pyridin-2-yl)acrylate (E-4.3). 
 
C11H13NO2 
M.W. (g/mol): 191.09 
 
IR-TF (NaCl) ν 3054, 2981, 2931, 2872, 1709 (CO), 1583, 1467, 1431, 1260, cm–1. 
TOF MS (EI
+
) m/z (%) 191 ([M
+
], 15), 119 (10), 118 (51), 117 (100), 146 (10), 145 
(22). 
TOF HRMS (EI
+
) m/z calc. for C11H13NO 191.0946; found 191.0955. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.65 (d, J = 4.7, 1H, H6) 
7.67 (dt, J = 1.8, 7.7, 1H, H4) 
7.61 (s,1H, H1') 
7.34 (d, J = 7.9, 1H, H3) 
7.16 (ddd, J = 1.1, 4.8, 7.6, 1H, H5) 
4.25 (q, J = 7.1, 2H, CO2-CH2-CH3) 
2.30 (s, 3H, CH3-C2') 
1.32 (t, J = 7.1, 3H, CO2-CH2-CH3) 
 
 
 
168.6 (C) 
155.2 (C)  
149.5 (CH) 
136.6 (CH) 
136.1 (CH) 
132.4 (C) 
125.7 (CH) 
122.4 (CH) 
61.0 (CH2, CO2-CH2-CH3) 
14.2 (CH3, CH3-C2') 
14.1 (CH3, CO2-CH2-CH3) 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3):
 
13C-NMR (100 MHz, CDCl3): 
 
 
(E)-2-Methyl-3-(pyridin-2-yl)-prop-2-en-1-ol (E-4.4). 
 
C9H11NO2 
M.W. (g/mol): 149.09 
 
IR-TF (NaCl) ν 3500-3000 (broad, OH), 2009, 2854, 1660, 1470, 1432, 1219 cm–1 
TOF MS (EI
+
) m/z (%) 148 ([M
+
], 44), 148 (25), 130 (100), 117 (58). 
TOF HRMS (EI
+
) m/z calc. for C9H11NO 149.0841; found 149.0845. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.47 (d, J = 4.9, 1H, H6 ) 
7.55 (dt, J =1.8, 7.7, 1H, H4) 
7.16 (d, J = 7.9, 1H, H3) 
7.01 (m, 1H, H5) 
6.60 (s, 1H, H1') 
4.12 (s, 2H, H3') 
1.91 (s, 3H, CH3-C1') 
 
 
156.7 (C, C2) 
148.6 (CH, C6) 
143.2 (C, C2') 
136.1 (CH, C) 
123.9 (CH, C) 
122.7 (CH, C) 
120.8 (CH, C) 
67.4 ( CH2, C3') 
15.3 (CH3-C2') 
 
 
 
  
1H-NMR (400 MHz, CDCl3):
 
13C-NMR (100 MHz, CDCl3): 
 
 
2-[(1E)-2-Formyl-2-methylprop-1-en-1-yl]pyridine (E-4.5). 
 
C9H9NO 
M.W. (g/mol): 147.07 
 
IR-TF (NaCl) ν 3051, 3006, 2924, 2852, 2173, 1680 (C=O) cm–1. 
TOF MS (EI
+
) m/z (%) 149 (12), 147 ([M
+
], 50), 118 (96), 83 (100). 
TOF HRMS (EI
+
) m/z calc. for C9H9NO 147.0684; found 147.0691. 
 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
9.63 (s, 1H, H3´) 
8.72 (d, J = 4.0, 1H, H6) 
7.75 (dt, J = 1.8, 7.7, 1H, H4) 
7.49 (d, J = 7.8, 1H, H3) 
7.23 (m, 2H, H5 and H1') 
2.15 (s, 3H, CH3-C2') 
 
 
 
195.8 (CH, C3') 
154.4 (C) 
150.0 (CH) 
147.5 (CH) 
141.5 (C) 
136.4 (CH) 
125.9 (CH) 
123.3 (CH) 
11.0 (CH3-C2') 
 
 
 
 
 
 
 
 
 
1H-NMR (400 MHz, CDCl3): 
13C-NMR (100 MHz, CDCl3): 
 
 
 (E)-2-(4',4'-Dibromo-2-methylbuta-1',3'-dienyl)pyridine (E-4.6). 
 
C9H9Br2N 
M.W. (g/mol): 300.91 
 
IR-TF (NaCl) ν 3052, 3002, 2923, 2853, 1582, 1561, 1469, 1432, 1293, 1149, 1026, 
899, 792, 764, 740, 625, 580, 527 cm
–1
. 
TOF MS (EI
+
) m/z (%) 305 (5), 303 ([M
+
], 12), 302 (7), 224 (90), 222 (100), 143 (60), 
142 (45) 
TOF HRMS (EI
+
) m/z calc. for C10H9Br2N 300.9102; found 300.9106. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.6 (d, J = 4.3, 1H, H6) 
7.65 (td, J = 1.9, 7.7, 1H, H4) 
7.26 (d, J = 8.2, 1H, H3) 
7.1 (m, 2H, H5 and H2') 
6.66 (s, 1H, H1') 
2.34 (s, 3H, CH3-C2') 
 
 
 
155.9 (C) 
149.4 (CH) 
140.9 (CH) 
137.5 (C) 
136.0 (CH) 
132.1 (CH) 
124.8 (CH) 
121.5 (CH) 
88.9 (C) 
17.4 (CH3-C2') 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3):  
13C-NMR (100 MHz, CDCl3): 
 
 
 
(E)-2-(2'-Methyl-but-1'-en-3'-ynyl)pyridine (E-4.1b). 
 
C10H9N 
M.W (g/mol): 143.07 
 
IR-TF (NaCl) ν 3298, 2924, 2854, 1726, 1582, 1467, 1431 cm–1. 
TOF MS (EI
+
) m/z (%) 144 (100), 143 ([M
+
], 27) 
TOF HRMS (EI
+
) m/z calc. for C10H9N 143.0735; found 143.0735. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.60 (d, J =4.5, 1H, H6) 
7.62 (td, J = 1.8, 7.7, 1H, H4) 
7.19 (d, J = 7.8, 1H, H3) 
7.1 (m, 1H, H5) 
6.85 (s, 1H, H1') 
3.02 (s, 1H, H4') 
2.30 (s, 3H, CH3-C2') 
 
 
155.5 (C) 
149.3 (CH) 
136.1 (CH) 
135.7 (CH) 
124.7 (CH) 
123.4 (C) 
121.7 (CH) 
87.3 (C) 
19.3 (CH3-C2') 
 
 
 
 
  
1H-NMR (400 MHz, CDCl3): 
13C-NMR (100 MHz, CDCl3): 
 
 
2-(2',2'-Dibromovinyl)pyridine (4.7). 
 
C7H5Br2N 
M.W. (g/mol): 260.88 
 
IR-TF (NaCl) ν 3052, 3005, 2923, 2853, 1585, 1462, 1432, 873, 771, 682 cm–1. 
TOF MS (EI
+
) m/z (%) 265 (11), 263 ([M
+
], 19), 261 (9), 185 (14), 182 (100), 104 
(18), 103 (32) 
 
1
H NMR (400 MHz, (CD3)2CO):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.62 (d, J = 4.2, 1H, H6)  
7.86 (td, J = 1.6, 7.8, 1H, H4) 
7.76 (d, J = 8.2, 2H, H3 y H1') 
7.36 (m, 1H, H5) 
 
 
153.8 (C) 
149.5 (CH) 
137.1 (CH) 
136.2 (CH) 
123.5 (CH) 
122.9 (CH) 
93.1 (C) 
 
 
 
 
  
1H-NMR (400 MHz, (CD3)2CO) 
13
C-NMR (100 MHz, CDCl3): 
 
  
(E)-2-(2'-Bromovinyl)pyridine (E-4.8).
7
 
 
C7H6BrN 
M.W. (g/mol): 182.97 
 
TOF MS (EI
+
) m/z (%) 184 (92), 183 ([M
+
], 8), 182 (100), 104 (5), 103 (27), 102 (6). 
 
1
H NMR (400 MHz, (CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.53 (d, J = 4.2, 1H, H6) 
7.76 (td, J = 1.8, 7.7, 1H, H4) 
7.49 (d, J = 13.6, 1H,H1')  
7.39 (d, J = 7.8, 1H, H3) 
7.28 (m, 1H, H5) 
7.24 (d, J = 13.7, 1H, H2') 
 
 
153.9 (C, C2) 
149.6 (CH, C6) 
136.6 (CH, C1') 
136.4 (CH, C4) 
122.7 (CH, C5) 
121.6 (CH, C3) 
112.6 (CH,C2') 
 
 
 
 
  
                                                 
7
 Horibe, H.; Kazuhiro, K.; Okuno, H.; Aoyama, T. Synthesis 2004, 7, 986. 
1H-NMR (400 MHz, CDCl3): 
 
13C-NMR (100 MHz, CDCl3): 
 
 
 
(E)-2-(4'-Trimethylsilyl-but-1'-en-3'-ynyl)pyridine (E-41c-TMS).
8
 
 
C12H15NSi 
M.W. (g/mol): 201.1 
 
IR-TF (NaCl) ν 3048, 3005, 2959, 2898, 2155, 2114, 1582, 1468, 1431, 1251, 1069, 
956 cm
–1
. 
TOF MS (EI
+
) m/z (%) 203 (4), 202 (12), 201([M
+
], 52), 186 (100). 
 
1
H NMR (400 MHz, (CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.53 (d, J = 4.7, 1H, H6)                                                  
7.61 (td, J = 1.8, 7.7, 1H, H4) 
7.19 (d, J = 7.8, 1H, H3) 
7.15 (ddd, J = 1.0, 4.8, 7.5, 1H, H5) 
6.99 (d, J = 15.9, 1H, H1') 
6.72 (d, J = 15.9, 1H, H2') 
0.23 (s, 9H, Si(CH3)3) 
 
 
154.0 (C, C2) 
149.9 (CH, C6) 
141.2 (CH, C1') 
136.7 (CH, C4) 
123.2 (CH, C3) 
122.5 (CH, C5) 
112.5 (CH, C2') 
104.1 (C, C3') 
99.2 (C, C4') 
0.02 (CH3, Si(CH3)3) 
 
 
 
  
                                                 
8
 Eberbach, W.; Maier, W. Tetrahedron Lett. 1989, 30, 5591. 
1H-NMR (400 MHz, CDCl3): 
13C-NMR (100 MHz, CDCl3):  
 
 
(E)-2-(But-1'-en-3'-ynyl)pyridine (E-41c).
9
 
 
C9H7N 
M. W (g/mol): 129.06 
 
IR-TF (NaCl) ν 3293, 3051, 3006, 2094, 1582, 1468, 1431 cm–1. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.56 (d, J = 4.7, 1H , H6) 
7.64 (dt, J = 1.8, 7.7, 1H, H4) 
7.23 (d, J = 7.8, 1H, H3) 
7.18 (ddd, J = 1.1, 4.8, 7.6, 1H, H5) 
7.05 (d, J = 16.0, 1H, H1') 
6.71 (dd, J = 2.4, 16.0, 1H, H2') 
3.15 (d, J = 2.4, 1H, H4') 
 
 
153.6 (C, C2') 
149.8 (CH, C6') 
141.9 (CH, C1') 
136.7 (CH, C4) 
123.3 (CH, C3) 
122.4 (CH, C5) 
111.4 (CH, C2') 
82.5 (C, C3') 
81.1(CH, C4'). 
 
 
  
                                                 
9
 Campbell, M. M.; Cosford, N. D. P.; Rae, D. R.; Sainsbury, M. J. Chem. Soc. Perkin Trans. 1, 1991, 
765. 
1H-NMR (400 MHz, CDCl3):
 
13C-NMR (100 MHz, CDCl3): 
 
(Z)-2-(2'-Bromovinyl)pyridine (Z-4.8).
10
 
 
C7H6BrN 
M. W (g/mol): 182.97 
 
IR-TF (NaCl) ν 2954, 2923, 2860, 1613, 1584, 1461, 1323, 1219, 772, 696, 575 cm–1. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.64 (d, J = 3.9, 1H, H6) 
8.04 (d, J = 7.9, 1H, H3) 
7.73 (t, J = 7.7, 1H, H4) 
7.27 (m, 2H, H5  and H2') 
6.68 (d, J = 7.2, 1H, H1') 
 
 
 
153.9 (C) 
149.5 (CH) 
136.0 (CH) 
133.2 (CH) 
123.7 (CH) 
122.8 (CH) 
109.2 (CH) 
 
 
 
 
                                                 
10
 Uenishi, J.; Kawahama, R.; Yonemitsu, O. J. Org. Chem. 1998, 63, 8965. 
1H-NMR (400 MHz, CDCl3): 
 
13C-NMR (100 MHz, CDCl3): 
 
(Z)-2-(4'-Trimethylsilyl-but-1'-en-3'-ynyl)pyridine (Z-41c-TMS).
11
 
 
C12H15NSi 
M.W. (g/mol): 201.1 
 
IR-TF (NaCl) ν 2958, 2924, 2854, 2141, 1464, 1434, 1251, 1220, 1020 cm–1. 
TOF MS (EI
+
) m/z (%) 201 ([M
+
], 15), 200 (46), 69 (100). 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
8.58 (d, J = 4.7, 1H, H6) 
8.45 (d, J = 8.1, 1H, H3) 
7.66 (dt, J = 1.8, 7.9, 1H, H4) 
7.16 (ddd, J = 1.9, 4.9, 7.3, 1H, H5) 
6.86 (d, J = 12.3, 1H, H1') 
5.93 (d, J = 12.3, 1H, H2') 
0.24 (s, 9H, Si(CH3)3) 
 
 
 
154.9 (C) 
149.3 (CH) 
140.6 (CH) 
135.8 (CH) 
122.9 (CH) 
122.8 (CH) 
110.8 (CH) 
103.9 (C) 
102.9 (C) 
-0.30 (CH3, Si(CH3)3) 
 
 
 
 
 
 
 
  
                                                 
11
 Kaloko, J. Jr.; Hayford, A. Org. Lett. 2005, 7, 4305. 
1H-NMR (400 MHz, CDCl3): 
13C-NMR (100 MHz, CDCl3): 
 
 
3-(tert-Butoxymethyl)-2-methylindolizine (In-4.1b). 
 
C14H19NO 
M.W (g/mol.)= 217.15 
 
HRMS-ESI: calc. for C14H20NO
+ 
[M+H]
+
 218.1539; found. 218.1535. 
 
1
H NMR (400 MHz, C6D6):  (ppm) 
13
C NMR (100 MHz, C6D6):  (ppm) 
 
8,01 (d, J = 6.8, 1H) 
7.21 (d, J = 2.0, 1H) 
6.47 (t, J= 6.7, 1H) 
6.34 (t, J = 6.7, 1H) 
6.25 (s, 1H) 
4.49 (s, 2H) 
2.31 (s, 3H,C2-CH3) 
1.13 (s, 9H, t-Bu) 
 
133.0 (C, C9) 
123.4 (C, C2) 
123.2 (CH, C5) 
119.1 (C, C3) 
118.5 (CH, C8) 
116.7 (CH,C6) 
109.5 (CH, C7) 
100.3 (CH, C1) 
72.7 (C, C-t-Bu) 
53.9 (CH2, C1') 
27.6 (CH3, CH3-t-Bu) 
11.8 (CH3, -Me) 
 
 
 
 
  
1H-NMR (400 MHz, C6D6):
 
13C-NMR (100 MHz, C6D6) 
 
3, 3'-Biindolizine (4.9). 
 
C16H12N2 
M.W (g/mol.): 232.10 
 
MS (EI
+
) m/z (%) 233 (15), 232 ([M
+
], 100), 231 (49), 230 (20), 229 (10), 155 (6), 154 
(47), 153(7), 152 (5) 
HRMS (EI
+
) m/z calc. for C16H12N2 232.1000; found 232.1003. 
 
 
1
H NMR (400 MHz, C6D6):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.31 (d, J = 7.0, 1H, H5) 
7.23 (d, J = 9.0, 1H, H8) 
6,91 (d, J =3.8, 1H, H2) 
6.58 (d, J =3.7, 1H, H1) 
6.41 (t, J= 7.68, 1H, H7) 
6.0 (t, J= 7.68, 1H, H6) 
 
 
 
133.8 (C, C9) 
123.3 (CH, C5) 
119.6 (CH, C8) 
117.5 (CH, C7) 
115.9 (CH, C2) 
115.3 (C, C3) 
110.8 (CH, C6) 
99.5 (CH, C1) 
 
 
 
 
  
1H-NMR (400 MHz, C6D6): 
13C-NMR (100 MHz, CDCl3): 
 
  
(1'RS, 2'SR)-ethyl 2-(indolizin-3-yl)cyclopropanecarboxylate (4.11-cis). 
 
C14H15NO2 
M.W (g/mol): 229.11 
 
MS (EI
+
) m/z (%) 230 (6), 229 ([M
+
], 35), 228 (4), 157 (16), 156 (100), 154 (81). 
HRMS (EI
+
) m/z calc. for C14H15NO2 229.1103; found 229.1104. 
 
1
H NMR (400 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, C6D6):  (ppm) 
 
7.95 (dd, J = 0.9, 7.1, 1H, H5) 
7.31 (dt, J = 1.2, 8.9, 1H, H8) 
6.65 (dd, J = 0.4, 3.9, 1H, H2) 
6.61 (ddd, J = 0.9, 6.4, 8.9, 1H, H7) 
6.49 (td, J = 1.3, 6.9, 1H, H6) 
6.35 (d, J = 3.9, 1H, H1) 
3.76 (m, 2H, -CO2CH2CH3) 
2.46 (q, J = 7.9, 16.1, 1H, H1') 
2.18 (dt, J=5.8, 8.0, 1H, H2') 
1.77 (ddd, J = 4.8, 5.7, 7.0, 1H, H3'b) 
1.48 (dt, J=4.8, 8.0, 1H, H3'a) 
0.79 (t, J = 7.1, 3H, -CO2CH2CH3) 
 
 
 
169.8 (C, -CO2Et) 
133.4 (C, C9) 
122.4 (CH, C5) 
120.4 (C, C3) 
119.6 (CH, C8) 
116.0 (CH, C7) 
114.9 (CH, C1) 
110.0 (CH, C6) 
98.8 (CH, C2) 
60.0 (CH2, -OCH2CH3) 
20.9 (CH, C2') 
16.3 (CH, C1') 
13.7 (CH3, -OCH2CH3) 
11.1 (CH2, C3') 
 
 
  
1H-NMR (400 MHz,CDCl3) 
13C-NMR (100 MHz, C6D6) 
 
(1'RS, 2'RS)-Ethyl 2-(indolizin-3-yl)cyclopropanecarboxylate        
(4.11-trans). 
 
C14H15NO2 
M.W (g/mol): 229.11 
 
HRMS (EI
+
) m/z calc. for C14H15NO2 229.1103; found 229.1111. 
 
1
H NMR (600 MHz, CDCl3):  (ppm) 
13
C NMR (100 MHz, CDCl3):  (ppm) 
 
7.91 (d, J= 7.1, 1H, H5) 
7.34 (dt, J=1.1, 9.0, 1H, H8) 
6.66 (ddd, J= 1.0, 6.5, 8.9, 1H, H7) 
6.54 (td, J= 1.1, 6.9, 1H, H6) 
6.51 (s, 1H, H2), 6.33 (s, 1H, H1) 
4.25 (q, J= 7.1, 2H, -CO2CH2CH3) 
2.52 (ddd, J= 4.2, 6.4, 9.2, 1H, H1') 
1.81 (ddd, J= 4.2, 5.0, 8.4, 1H, H2') 
1.63 (ddd, J= 4.2, 5.0, 9.2, 1H, H3'b) 
1.35 (ddd, J= 4.3, 6.4, 8.4, 1H, H3'a ) 
1.30 (t, J= 7.1, 3H, -CO2CH2CH3). 
 
 
 
173.6 (C, -CO2Et) 
133.3 (C, C4) 
122.7 (C, C3) 
122.3 (CH, C5) 
119.5 (CH, C8) 
116.7 (CH, C7) 
111.8 (CH, C2) 
110.6 (CH, C6) 
98.0 (CH, C1) 
61.1 (CH2, -O-CH2-CH3) 
21.7 (CH, C2') 
17.5 (CH, C1') 
14.9 (CH2, C3') 
14.5 (CH3, -O-CH2-CH3). 
 
 
  
1H-NMR (600 MHz, CDCl3): 
1H-NMR (400 MHz, CDCl3 with CaCO3): 
 
 
  
13C-NMR (100 MHz, CDCl3): 
 
  
3-(3
'
,3
'
,4
'
-Trimethyl-2
'
-oxapent-4
'
-en-1
'
-yl)indolizina (4.12). 
 
C15H19NO 
M.W (g/mol): 229,15 
 
MS (EI
+
) m/z (%) 230 (3), 229 ([M
+
], 23), 146 (11), 145 (57), 131 (18), 130 (100), 117 
(23), 116 (4). 
HRMS (EI
+
) m/z calc. for C15H19NO 229.1467; found 229.1476. 
 
1
H NMR (400 MHz, C6D6):  (ppm) 
13
C NMR (100 MHz, C6D6):  (ppm) 
 
7.98 (d, J = 7.0, 1H, H5) 
7.20 (d, J = 9.0, 1H, H8) 
6.72 (d, J = 3.8, 1H, H1) 
6.46 (d, J = 3.8, 1H, H2) 
6.44-6.37 (m, J = 6.5, 8.1, 1H, H7) 
6.21 (t, J = 6.7, 1H, H6) 
5.00–4.84 (m, 2H) 
4.38 (s, 2H) 
1.69 (d, J = 9.0, 3H) 
1.23 (s, 6H) 
 
 
 
148.9 (C, C4') 
134.0 (C, C9) 
123.5 (CH, C5) 
122.1 (C, C3) 
119.5 (CH, C8) 
116.7 (CH, C7) 
114.4 (CH, C2) 
112.3 (CH2, C4'-CH2) 
110.1 (CH,C6) 
98.8 (CH, C1) 
77.4 (C, C3') 
57.1 (CH2, C1') 
25.8 (CH3, C3'-(Me)2) 
18.7 (CH3, C4'-Me) 
 
 
 
  
1H-NMR (400 MHz, C6D6): 
13C -NMR (100 MHz, C6D6) 
 
